Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10, depalmitoylase"	Q9NUJ1	3	111979010-111993368	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		71000	"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	11.0	21.9	23.0	10.6	25.3	10.9	15.0	24.5	29.3	11.3	22.9	14.1	11.7	11.1	50.8	8.2	14.9	10.1	25.0	23.9	24.6	49.4	34.4	10.1	17.9	23.5	23.2	19.8	13.7	16.7	27.9	10.8	23.7	20.4	14.7	27.0	25.5	13.7	14.1	10.0	10.3	10.0	24.4	14.6	14.9	16.4	26.3	21.8	31.1	19.6	16.2	9.5	8.3	25.3	40.2	34.1	36.4	12.0	20.5	27.5	19.8	41.4	21.5	33.0	31.7	35.3	22.4	36.0	22.6	17.2	22.7	21.6	16.3	23.0	44.9	12.1	20.6	29.7	15.4	30.7	16.3	60.3	30.4	16.9	16.7	17.0	42.4	22.7	35.9	42.1	13.9	14.9	36.7	13.7	56.9	27.9	23.7	43.8	53.2	50.9	23.4	16.7	34.6	17.1	24.6	17.9	33.2	23.7	39.8	14.3	26.8	21.8	20.6	19.7	25.3	14.4	21.7	23.6	9.0	61.4	20.1	32.4	21.5	29.4	16.5	25.2	9.8	21.6	16.8	26.2	12.2	11.3	28.1	21.6	15.4	13.9	2.5	11.4	17.3	17.8	13.2	16.1	23.0	25.3	24.5	29.3	23.9	24.6	23.5	23.2	23.7	24.4	26.3	25.3	9.1	0.0	7.2	11.1	19.7	7.0	10.2	12.1	14.2	21.8	12.7	10.9	26.1	7.2	12.4	11.0	8.4	19.2	16.1	7.0	35.2	5.2	1.0	11.1	10.3	8.8	12.1	24.2	16.0	7.8	14.9	12.3	12.8	6.8	9.5	9.5	10.0	26.2	14.1	42.1	16.2	13.4	6.1	19.5	7.0	3.0	10.5	11.0	10.6	15.0	10.7	20.4	12.3	14.6	15.6	5.4	4.0	7.5	25.0	5.1	7.0	42.5	19.5	16.2	0.0	7.9	8.9	29.7	37.0	13.6	8.2	5.5	14.6	19.2	12.1	4.5
ABHD11	"PP1226, WBSCR21"	ENSG00000106077	"Abhydrolase domain containing 11"	Q8NFV4	7	73736094-73738867	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Hydrolase	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.9;Urothelial cells: 241.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 92.6;SK-BR-3: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024042, HPA049641"	Approved		Supported	Mitochondria		NA	NA		31000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA024042: AB_1844445, HPA049641: AB_2680838"	"unprognostic (4.74e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.66e-7)"	"unprognostic (3.61e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.29e-2)"	7.5	13.5	9.3	5.6	9.8	4.5	12.2	10.6	11.3	9.3	16.4	31.3	15.9	7.2	5.8	13.6	13.8	8.6	21.6	9.1	9.9	29.4	9.5	9.5	4.0	11.4	11.1	3.9	25.7	12.9	16.4	7.6	11.0	23.2	17.4	3.0	21.3	8.2	11.3	13.3	19.8	3.5	10.4	8.1	9.0	7.2	12.3	3.3	28.1	10.3	5.4	8.5	6.9	10.4	46.9	10.7	7.1	16.4	3.7	5.0	39.7	21.1	8.9	12.7	14.9	13.1	51.4	22.2	6.2	9.0	17.3	20.2	3.2	12.1	8.8	8.2	15.4	10.8	6.7	8.3	6.5	11.8	11.4	4.6	5.0	16.4	7.6	4.6	9.2	7.4	15.1	11.8	12.0	92.6	9.2	14.9	8.3	29.5	39.1	5.0	11.4	41.0	29.7	21.8	18.3	7.6	17.1	113.0	7.1	5.1	36.8	7.8	9.1	10.8	10.2	46.5	22.2	7.3	4.2	14.8	17.3	11.2	20.3	10.2	19.1	19.3	8.2	32.7	6.8	10.1	9.1	8.7	19.4	12.7	8.4	5.9	15.2	14.9	33.5	9.2	6.3	11.9	9.3	9.8	10.6	11.3	9.1	9.9	11.4	11.1	11.0	10.4	12.3	10.4	7.9	44.8	15.7	3.3	10.6	5.5	60.3	39.8	10.2	16.6	43.1	21.7	16.9	54.3	60.7	57.0	4.2	86.3	8.7	156.9	72.4	52.1	1.2	98.9	17.3	9.7	62.6	9.4	5.8	40.8	120.1	9.9	35.7	98.1	15.2	6.3	4.6	8.7	28.0	5.0	4.0	106.8	95.6	11.3	10.5	2.3	9.0	13.7	14.2	4.7	10.4	26.6	14.4	3.0	3.7	38.2	151.7	3.4	10.5	53.1	128.2	55.3	127.6	15.2	0.0	10.3	14.4	6.8	7.1	23.3	6.3	127.7	9.6	22.1	128.9	241.3
AC093525.2		ENSG00000260272	"Novel protein"		16	2496032-2520218	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.1;Club cells: 17.3;granulocytes: 17.7;Macrophages: 7.7;Respiratory ciliated cells: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;RPMI-8226: 1.1;SCLC-21H: 1.0;SH-SY5Y: 1.3"									HPA044712	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"			"HPA044712: AB_10795619"	"unprognostic (4.12e-1)"	"unprognostic (9.64e-2)"			"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.13e-2)"		"unprognostic (9.83e-2)"	"unprognostic (5.98e-3)"	0.4	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.0	0.3	0.0	0.0	3.0	0.2	0.7	0.0	0.1	0.0	0.1	0.4	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.7	0.1	0.3	0.0	0.0	0.3	0.1	0.0	1.1	0.1	0.0	1.0	1.3	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.4	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 216.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 222.5;Exocrine glandular cells: 170.7;NK-cells: 208.1;Syncytiotrophoblasts: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 160.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 160.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 218.4;SK-BR-3: 277.7;SK-MEL-30: 297.8;TIME: 241.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	50.9	13.2	79.6	12.7	67.7	19.6	50.5	46.9	115.2	36.3	0.0	36.7	26.1	19.7	84.2	46.7	52.2	69.6	36.8	68.7	71.5	158.9	4.2	37.3	5.2	64.6	76.2	5.3	59.8	28.4	17.7	101.3	73.9	31.7	33.4	6.6	92.2	57.5	15.7	87.5	19.3	19.8	54.8	12.3	47.9	45.4	92.5	28.9	216.3	16.9	15.6	37.1	37.8	51.6	41.8	47.1	12.0	0.6	0.0	0.1	127.7	8.5	3.9	14.4	2.6	34.7	218.4	0.2	110.5	8.2	196.1	149.1	0.0	103.4	5.1	1.6	0.0	5.1	56.0	39.3	0.3	0.4	2.1	2.4	143.8	24.5	10.2	15.8	118.1	1.0	0.1	1.2	3.2	51.4	107.3	0.8	1.7	143.3	42.6	3.8	1.4	30.8	209.4	134.9	38.2	1.2	2.0	277.7	297.8	8.4	123.8	0.8	241.4	25.6	38.0	1.5	96.2	0.2	2.1	0.6	200.5	0.7	62.9	2.9	0.8	0.2	160.3	0.5	1.9	0.3	10.5	62.6	0.2	0.1	5.3	45.2	3.3	30.6	0.7	0.3	0.2	37.1	79.6	67.7	46.9	115.2	68.7	71.5	64.6	76.2	73.9	54.8	92.5	51.6	107.7	9.6	11.9	113.9	3.7	0.0	24.1	0.0	11.4	0.9	29.6	27.2	4.3	15.7	21.7	79.1	0.0	222.5	120.4	17.7	27.4	33.9	74.0	24.6	4.3	53.9	20.6	17.7	3.5	170.7	25.1	4.7	29.0	45.2	5.1	88.2	30.0	0.5	22.8	0.0	4.9	23.2	0.0	3.5	0.0	31.3	3.1	6.1	0.0	41.2	1.1	4.8	208.1	85.5	1.3	101.1	12.3	0.0	19.1	15.2	5.6	132.6	16.8	0.5	0.0	1.6	7.1	2.7	0.9	23.0	0.0	186.5	35.1	0.4	24.6	19.5
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.37e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.83e-4)"	15.9	20.2	24.6	21.1	24.9	21.3	32.4	31.2	38.4	22.5	28.3	30.5	23.1	18.8	43.7	29.6	22.9	21.9	12.0	25.3	25.6	56.1	33.6	21.9	37.2	24.6	24.6	19.3	31.6	38.0	25.1	15.0	24.5	34.5	33.7	36.8	28.9	18.6	15.4	33.2	24.5	17.3	24.8	26.4	33.7	24.6	25.4	29.3	25.3	12.9	41.4	25.5	22.4	26.2	29.8	19.3	14.1	17.1	17.8	15.1	23.4	16.7	24.9	26.9	20.1	22.4	21.9	43.9	16.0	20.7	31.1	23.5	24.6	23.3	34.8	42.8	13.5	21.0	12.0	26.5	18.8	40.5	34.5	7.5	48.6	17.4	39.6	19.8	21.4	21.8	16.0	38.7	16.8	16.9	21.9	49.1	13.0	55.9	14.3	17.7	22.6	28.8	48.9	31.5	25.9	13.1	17.7	39.9	35.7	18.0	24.0	30.6	18.5	20.0	23.0	17.0	18.8	43.3	27.8	66.7	15.1	45.3	22.6	40.5	9.3	16.6	7.4	9.3	8.7	21.8	9.3	9.1	12.2	20.3	8.8	6.9	16.3	7.1	14.7	15.8	12.8	5.9	24.6	24.9	31.2	38.4	25.3	25.6	24.6	24.6	24.5	24.8	25.4	26.2	24.6	25.6	39.7	43.1	75.4	122.6	29.6	21.5	55.8	24.2	43.8	23.0	16.0	40.0	33.6	20.2	20.9	13.8	40.5	60.7	37.2	25.5	34.8	44.6	17.8	27.1	46.6	52.0	72.1	25.7	12.4	23.6	35.2	55.9	46.9	17.8	17.5	36.8	20.8	37.0	62.9	40.3	20.3	45.2	77.9	55.1	15.8	52.1	23.2	65.6	60.8	35.0	26.8	52.3	67.0	27.3	43.0	20.7	60.5	42.6	29.0	70.5	40.2	32.9	26.3	25.3	21.2	43.1	21.9	59.0	123.5	27.2	36.5	10.2	40.3	46.1
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.4;kidney: 313.2;lymphoid tissue: 206.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 122.9;Collecting duct cells: 356.8;Distal tubular cells: 289.5;Extravillous trophoblasts: 383.2;Proximal tubular cells: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 140.3;MCF7: 96.7;NTERA-2: 106.7;RPTEC TERT1: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	44.7	4.8	165.6	4.7	199.6	2.3	39.9	179.6	284.4	20.2	101.5	7.2	1.3	13.5	9.3	105.8	10.8	8.3	41.8	145.4	160.9	313.2	1.6	12.2	1.9	209.2	204.2	5.1	6.5	80.6	18.2	23.8	196.2	6.6	5.7	6.9	32.1	36.6	14.6	15.9	7.9	10.0	172.9	206.8	9.0	6.5	188.0	3.9	91.9	21.9	5.8	9.2	35.3	225.1	0.5	2.2	140.3	24.1	0.0	0.0	59.5	0.0	0.3	0.1	0.3	26.8	11.3	0.0	63.5	0.0	3.0	13.5	21.2	1.5	0.8	0.3	30.0	15.7	7.4	51.4	0.3	0.1	7.6	1.2	6.6	0.5	0.7	0.4	6.7	39.3	10.6	0.1	0.0	96.7	9.3	1.9	106.7	9.0	10.1	0.2	1.9	39.6	299.9	8.5	54.3	8.7	7.4	60.0	20.4	82.7	57.6	0.9	0.9	3.8	10.2	0.5	30.8	0.4	0.5	0.4	6.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	165.6	199.6	179.6	284.4	145.4	160.9	209.2	204.2	196.2	172.9	188.0	225.1	122.9	0.0	0.0	5.9	2.8	4.1	2.1	1.5	1.2	0.1	45.0	29.5	6.6	0.0	3.5	356.8	0.0	4.5	1.3	0.8	289.5	1.5	1.0	4.1	3.5	35.0	3.6	0.0	0.3	0.8	383.2	15.5	0.5	15.0	0.0	10.1	33.5	0.0	7.0	0.0	0.3	2.1	2.0	0.3	2.0	3.5	37.6	2.3	67.6	21.5	0.0	15.1	0.0	8.0	36.3	2.9	0.3	59.0	0.0	7.7	0.0	201.5	0.6	0.2	0.0	3.3	10.3	0.2	5.3	4.4	2.4	21.1	1.7	29.9	1.3	2.0
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 463.7;Proximal tubular cells: 373.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	56.7	73.3	54.1	29.0	56.1	30.0	65.9	58.0	68.6	49.1	74.4	44.6	35.2	46.8	114.4	35.1	48.2	48.0	98.5	56.8	63.4	121.2	86.8	45.4	38.8	60.3	58.6	52.2	50.1	77.2	63.7	51.1	62.3	60.0	45.8	62.6	53.7	54.4	87.1	38.1	33.8	48.1	58.0	40.1	54.3	29.3	57.2	35.7	95.6	67.9	36.6	51.3	33.3	58.3	91.9	56.2	87.4	74.9	144.7	191.6	67.5	116.0	106.4	83.4	77.9	70.6	52.9	61.9	244.8	172.2	100.1	53.0	82.6	83.6	119.9	31.7	37.7	63.3	43.2	119.3	104.6	104.2	43.5	127.7	90.3	83.5	155.1	93.4	130.9	59.3	85.9	51.2	266.9	117.3	53.5	103.1	59.8	157.7	54.5	42.6	68.5	113.7	165.3	56.0	35.4	58.0	103.2	37.8	107.4	92.8	94.2	101.6	91.9	115.2	47.0	164.1	52.2	56.2	65.6	127.3	71.4	57.4	100.9	112.9	96.6	86.5	52.7	108.2	69.7	86.1	78.7	69.9	91.8	68.9	94.2	80.7	236.4	67.6	111.4	70.1	72.9	84.8	54.1	56.1	58.0	68.6	56.8	63.4	60.3	58.6	62.3	58.0	57.2	58.3	46.6	35.3	47.0	3.6	41.7	42.1	47.6	72.2	47.8	41.0	60.8	49.9	112.8	67.2	41.7	84.6	12.5	95.8	26.8	22.1	463.7	51.5	42.5	38.1	39.5	51.8	40.8	26.3	7.0	53.8	96.6	57.2	38.2	28.9	18.9	34.5	53.6	64.5	78.7	20.2	8.3	40.6	77.3	71.3	48.8	104.6	50.7	43.8	97.8	6.5	33.4	85.0	42.2	4.0	6.3	39.5	42.6	44.0	46.0	74.7	54.6	373.4	49.3	38.3	19.7	26.6	58.5	46.2	64.2	44.3	50.6	70.3	35.4	59.5	35.4	52.9
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 subunit mu 2"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 162.0;Proximal tubular cells: 373.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.3;neutrophil: 7.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	3.4	0.1	0.8	6.4	0.3	0.9	32.9	0.6	0.8	27.1	0.3	67.1	64.0	6.6	61.8	51.9	46.6	22.7	0.4	0.5	0.4	76.3	1.5	19.2	0.4	0.7	0.6	0.3	55.9	62.4	34.8	16.2	0.4	30.8	63.4	0.1	41.5	24.0	0.3	42.1	54.8	3.0	0.3	0.6	59.1	9.6	0.7	4.2	58.8	0.3	9.5	23.4	19.1	0.6	144.2	71.1	0.4	10.4	0.0	0.0	65.0	0.2	0.0	2.3	1.6	172.8	82.1	0.4	64.7	1.2	43.4	97.6	0.1	109.0	3.2	0.6	1.0	6.7	48.5	313.8	1.3	0.3	0.8	0.2	81.6	3.9	0.1	5.0	0.0	0.4	0.3	0.6	1.2	268.3	0.6	1.8	31.4	156.7	0.0	2.4	9.3	0.7	2.7	164.9	67.3	0.2	0.0	120.0	0.6	34.6	123.3	0.4	0.0	0.4	166.7	0.9	2.2	0.4	0.9	1.4	0.2	0.4	0.2	4.3	0.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.6	0.0	1.4	0.2	0.0	2.7	0.8	0.3	0.6	0.8	0.5	0.4	0.7	0.6	0.4	0.3	0.7	0.6	0.4	28.9	34.8	0.0	1.9	6.9	19.2	68.9	13.1	0.0	49.3	30.0	0.5	47.1	64.2	86.5	0.0	123.0	0.5	112.2	137.0	141.3	43.4	52.4	5.4	1.7	74.4	0.0	0.3	115.8	101.0	1.5	73.4	57.7	2.5	0.0	0.7	0.0	9.8	0.0	0.2	95.5	97.6	0.8	0.0	19.9	1.5	2.6	3.6	0.0	1.7	0.0	0.0	0.0	0.2	130.2	125.6	0.7	0.0	37.6	162.0	373.6	61.5	0.0	0.0	0.0	6.2	16.9	4.1	39.1	13.1	66.1	2.8	0.0	131.4	48.3
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877178-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.2;prostate: 4.2"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 28.2;Proximal tubular cells: 28.5;Syncytiotrophoblasts: 40.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 41.7;SuSa: 25.1"														"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	2.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.2	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	3.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.7	4.3	0.3	0.0	0.0	1.8	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	28.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	40.9	0.1	0.1	0.0	0.3
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 870.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 38.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		26000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	249.9	498.0	413.0	157.4	457.6	134.4	447.5	413.1	572.4	264.2	396.8	357.2	226.4	281.1	293.3	178.6	308.1	350.8	389.0	456.2	405.3	532.5	298.2	279.4	78.9	425.0	481.9	306.2	323.5	278.6	155.4	451.9	448.7	260.6	328.5	209.3	270.7	343.6	107.5	218.6	200.3	379.9	419.7	154.4	213.5	165.6	426.4	159.2	469.9	176.0	78.2	304.9	151.7	523.5	388.7	489.9	538.4	448.5	707.7	869.8	559.8	757.1	1029.2	386.6	449.3	286.4	941.0	0.9	848.3	614.8	505.1	255.6	326.4	921.6	324.4	14.7	253.1	0.8	275.6	204.1	688.0	372.0	19.6	790.4	990.7	456.8	823.0	1584.3	1750.7	158.6	0.8	39.0	614.5	433.1	6.5	4.0	416.2	644.9	418.6	241.2	505.2	325.3	1283.3	270.1	267.3	385.6	824.0	549.0	393.4	720.0	482.4	400.1	1837.1	850.8	350.2	310.4	371.6	232.3	3.1	4.8	690.4	1.6	836.3	1.1	7.5	0.0	0.2	2.2	0.3	0.8	2.2	0.7	5.6	2.2	2.3	0.6	1.5	0.5	1.6	38.1	0.6	3.3	413.0	457.6	413.1	572.4	456.2	405.3	425.0	481.9	448.7	419.7	426.4	523.5	330.2	109.0	39.6	70.5	47.6	181.6	215.6	449.0	306.7	45.2	280.3	199.6	143.2	296.0	214.0	502.1	29.2	472.6	180.7	395.2	56.7	398.7	46.1	78.8	162.2	416.0	162.6	29.2	481.6	180.4	141.2	309.5	164.7	110.7	8.2	100.3	539.7	125.7	76.3	84.1	525.5	303.1	256.3	61.6	79.9	61.8	242.6	69.9	161.9	189.3	89.9	329.9	4.1	423.2	870.8	205.4	223.1	296.8	24.0	187.5	95.2	165.8	164.7	24.5	118.3	336.5	198.5	38.3	86.9	85.9	106.1	552.1	27.0	111.4	283.5	133.6
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 386.9;seminal vesicle: 212.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	1.5	0.0	0.0	386.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	212.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 52.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.2;Cardiomyocytes: 8.3;Collecting duct cells: 5.5;Ionocytes: 2.0"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.4"	"Region enriched"	"Detected in some"	7	"cerebellum: 21.0"	"Not detected"	"Not detected"			HPA015278	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	2.8	0.1	4.1	0.0	0.1	5.6	2.6	0.3	1.6	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	2.7	2.5	52.7	0.3	0.1	0.0	4.9	4.6	0.0	0.1	0.2	0.2	0.0	5.2	0.2	0.0	0.2	1.0	0.2	0.0	0.3	0.2	0.1	3.4	0.0	0.4	2.4	6.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	1.4	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.1	5.6	2.6	2.7	2.5	4.9	4.6	5.2	3.4	6.1	3.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.6	0.0	0.1	0.4	0.3	8.3	0.0	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	1.6	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.6	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475150-86002668	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 99.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1364.3;Microglial cells: 905.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7"	"Group enriched"	"Detected in many"	5	"B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	14.6	2.2	6.5	7.5	5.1	18.7	9.2	6.2	5.8	5.5	3.9	7.4	7.3	9.4	4.6	6.1	4.1	10.9	27.3	5.7	6.6	99.8	9.5	15.7	10.5	15.7	11.5	5.5	30.1	8.1	5.4	22.4	17.2	5.4	6.1	8.4	10.6	7.2	10.2	7.0	10.3	14.1	12.1	16.4	26.0	3.4	10.4	7.5	27.8	7.7	15.5	9.1	5.6	19.1	3.0	6.2	4.4	0.1	109.0	65.5	4.8	21.5	28.5	5.2	8.4	0.1	0.0	2.8	7.4	48.8	6.4	0.0	0.2	9.0	11.0	0.0	1.2	3.6	0.6	0.2	63.6	0.4	0.0	48.4	0.9	10.3	4.7	23.9	121.9	0.0	6.6	0.4	46.1	0.0	0.1	0.0	0.3	1.5	11.3	0.6	22.4	11.8	67.2	0.0	2.3	2.3	2.5	3.5	7.8	4.7	0.4	0.2	87.0	59.9	1.2	4.4	0.3	0.3	0.0	3.9	10.1	2.2	19.9	0.0	15.9	0.0	0.0	3.0	0.0	47.3	0.0	0.0	3.8	36.8	0.0	0.0	5.5	0.0	2.3	12.7	0.0	3.1	6.5	5.1	6.2	5.8	5.7	6.6	15.7	11.5	17.2	12.1	10.4	19.1	14.0	57.7	28.8	1364.3	142.1	8.2	3.9	35.6	10.2	6.6	1.2	4.7	26.4	47.1	18.3	46.0	6.2	54.8	9.9	1.0	226.9	9.4	30.5	1.2	12.9	9.5	2.4	0.0	12.2	11.8	26.2	24.7	25.0	1.4	1.3	6.7	4.2	9.5	10.5	111.0	51.3	3.3	6.1	33.7	21.3	8.8	16.8	26.3	19.6	905.0	34.0	27.7	0.0	27.2	21.8	7.4	2.9	12.4	2.0	2.3	0.2	205.9	24.8	6.6	6.6	50.0	21.3	8.1	5.9	4.0	6.3	232.9	4.1	18.4	5.0	1.9
ARHGAP8	"BPGAP1, FLJ20185"	ENSG00000241484	"Rho GTPase activating protein 8"	P85298	22	44752558-44862788	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 20.5;Cytotrophoblasts: 26.9;Ductal cells: 25.6;Pancreatic endocrine cells: 30.5;Urothelial cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.9;BEWO: 47.5;CACO-2: 30.9;HEK 293: 43.6;MCF7: 44.9;SK-BR-3: 40.1"	"Not detected"	"Not detected"							HPA069694	Approved					NA	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA069694: AB_2686173"	"unprognostic (4.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.78e-3)"	"unprognostic (9.58e-2)"	"unprognostic (7.65e-6)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-2)"	1.0	0.4	0.4	1.2	0.2	0.6	9.5	1.1	1.0	3.0	4.2	10.0	1.7	1.6	11.4	7.5	6.8	4.3	0.1	0.4	0.1	28.1	1.1	4.4	0.7	0.2	0.1	0.3	10.3	5.6	6.4	7.4	0.4	13.5	7.1	0.3	23.2	8.3	0.1	2.0	3.6	0.3	0.1	9.0	6.5	3.3	0.4	0.5	17.5	0.0	1.1	2.0	2.9	0.2	26.9	0.4	0.4	0.2	0.0	0.4	47.5	0.2	3.1	0.0	0.2	30.9	13.5	0.2	1.6	0.0	0.4	19.1	8.5	21.9	0.2	0.1	43.6	0.0	0.9	0.4	0.1	0.1	0.4	0.2	9.3	0.2	0.4	0.6	0.1	0.5	0.9	0.7	0.1	44.9	0.1	0.2	6.7	19.3	0.0	0.0	0.1	0.4	11.6	17.9	2.7	0.1	0.0	40.1	0.9	9.9	17.5	0.3	0.4	0.0	1.5	0.1	0.2	3.9	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.2	1.1	1.0	0.4	0.1	0.2	0.1	0.4	0.1	0.4	0.2	0.1	3.2	12.5	0.0	0.5	0.6	20.5	5.9	3.4	0.4	8.9	2.4	0.8	4.3	9.1	18.4	4.2	26.9	0.7	8.6	0.0	25.6	2.3	4.1	1.0	1.1	7.2	0.0	0.0	10.8	2.1	1.3	7.1	12.3	0.0	0.5	0.4	0.0	3.3	0.0	0.0	11.7	12.2	1.0	0.4	3.2	0.3	0.6	0.0	0.0	0.1	0.7	5.2	0.0	0.0	30.5	12.1	0.4	0.6	20.0	1.2	2.0	4.1	0.7	0.0	1.7	0.7	0.1	3.9	6.0	0.3	7.0	1.0	6.9	17.0	20.8
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.1;Granulosa cells: 83.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.98e-4)"	4.8	23.9	4.5	1.1	4.7	0.0	7.5	0.4	5.1	3.9	0.0	3.3	3.2	4.1	2.5	6.4	9.8	5.3	1.9	5.0	4.3	31.5	6.4	7.3	0.4	1.6	2.0	19.0	20.7	1.2	6.0	0.5	3.2	5.0	3.7	6.0	19.2	3.6	0.9	14.8	2.5	3.5	1.4	2.8	21.8	1.5	3.2	4.0	13.6	0.9	2.9	3.7	6.6	2.8	30.1	21.0	0.1	2.6	2.6	3.6	0.0	10.8	21.5	13.5	13.3	6.3	12.8	0.1	22.5	3.7	30.4	10.0	1.4	17.4	20.2	0.2	3.1	0.6	3.3	27.2	20.9	0.0	0.0	3.3	7.0	21.0	97.8	25.2	44.4	0.6	0.0	0.0	92.2	2.8	0.0	0.0	0.2	7.9	8.5	0.0	5.5	3.7	36.4	18.0	2.0	3.9	5.3	0.8	0.6	0.0	4.6	0.1	59.8	6.6	9.2	0.5	10.3	1.1	0.0	0.2	10.1	1.4	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	4.7	0.4	5.1	5.0	4.3	1.6	2.0	3.2	1.4	3.2	2.8	9.1	28.9	16.4	3.9	0.2	25.7	14.1	14.1	40.5	4.9	7.5	11.0	2.0	24.3	15.5	31.3	0.0	0.3	2.1	3.7	15.6	13.0	9.6	32.7	1.7	12.8	11.4	2.7	73.1	11.3	0.3	3.1	35.7	12.6	1.3	83.2	2.2	7.3	0.3	13.5	34.5	10.7	40.7	0.3	0.9	2.6	10.2	3.3	1.8	32.8	0.6	26.8	1.0	34.7	15.2	26.3	4.6	5.7	1.2	16.0	3.9	26.7	50.4	1.6	6.6	0.5	7.0	1.0	1.3	20.4	25.6	0.1	1.2	32.3	6.7	17.3
ARHGEF35	"ARHGEF5L, CTAGE4, FLJ43692"	ENSG00000213214	"Rho guanine nucleotide exchange factor 35"	A5YM69	7	144186083-144195833	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 107.0;Urothelial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.9;HBEC3-KT: 21.8;hTCEpi: 33.7;OE19: 32.2;RPTEC TERT1: 46.4;WM-115: 23.5"									"HPA044188, HPA045619, HPA045699"	Supported					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.97e-2)"	2.5	0.9	0.4	2.1	0.5	1.1	14.5	0.4	0.4	5.5	2.7	11.0	12.2	2.3	3.9	16.5	5.8	5.0	1.8	0.3	0.4	11.1	5.4	3.5	1.3	0.6	0.7	1.6	7.5	7.2	3.4	3.8	0.6	5.6	14.3	1.0	10.4	4.1	0.2	17.9	8.6	1.1	0.6	1.6	10.5	0.6	0.6	1.3	20.5	0.7	3.4	5.7	7.0	0.4	39.9	0.8	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.2	13.0	13.6	0.0	0.0	1.6	3.3	11.0	0.0	21.8	0.4	0.1	0.0	0.0	2.7	0.0	3.6	0.0	0.0	3.4	33.7	0.2	8.1	2.9	0.1	0.0	0.0	0.0	1.4	6.9	0.0	0.0	4.4	32.2	3.7	0.1	0.0	0.0	46.4	9.8	0.0	0.0	8.0	14.8	3.5	2.3	18.1	0.8	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.5	0.4	0.4	0.3	0.4	0.6	0.7	0.6	0.6	0.6	0.4	3.3	9.6	11.5	0.0	2.5	46.5	107.0	27.0	18.2	0.8	29.9	32.5	1.0	35.8	32.6	62.5	16.7	49.0	1.5	46.4	17.6	44.4	4.3	46.1	5.9	2.0	19.2	0.0	0.0	29.7	72.2	3.9	18.8	49.9	0.0	2.9	1.1	19.4	5.3	0.0	0.0	24.8	12.2	1.3	3.2	1.4	4.7	1.4	16.0	0.0	0.0	3.9	0.0	0.0	0.0	43.8	46.1	3.0	3.1	27.4	56.6	28.8	17.1	5.6	0.0	1.0	4.3	0.8	2.1	21.5	47.0	59.9	2.5	1.7	23.6	91.8
ARMC7	FLJ22160	ENSG00000125449	"Armadillo repeat containing 7"	Q9H6L4	17	75109952-75130272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024229, HPA053076"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA024229: AB_2059152, HPA053076: AB_2682036"	"unprognostic (1.35e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (7.73e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-2)"	7.4	6.7	7.3	5.8	7.5	4.1	7.4	12.7	9.0	7.7	7.7	12.4	9.6	7.0	4.8	11.2	6.6	4.7	8.8	7.6	7.7	39.5	13.2	12.3	7.0	7.3	7.1	5.2	7.0	6.6	7.0	5.8	7.6	11.8	6.9	2.7	8.9	6.4	5.5	12.0	11.9	4.0	7.0	14.0	11.4	7.3	7.9	8.2	9.9	3.9	6.4	8.7	9.3	7.9	15.2	30.2	8.9	8.5	7.0	4.3	9.4	8.3	9.0	15.9	14.3	25.3	14.7	9.0	10.8	7.7	8.7	12.4	14.6	6.1	7.6	8.7	23.2	17.5	13.4	15.9	15.5	13.5	16.1	5.6	11.4	10.0	5.8	7.7	14.6	14.5	15.8	17.6	5.3	21.7	25.9	14.8	4.5	32.8	22.6	14.6	18.0	16.8	35.6	27.4	8.3	11.9	15.6	15.7	18.6	15.2	18.4	12.9	11.3	16.1	14.9	6.4	13.1	14.7	5.5	12.7	7.2	9.6	11.8	31.7	13.7	28.5	18.0	9.9	15.8	13.4	12.9	15.1	12.7	10.0	9.8	14.9	18.6	15.7	7.9	11.1	20.8	11.7	7.3	7.5	12.7	9.0	7.6	7.7	7.3	7.1	7.6	7.0	7.9	7.9	6.6	12.8	8.8	1.3	10.4	4.6	2.8	5.8	2.2	6.0	6.0	5.1	2.5	7.2	5.2	22.0	0.0	14.1	10.1	28.6	35.2	8.7	6.2	4.6	3.0	9.0	6.0	1.7	3.0	9.4	8.3	4.1	8.6	5.1	10.8	4.4	14.3	4.6	15.2	0.0	2.9	9.8	6.1	7.5	3.3	12.2	5.3	9.7	12.4	1.9	13.9	3.3	11.3	2.5	1.8	11.3	27.1	3.8	6.4	4.8	15.8	15.4	7.2	3.4	19.7	2.2	4.6	3.8	5.9	4.4	4.5	4.9	8.7	6.6	12.4	3.8
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 25.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	6.9	4.5	3.9	8.1	3.9	8.1	2.6	3.1	4.6	5.3	4.2	5.5	3.1	6.4	3.5	4.8	2.9	7.3	8.3	4.7	3.6	21.3	7.6	7.0	5.4	4.6	5.3	2.2	4.6	6.6	2.5	11.5	4.0	5.0	8.2	6.7	3.1	6.6	3.8	2.1	3.6	14.1	4.3	5.2	3.9	2.6	5.2	2.6	4.2	4.3	4.8	8.0	2.3	5.0	5.0	11.3	18.6	6.3	41.9	16.4	16.7	29.2	23.0	18.9	23.0	9.9	8.4	6.5	31.5	25.5	29.0	3.9	7.0	7.4	18.5	55.6	6.2	9.2	11.2	40.1	9.7	10.5	10.4	19.4	2.4	19.7	6.5	15.6	22.4	3.9	2.0	12.9	19.6	9.2	5.8	19.3	5.6	1.1	6.7	7.7	10.9	5.9	12.0	6.2	6.8	15.9	20.3	6.2	12.1	12.7	6.9	26.2	16.2	17.5	10.4	7.6	26.4	14.8	28.0	7.2	21.6	21.4	40.3	19.0	8.3	25.6	1.0	6.7	0.6	2.0	0.4	0.4	7.8	1.3	0.3	0.5	4.6	0.2	5.6	5.7	0.7	2.7	3.9	3.9	3.1	4.6	4.7	3.6	4.6	5.3	4.0	4.3	5.2	5.0	3.9	0.0	2.0	40.8	5.1	0.8	1.4	1.3	0.6	3.7	1.6	1.0	7.2	1.5	0.7	3.7	6.2	2.2	5.5	1.4	3.9	3.7	0.5	1.9	7.2	4.5	1.2	16.2	37.4	9.2	5.1	6.6	2.6	9.0	0.0	6.3	13.6	3.8	16.7	6.7	42.5	6.0	0.0	25.2	14.3	0.5	4.4	15.9	14.2	40.3	16.1	3.6	2.1	71.4	56.2	4.0	3.0	3.8	8.1	2.2	0.5	18.8	2.5	2.7	6.6	5.0	4.4	2.2	3.1	0.7	1.3	2.6	3.4	1.6	2.2	1.3
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 1337.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 1723.3;Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 919.7;RPTEC TERT1: 513.0;SH-SY5Y: 382.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		2100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	12.4	146.9	197.7	48.0	216.2	4.4	79.4	370.0	451.1	37.5	369.3	246.1	336.6	108.8	64.3	159.8	48.8	178.7	160.5	326.4	332.1	1337.8	180.1	92.6	8.5	558.7	264.3	58.1	178.5	732.7	79.8	44.1	540.2	48.6	201.1	99.3	314.1	72.6	342.9	67.0	284.4	96.6	248.8	52.6	402.1	46.3	375.1	19.2	330.2	337.8	84.0	101.2	52.1	382.2	89.7	215.8	73.3	56.3	15.9	3.3	23.8	45.3	33.1	41.7	43.3	276.8	183.5	0.1	158.3	35.1	50.8	102.4	38.1	83.2	45.1	1.1	16.6	5.7	152.6	138.9	26.6	4.0	7.5	9.1	21.1	31.8	42.5	79.7	40.5	6.6	1.3	1.4	52.6	38.0	7.9	16.0	28.1	919.7	47.4	1.3	89.3	15.6	513.0	118.6	54.3	382.5	263.1	271.3	12.5	85.4	55.7	9.8	92.0	35.2	90.4	60.9	159.3	4.8	6.8	2.0	42.0	13.9	47.9	13.2	1.0	0.2	2.7	3.2	1.5	1.5	3.3	1.3	9.3	0.2	1.0	1.1	0.3	6.2	1.1	0.4	10.1	1.4	197.7	216.2	370.0	451.1	326.4	332.1	558.7	264.3	540.2	248.8	375.1	382.2	14.4	240.4	251.5	79.0	18.4	52.5	156.5	490.4	153.1	86.9	274.2	166.5	147.3	664.8	425.7	1723.3	14.6	4.8	21.0	817.1	923.4	629.9	3.8	199.6	11.6	18.6	160.9	6.9	344.7	591.9	9.0	78.7	353.7	190.6	23.4	89.0	45.7	273.3	385.3	580.5	602.3	296.7	370.2	99.5	676.1	9.0	89.8	101.5	247.3	81.5	27.1	23.4	1.0	94.5	514.7	377.9	666.4	149.0	16.9	84.4	646.8	1070.2	332.5	64.9	6.6	93.6	32.5	10.6	66.9	142.8	31.7	9.9	48.2	111.8	436.0	322.8
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"kidney: 63.6;salivary gland: 78.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.2	0.0	0.3	0.0	0.4	0.0	4.7	0.1	0.5	3.7	3.1	0.0	0.1	0.1	1.2	4.9	0.0	0.0	0.0	0.6	0.2	63.6	0.0	0.4	0.0	0.3	0.2	0.0	0.1	1.6	0.1	2.5	0.2	0.9	0.0	0.0	78.4	1.5	0.0	10.2	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.4	0.0	0.0	3.7	0.1	0.2	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.6	0.6	1.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	5.0	1.9	0.0	0.1	0.0	0.1	0.1	0.6	0.0	4.5	0.2	0.0	0.0	0.1	55.7	1.9	2.9	0.1	0.0	0.2	0.6	1.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.6	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.0	0.0	1.1	0.3	0.0	0.0	1.1	0.9	0.0	0.0	2.5	1.4	0.5	0.0	1.7	16.5	2.1	13.4	0.3	0.0	31.3	0.0	2.2	0.9	0.1	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	57.0	0.0	0.0	2.8	0.3	0.0	7.2	1.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	4.4	0.1	0.0	0.0	0.1	0.6	0.7	0.0	0.1	5.1	0.2	0.0	0.0	1.3
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154225	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 60.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.3;SuSa: 5.8;U-87 MG: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	0.3	0.0	0.6	0.7	1.4	1.9	0.8	0.4	0.7	0.4	0.4	3.1	1.6	0.3	1.4	0.7	0.0	0.5	0.4	0.5	0.7	60.5	0.4	2.6	1.3	0.6	1.1	0.0	0.4	1.3	0.0	0.8	0.6	1.4	3.5	14.0	1.1	2.5	0.0	1.7	1.3	0.4	0.3	1.1	0.3	0.2	1.0	0.5	1.0	0.0	1.1	0.5	0.0	1.4	0.4	0.6	0.3	0.4	0.0	0.3	1.3	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.0	1.4	1.2	0.4	0.9	0.2	0.2	0.0	0.5	0.7	0.1	0.0	0.4	0.6	0.3	0.0	0.2	0.4	1.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	2.0	0.1	0.0	0.4	3.3	5.8	0.9	0.0	0.2	0.3	0.4	0.2	0.3	0.2	0.1	0.3	5.1	0.3	0.4	0.7	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.0	0.5	0.2	0.4	0.2	0.1	0.6	1.4	0.4	0.7	0.5	0.7	0.6	1.1	0.6	0.3	1.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.1	7.3	31.3	0.0	0.0	0.0	209.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	30.5	0.0	1.1	0.0	0.0	6.9	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.0	11.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1FNB		ENSG00000272899	"ATP6V1F neighbor"	A0A1B0GUX0	7	128866330-128872047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7;kidney: 25.1;skeletal muscle: 11.7"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.0;Glandular and luminal cells: 1.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Region enhanced"	"Detected in many"		"cerebellum: 11.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;U-266/70: 3.3;U-266/84: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"				"unprognostic (8.17e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.33e-3)"	2.1	0.4	3.2	0.4	2.6	0.3	0.6	11.7	3.7	1.3	0.0	1.1	1.2	0.5	0.2	1.5	1.1	0.8	6.8	2.8	0.7	25.1	0.1	0.5	0.2	0.8	1.0	0.3	0.3	0.4	1.0	0.3	1.1	0.9	0.1	0.7	0.6	0.1	11.7	0.7	4.1	0.4	0.2	0.7	1.7	3.7	1.2	0.2	0.6	0.2	0.2	0.8	0.8	1.8	0.6	0.3	0.3	3.0	0.9	0.4	0.0	0.2	0.4	0.4	0.2	0.2	3.9	1.0	0.2	0.1	0.7	0.7	0.3	0.1	0.2	3.0	0.5	1.2	0.2	0.0	0.5	0.1	2.9	0.4	0.2	0.2	0.2	0.5	0.1	0.3	0.8	1.6	0.3	0.2	0.3	1.5	0.0	0.1	0.2	0.5	1.0	0.5	0.1	0.2	1.2	0.6	0.2	1.5	0.2	0.8	0.3	0.5	0.1	1.5	0.3	2.6	0.2	3.3	3.8	0.7	1.5	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	2.6	11.7	3.7	2.8	0.7	0.8	1.0	1.1	0.2	1.2	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	2.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.9	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"kidney: 59.3"	"Cell type enriched"	"Detected in some"	48	"Distal tubular cells: 444.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.8;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028701	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.1	0.8	0.3	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	444.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 467.9;liver: 131.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 1623.0"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 13.7;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		35000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	1.4	0.0	24.3	0.0	23.4	0.0	25.1	28.8	34.0	5.1	17.3	0.2	0.0	0.1	8.1	17.5	9.0	9.6	0.0	22.8	25.6	467.9	131.9	0.3	0.1	27.2	33.1	0.0	0.8	0.0	6.9	0.3	35.0	0.5	0.0	0.4	6.1	4.1	0.9	51.8	0.0	0.0	28.8	0.0	0.2	0.1	25.2	1.1	9.6	0.0	0.6	0.1	11.3	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.2	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	23.4	28.8	34.0	22.8	25.6	27.2	33.1	35.0	28.8	25.2	27.0	0.1	0.0	0.6	66.3	5.3	8.2	9.0	80.9	0.6	0.0	16.3	11.0	0.0	15.7	18.1	46.0	0.0	0.3	0.2	0.0	223.0	0.7	1.1	10.3	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.4	27.9	0.0	0.0	0.8	0.0	12.2	0.6	1.1	1.1	0.0	7.1	1.8	4.7	0.0	13.8	0.0	2.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	1623.0	9.4	0.4	0.0	0.0	1.4	0.0	0.6	16.9	35.8	0.3	5.0	0.0	0.0	2.6
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809071-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		18000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	105.0	23.3	24.0	9.9	23.3	3.8	125.6	23.7	39.6	87.7	38.2	32.2	13.5	78.1	21.3	29.1	115.1	15.8	118.3	21.3	24.6	316.8	38.4	89.0	9.8	26.7	27.4	50.2	51.5	20.0	38.3	44.1	26.7	130.1	5.3	3.1	65.6	49.2	44.7	54.1	31.2	19.6	24.0	36.4	39.3	20.6	28.2	13.8	215.7	30.8	7.1	52.8	72.0	21.6	34.7	44.3	1.2	120.8	0.6	0.8	142.7	13.3	6.3	10.7	7.1	66.8	83.5	0.0	65.7	1.6	0.6	298.4	10.4	74.5	3.2	0.1	7.3	0.2	8.8	93.9	23.6	0.0	15.9	11.6	28.6	3.7	4.4	34.2	6.6	0.0	7.3	0.5	1.6	17.7	0.4	1.2	13.5	10.0	15.1	0.5	14.2	3.6	90.4	21.9	0.4	0.5	54.0	276.8	3.4	13.1	157.2	5.1	17.4	2.7	130.2	3.4	6.5	0.6	1.4	0.1	1.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	23.3	23.7	39.6	21.3	24.6	26.7	27.4	26.7	24.0	28.2	21.6	374.9	6.4	12.3	5.5	4.4	40.7	118.0	454.1	80.2	2.5	109.5	185.4	12.8	52.9	48.5	548.1	0.0	705.4	3.2	8.6	82.2	34.0	1.3	62.9	8.2	214.0	52.0	4.8	0.5	4.0	36.9	21.7	15.8	45.3	0.0	14.3	73.2	31.0	44.7	0.0	1.2	5.6	40.7	8.0	21.3	2.1	29.5	3.5	16.0	9.4	0.1	23.6	0.0	1.0	0.3	14.3	21.4	15.1	2.5	80.4	4.9	149.6	20.7	1.1	157.8	14.1	240.6	3.2	18.3	8.9	24.6	433.3	3.5	6.4	13.0	40.7
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58512872-58831435	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2"	"Group enriched"	"Detected in all"	4	"pancreatic cancer: 9.2;renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	10.6	6.1	0.3	4.0	0.5	0.3	8.7	0.0	1.6	5.8	1.9	4.5	1.2	4.9	4.0	3.5	7.5	11.6	10.5	0.6	1.0	28.6	2.4	5.8	2.4	1.2	0.6	13.9	16.9	0.8	3.6	3.6	0.2	3.8	4.1	1.4	4.3	4.2	7.6	6.1	2.7	4.7	1.2	2.9	2.7	3.1	0.7	1.4	4.6	6.2	2.7	5.5	5.6	0.7	0.0	59.1	0.8	0.0	17.9	23.0	0.0	38.5	61.4	34.4	40.4	93.1	12.3	0.0	39.8	39.3	8.8	0.8	6.1	7.0	47.4	0.1	5.9	0.0	7.4	0.1	11.5	0.0	0.0	36.0	2.2	26.9	28.6	42.3	0.1	0.0	0.0	0.2	13.4	0.1	0.0	0.0	0.5	0.0	3.8	0.0	14.3	0.0	140.8	7.1	0.2	7.3	0.1	0.4	3.4	2.4	0.0	0.6	0.0	8.2	7.7	1.4	5.0	0.0	0.0	0.1	23.8	0.0	7.8	6.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.5	0.1	0.0	0.3	0.5	0.0	1.6	0.6	1.0	1.2	0.6	0.2	1.2	0.7	0.7	4.1	0.0	0.5	120.5	1.5	7.1	1.3	1.3	0.6	0.6	1.1	4.3	3.3	158.7	1.7	86.5	0.0	0.4	0.1	0.3	78.2	98.5	5.2	43.8	14.4	1.4	3.6	0.0	70.4	3.5	0.2	79.6	0.5	7.2	0.0	4.2	3.3	1.4	3.5	0.0	37.2	1.2	0.0	0.6	18.5	3.2	71.1	1.7	21.4	165.8	1.1	10.1	0.0	25.6	2.7	35.3	1.2	50.0	0.3	2.4	0.0	148.2	14.1	0.2	6.6	40.0	9.8	0.1	3.9	0.3	4.7	4.1	1.5	8.7	1.6	0.1
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 128.7;pituitary gland: 80.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 12.9;dendritic cells: 13.7;Distal tubular cells: 23.5;Plasma cells: 12.8;Proximal tubular cells: 27.3;T-cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 48.9;MCF7: 27.7;OE19: 25.2;SCLC-21H: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favorable (3.15e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (3.93e-5)"	"prognostic favorable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	24.8	2.7	7.6	10.8	8.8	3.0	2.9	5.4	13.3	7.4	0.2	3.2	4.0	0.7	37.5	35.8	4.2	4.1	2.9	7.6	10.9	128.7	5.6	6.0	23.8	5.6	3.4	1.1	7.7	2.5	80.2	1.1	5.6	4.9	3.1	67.6	8.3	1.0	0.4	64.2	7.3	0.6	2.6	7.1	20.9	40.8	6.9	18.2	24.4	0.0	15.5	3.1	21.5	6.6	3.5	10.6	0.6	0.0	0.9	0.0	12.6	0.0	0.0	0.0	0.0	9.5	5.9	16.8	4.4	0.0	9.1	7.9	1.3	1.6	0.0	1.2	1.7	0.1	4.7	18.3	0.0	2.1	17.1	0.0	48.9	0.0	0.6	0.0	0.0	14.1	0.5	2.1	0.0	27.7	12.3	0.2	21.1	25.2	5.0	1.3	0.9	4.5	6.2	8.4	30.8	2.2	3.6	9.7	2.6	5.1	22.4	8.3	0.0	0.1	2.9	0.0	0.2	4.2	17.1	6.5	0.6	2.4	1.7	0.3	0.0	0.0	1.2	0.0	0.4	0.1	1.2	1.0	0.0	0.1	0.9	0.7	0.0	0.0	0.3	0.0	0.2	0.2	7.6	8.8	5.4	13.3	7.6	10.9	5.6	3.4	5.6	2.6	6.9	6.6	0.6	0.0	1.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.8	2.2	0.0	0.0	1.3	12.9	0.0	1.0	13.7	0.0	23.5	1.1	0.0	3.1	1.0	0.1	0.0	0.0	0.0	3.5	0.6	2.7	0.0	7.7	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	12.8	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	17.6	0.7	0.0	0.0
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory subunit beta"	Q8WZ55	1	54998933-55017172	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 9.4"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 25.4;Ionocytes: 87.5"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"RPMI-8226: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041947, HPA042980"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA041947: , HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.4	13.5	8.3	10.1	8.1	13.9	13.2	12.4	10.8	11.0	6.1	12.4	13.7	9.2	19.8	12.1	9.0	6.5	8.1	8.1	6.7	19.1	13.0	8.2	13.5	8.1	6.3	10.5	12.4	9.7	9.3	7.6	7.6	9.4	8.2	10.2	12.4	5.8	12.4	14.7	12.9	6.1	4.2	11.9	11.2	13.9	7.0	10.7	10.3	6.7	11.2	10.1	10.7	15.3	16.8	19.7	12.8	17.4	15.9	14.4	11.6	10.1	16.0	9.7	10.9	13.7	26.6	16.6	13.4	7.6	23.8	29.5	28.5	20.2	10.9	32.1	19.0	15.7	26.4	15.9	15.3	26.6	15.6	12.1	28.8	16.1	18.1	12.8	16.8	43.6	22.1	26.6	9.3	15.7	22.6	14.3	21.4	23.8	12.5	30.5	17.3	22.7	16.7	23.5	29.7	18.2	26.0	20.4	40.8	16.2	23.3	15.4	10.4	20.0	29.1	15.5	17.7	25.4	42.0	31.8	26.0	26.4	22.4	58.0	20.9	31.2	28.1	22.0	31.4	46.7	29.7	29.5	21.2	38.8	34.7	29.9	20.6	42.2	21.4	29.6	41.1	20.5	8.3	8.1	12.4	10.8	8.1	6.7	8.1	6.3	7.6	4.2	7.0	15.3	27.3	28.9	32.5	16.6	41.1	12.0	27.8	45.2	51.2	28.9	33.6	41.0	11.6	38.6	46.2	25.8	12.5	46.6	22.3	42.3	93.9	47.3	36.7	30.0	21.1	27.2	28.8	32.4	11.6	56.1	30.0	29.9	32.1	19.0	27.8	33.7	26.0	37.7	30.0	30.3	14.3	26.4	34.6	28.4	12.0	30.8	33.2	28.0	26.6	8.4	42.7	32.1	63.8	11.6	19.9	62.7	29.6	36.1	41.2	26.7	77.6	127.3	51.2	30.1	19.7	28.6	25.9	107.3	66.8	46.5	15.3	35.6	39.3	39.9	29.9	26.3
C2orf15	MGC29762	ENSG00000273045	"Chromosome 2 open reading frame 15"	Q8WU43	2	99141707-99151669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Proximal tubular cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 12.6;SCLC-21H: 12.2"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (2.61e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (2.54e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (2.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.08e-1)"	"unprognostic (2.97e-2)"	0.4	0.7	1.5	0.8	1.5	1.3	3.5	3.3	1.8	2.4	1.7	2.1	4.1	1.2	6.0	1.4	3.9	1.8	0.3	1.4	1.6	5.4	0.5	1.4	1.5	1.5	1.5	0.8	3.1	6.1	0.7	1.1	1.7	1.3	2.4	3.8	2.7	1.8	0.3	2.0	3.2	0.3	1.2	1.0	3.8	1.4	2.1	1.2	6.3	0.0	1.6	1.7	0.1	2.5	9.8	1.5	0.3	1.3	0.2	0.0	7.2	0.0	0.7	0.5	0.3	10.1	7.0	4.3	3.0	0.0	0.8	6.0	1.4	1.1	0.0	0.8	4.5	0.3	1.8	6.8	0.1	1.5	1.8	0.2	2.2	0.0	0.7	0.4	0.0	5.5	0.4	0.9	0.4	8.5	1.2	1.9	2.2	5.3	2.1	0.7	0.2	4.8	9.9	12.6	12.2	1.5	1.0	10.2	0.4	1.7	8.2	0.4	0.0	0.5	0.5	0.3	0.4	2.9	4.8	1.5	0.2	1.4	0.1	0.3	0.3	0.2	2.0	0.2	4.7	1.8	3.2	2.5	0.1	2.0	4.3	2.2	0.9	3.8	0.1	0.4	1.7	1.2	1.5	1.5	3.3	1.8	1.4	1.6	1.5	1.5	1.7	1.2	2.1	2.5	0.4	3.2	3.1	0.7	2.5	1.1	1.7	2.1	0.0	5.6	5.4	4.6	0.4	2.8	2.2	7.3	6.2	6.8	0.7	0.8	15.6	5.5	1.8	3.7	0.4	0.9	1.2	0.8	3.3	2.9	0.7	0.6	1.1	2.5	0.0	1.3	0.4	0.1	0.6	6.7	2.5	2.9	0.0	0.0	1.4	0.3	0.6	0.5	0.0	0.0	0.5	4.1	0.0	0.5	2.8	2.8	3.7	0.4	0.7	1.5	3.7	9.8	7.9	7.7	0.0	0.9	0.5	3.4	3.7	0.9	1.4	2.1	1.8	1.6	3.4	1.3
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63381846	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 290.2;skin 1: 142.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 174.6;Distal enterocytes: 422.6;Paneth cells: 160.8;Squamous epithelial cells: 185.3;Suprabasal keratinocytes: 252.2;Undifferentiated cells: 138.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 109.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 42.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 213.0;ASC TERT1: 213.0;RT4: 226.2;SK-BR-3: 177.9;T-47d: 286.8;U-138 MG: 300.5;U-87 MG: 361.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008773, CAB025181, CAB062549, CAB068179, HPA073203"	Enhanced					NA	NA		52000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394, HPA073203: AB_2686580"	"unprognostic (2.01e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.47e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-1)"	8.3	0.2	6.1	18.7	42.9	0.1	42.8	5.2	7.2	50.7	129.0	104.1	0.4	28.4	4.1	75.4	25.0	7.7	3.2	6.8	6.6	290.2	0.7	3.0	0.3	0.9	9.6	0.6	70.2	0.3	10.7	2.3	3.2	5.5	94.2	1.9	26.3	8.7	0.6	142.1	8.2	56.2	0.9	0.8	7.9	0.6	16.1	0.1	4.6	0.1	8.7	27.4	49.0	1.5	0.0	213.0	3.5	0.5	27.3	213.0	11.2	15.7	13.7	2.5	4.1	1.6	0.5	0.0	51.4	12.6	81.7	1.1	0.0	10.4	6.2	0.3	7.7	0.0	13.9	0.4	0.6	0.0	0.3	81.3	11.4	63.6	20.4	0.1	2.7	0.1	0.0	0.3	2.8	125.2	0.3	0.2	3.4	0.0	33.4	0.1	0.0	0.1	0.2	226.2	1.8	0.2	0.9	177.9	0.0	2.1	286.8	0.1	0.4	300.5	16.0	10.1	0.2	0.0	0.0	0.1	361.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	42.9	5.2	7.2	6.8	6.6	0.9	9.6	3.2	0.9	16.1	1.5	0.7	0.0	6.9	11.4	1.1	174.6	20.0	87.7	93.4	0.1	93.5	50.4	1.3	1.5	30.3	40.5	0.0	0.4	1.6	422.6	54.8	17.2	12.1	28.4	6.2	2.1	8.4	0.0	1.3	58.4	2.0	14.6	8.2	75.0	1.3	0.3	0.0	0.2	0.6	0.0	0.8	111.4	20.3	0.3	11.9	3.9	0.0	4.0	23.2	0.0	0.0	2.7	0.0	1.0	0.1	10.2	160.8	0.0	0.0	19.8	15.6	73.9	6.9	0.2	0.0	0.2	4.1	0.0	0.0	185.3	252.2	1.8	2.8	0.1	138.8	17.4
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 320.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 26.1;Collecting duct cells: 27.6;Cone photoreceptor cells: 91.8;Distal tubular cells: 31.3;Horizontal cells: 99.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.8;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 134.9;EFO-21: 189.8;HeLa: 65.9"	"Region enhanced"	"Detected in all"		"cerebellum: 430.7"	"Group enriched"	"Detected in all"	4	"basal ganglia: 49.7;cerebellum: 119.6"	"CAB002138, HPA023099, HPA056734"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"	2.4	1.6	7.4	2.0	31.3	1.3	1.7	63.0	21.1	5.5	0.0	1.7	3.2	1.2	3.4	8.5	1.9	1.4	0.9	9.2	14.0	320.6	2.6	3.6	0.9	16.8	10.4	1.2	2.5	2.2	8.4	3.9	6.3	0.8	2.5	54.1	1.7	0.5	1.9	3.5	2.7	1.3	15.9	1.3	2.3	3.6	32.1	2.7	2.5	0.3	1.2	0.5	0.1	7.8	134.9	6.1	30.2	1.2	1.1	4.9	4.0	2.0	5.8	0.7	1.1	2.9	15.1	0.5	189.8	0.1	0.8	47.8	46.0	54.6	9.1	0.3	2.5	3.2	65.9	0.7	5.3	0.8	4.4	1.5	17.3	2.5	25.4	7.0	36.1	2.6	9.9	3.4	35.9	0.6	1.9	0.1	45.3	2.9	17.9	1.3	1.2	3.9	12.9	0.7	5.0	2.9	38.2	2.3	0.6	45.8	1.7	1.1	0.1	3.9	28.1	6.6	11.9	3.1	3.9	1.0	0.5	0.9	0.2	1.5	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.4	0.3	0.0	0.4	7.4	31.3	63.0	21.1	9.2	14.0	16.8	10.4	6.3	15.9	32.1	7.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	1.5	0.0	0.0	27.6	91.8	0.0	0.0	0.0	31.3	0.0	14.9	0.0	0.1	0.3	3.5	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	99.3	14.7	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	15.8	0.0	1.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.8	0.0	0.3	0.4	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469300-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 27.5;kidney: 97.3;liver: 36.8;pancreas: 34.0"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 57.0;Distal tubular cells: 68.4;Proximal tubular cells: 191.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 25.1"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"A549: 11.5;RPTEC TERT1: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favorable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.5	0.5	0.7	0.6	0.0	1.0	0.6	1.3	0.0	0.2	1.5	0.5	1.9	0.1	27.5	16.8	0.2	0.4	0.4	97.3	36.8	0.1	0.1	0.7	0.5	0.1	34.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.0	1.5	0.2	0.6	0.2	0.0	0.4	0.1	0.4	0.1	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.0	11.5	0.0	0.0	0.0	0.6	0.2	0.1	0.1	0.0	0.0	1.1	0.9	0.1	2.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.2	0.2	0.0	0.2	0.1	0.0	0.2	34.3	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.1	0.0	0.3	0.3	0.3	1.6	0.4	0.0	1.7	0.3	0.2	0.7	0.1	0.9	0.6	1.4	1.0	0.0	1.2	1.2	1.9	1.5	1.0	0.3	0.5	2.2	1.9	0.5	0.7	1.0	0.6	0.4	0.4	0.7	0.5	0.8	0.4	0.8	1.6	0.0	3.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.1	0.0	68.4	22.2	0.0	19.7	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.0	0.0	191.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.6;Late spermatids: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA047615: AB_2680104, HPA058314: AB_2683677"	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	5.0	6.8	4.9	2.3	4.5	6.3	4.2	5.8	6.5	4.0	5.8	4.7	3.1	3.8	5.1	3.2	4.2	2.7	4.3	4.5	5.5	9.5	8.1	3.5	3.1	4.9	5.4	4.5	2.7	5.5	3.2	2.0	5.1	3.9	3.2	5.2	3.4	4.4	4.4	2.2	3.0	3.7	4.7	4.1	3.9	7.9	5.6	4.3	9.4	5.2	2.6	3.5	3.6	5.4	2.1	2.6	2.2	2.7	10.8	5.9	1.1	5.0	3.1	2.5	2.6	2.6	1.7	2.9	1.0	2.2	2.4	3.6	4.6	2.2	3.2	6.3	3.7	3.3	2.5	2.7	4.7	6.3	1.7	4.1	5.5	2.3	3.0	4.4	3.7	5.6	2.1	2.1	3.2	0.7	6.0	5.1	0.8	3.6	2.2	4.0	2.4	2.9	3.6	0.7	1.3	1.1	3.4	2.1	2.9	1.4	1.5	5.4	2.8	1.3	2.4	3.5	2.4	0.6	2.4	1.8	1.1	7.2	3.7	9.9	1.1	0.9	1.4	0.9	1.5	0.4	1.0	1.9	0.8	0.6	0.9	1.3	1.2	1.2	1.8	0.8	1.6	0.9	4.9	4.5	5.8	6.5	4.5	5.5	4.9	5.4	5.1	4.7	5.6	5.4	12.4	6.4	12.4	9.4	6.6	8.0	7.3	10.7	11.4	12.7	8.5	9.7	15.0	5.7	8.6	18.4	12.5	4.6	19.1	4.7	9.8	5.3	174.6	12.6	14.6	8.7	6.7	10.3	16.0	10.7	10.9	17.1	6.6	6.0	24.7	10.0	11.7	11.5	6.2	3.3	21.4	6.9	4.1	9.1	8.3	77.7	15.8	9.9	7.2	3.7	5.4	25.9	9.2	14.1	12.4	6.7	5.7	14.3	10.6	7.3	7.9	25.4	18.9	12.2	0.0	15.3	17.8	39.3	15.5	7.7	5.4	2.5	14.1	17.2	6.0	5.7
CDH16		ENSG00000166589	"Cadherin 16"	O75309	16	66908122-66918917	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 250.0"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 617.9"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 96.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	99	"RPTEC TERT1: 225.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB013526, HPA036260"	Enhanced					NA	NA		130000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB013526: , HPA036260: AB_2675027"		"unprognostic (1.07e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"		"unprognostic (9.81e-2)"	"unprognostic (4.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-2)"		"prognostic favorable (1.02e-7)"	"unprognostic (2.19e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.3	0.3	4.7	0.3	11.0	0.3	0.1	0.0	0.0	250.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.4	6.7	0.0	0.0	617.9	0.0	0.1	0.0	0.4	74.3	0.1	2.9	18.0	2.1	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	1.9	124.4	0.0	0.0	0.0	0.6	0.9	0.0	0.2	1.9	0.0	1.0	0.8	0.0	0.7	0.0
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922596-50099235	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 23.7;kidney: 46.2;liver: 16.9"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 214.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"CACO-2: 49.0;RH-30: 66.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	2.1	2.5	1.7	1.7	1.9	1.5	1.6	3.8	1.6	1.8	2.5	2.4	4.9	4.0	23.7	2.4	3.0	3.9	1.3	1.5	2.9	46.2	16.9	2.8	1.3	3.2	3.2	7.0	2.1	1.4	2.3	5.8	3.7	1.7	2.8	3.4	2.5	1.0	4.0	4.8	3.8	2.9	2.5	1.8	2.9	2.1	2.7	1.1	2.2	2.8	1.2	1.4	2.0	2.3	2.9	5.4	4.2	5.5	12.8	7.5	7.9	2.8	1.2	1.6	1.9	49.0	3.0	3.5	1.2	2.5	9.7	2.8	9.9	1.7	2.2	1.1	7.5	3.3	2.7	12.8	7.2	4.1	5.7	4.9	1.6	3.7	5.9	1.2	5.8	4.0	4.3	4.7	5.3	3.2	1.6	1.4	5.7	7.4	2.4	1.9	66.0	5.2	6.0	5.5	7.2	5.2	3.3	3.0	5.1	14.1	3.0	2.1	3.8	1.6	3.7	12.7	1.4	3.6	11.9	7.3	2.8	6.6	8.5	0.0	0.9	0.0	0.1	0.9	0.1	0.1	0.2	0.2	2.6	0.1	0.0	0.0	0.2	0.1	0.1	2.8	0.0	0.3	1.7	1.9	3.8	1.6	1.5	2.9	3.2	3.2	3.7	2.5	2.7	2.3	4.3	9.6	8.4	20.5	2.1	7.1	1.8	1.6	5.2	27.4	1.8	1.4	1.9	2.8	2.3	12.9	2.1	6.2	17.7	11.3	11.7	4.1	2.0	8.0	10.0	5.5	0.0	3.4	11.5	3.5	2.6	7.9	8.6	22.8	2.5	0.8	1.4	35.2	11.1	8.4	15.6	6.6	4.1	17.6	19.8	0.6	5.3	10.9	3.6	46.9	10.1	2.7	2.1	20.6	9.6	7.7	7.3	13.2	2.2	4.0	20.4	38.8	4.2	4.3	0.0	214.4	4.8	0.9	2.3	8.1	9.5	5.1	1.9	9.3	7.0	4.8
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 344.0"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 271.5"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 7.4"									HPA057717	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.7	2.9	0.4	0.0	0.4	0.0	0.9	2.2	0.4	0.6	4.9	0.4	0.0	0.6	0.5	0.0	0.5	0.1	0.6	0.7	0.4	344.0	0.2	0.3	0.0	0.4	0.5	0.9	3.5	48.9	18.2	0.0	0.7	0.8	0.0	2.3	6.9	0.2	0.5	0.7	0.1	0.2	0.3	0.1	3.9	4.5	0.4	0.0	21.6	0.3	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.2	0.4	0.7	0.4	0.4	0.5	0.7	0.3	0.4	0.4	0.0	3.2	0.5	0.3	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.1	3.8	0.0	0.7	25.8	0.0	0.4	0.0	0.1	25.4	0.3	40.2	0.1	0.0	0.1	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	13.5	0.2	0.1	67.1	0.0	0.0	271.5	0.3	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	1.9	1.2	0.0	0.0	0.7	0.1	0.0	0.3	0.2
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 209.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Distal tubular cells: 58.7;Early spermatids: 24.6;Ionocytes: 116.0;Late spermatids: 104.2"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in some"	6	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;HeLa: 1.1"									HPA057717	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.6	1.7	0.1	0.0	0.3	0.0	0.3	7.0	0.3	0.7	0.6	0.4	0.0	0.9	0.7	0.2	0.4	0.2	4.0	0.1	0.3	209.7	0.0	0.4	0.0	0.4	0.5	1.3	1.1	4.9	2.5	0.3	1.2	0.7	0.3	1.2	48.1	1.5	0.1	0.1	0.1	0.3	0.3	0.1	0.7	2.8	0.5	0.1	16.1	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.7	0.0	1.6	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.3	0.1	0.3	0.4	0.5	1.2	0.3	0.5	0.6	0.0	3.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.3	4.2	0.0	1.4	23.9	0.0	0.3	0.0	0.6	58.7	1.0	24.6	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.3	116.0	0.0	0.0	104.2	0.9	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	1.6	0.9	0.0	0.0	0.5	0.1	0.0	0.9	0.1
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 63.6"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.1	1.5	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.2	63.6	2.2	0.4	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.1	0.1	0.1	0.1	0.3	0.3	9.7	0.0	1.0	0.3	0.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"choroid plexus: 19.8;kidney: 39.1;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.8	0.1	0.1	0.0	0.1	0.1	1.1	0.4	0.5	0.0	19.8	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.0	39.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.3	0.0	0.0	0.8	0.7	0.2	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	1.3	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 114.7;gallbladder: 101.6;kidney: 165.2;seminal vesicle: 90.1"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.1	2.2	0.1	0.1	0.6	1.6	0.5	0.0	114.7	2.1	21.0	0.1	33.7	0.1	0.3	101.6	0.0	8.4	0.0	165.2	44.2	1.3	0.0	0.2	0.2	0.0	13.2	0.0	0.2	0.0	0.1	1.2	4.5	0.7	0.1	90.1	0.2	0.3	24.5	0.2	0.0	0.0	7.7	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.5	8.4	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216097	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.9;intestine: 50.8;kidney: 69.3;salivary gland: 40.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 224.3;Distal enterocytes: 110.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HaCaT: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.7	0.0	27.2	0.0	0.1	9.3	3.9	1.1	0.0	0.0	0.0	0.0	69.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.5	0.0	7.5	50.8	0.0	40.1	13.9	0.0	8.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	0.3	0.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	10.8	2.7	0.0	0.0	29.9	11.6	0.0	0.0	10.5	224.3	0.0	0.0	0.1	110.2	11.7	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.4	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	15.9	0.6	0.4	20.3	0.0	0.0	0.0	0.3	0.0	0.0	4.6	8.4	0.0	0.4	0.0	18.0	23.1
CLEC18A	MRCL	ENSG00000157322	"C-type lectin domain family 18 member A"	A5D8T8	16	69950705-69964452	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 23.9"	"Cell type enriched"	"Detected in some"	23	"Proximal tubular cells: 78.0"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"	"unprognostic (1.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-4)"	"unprognostic (6.73e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.03e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	0.2	0.9	0.1	0.0	0.2	0.3	0.3	0.6	0.5	0.3	2.8	0.4	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.2	23.9	0.2	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.4	0.0	0.4	0.3	0.1	0.1	0.6	0.0	0.2	0.3	0.7	0.0	0.2	1.2	0.5	3.2	0.2	0.3	0.4	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.5	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.0	1.1	0.0	0.9	0.1	0.0	0.2	0.0	1.6	0.3	0.4	0.5	2.8	0.4	0.0	2.1	0.1	0.3	3.3	1.9	0.3	0.4	0.4	0.1	0.4	0.0	0.0	0.3	0.2	0.1	0.3	2.0	0.5	0.0	0.6	2.5	0.4	0.4	3.3	0.4	1.0	0.0	0.6	0.3	0.8	0.3	1.1	0.0	0.0	0.9	0.9	1.0	0.0	0.0	0.5	0.4	0.0	0.2	0.2	1.5	78.0	0.7	1.3	0.0	0.7	1.3	0.5	0.2	0.0	0.0	0.3	0.6	0.6	1.3	0.2
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 33.4;testis: 11.8"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 26.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;renal cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;JURKAT: 1.6;K-562: 3.1;U-266/70: 1.1"									HPA048976	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.9	3.4	0.4	3.7	0.1	0.2	4.5	4.9	0.5	2.6	0.2	0.4	0.1	0.6	2.7	0.3	0.3	0.2	3.8	3.8	33.4	0.6	0.2	0.1	3.7	3.6	0.2	0.6	0.0	0.8	0.1	4.0	0.5	0.1	2.3	0.6	0.0	0.2	0.2	0.3	0.1	3.6	0.6	0.3	11.8	3.3	0.2	0.6	0.0	0.0	0.1	1.7	4.4	0.0	0.6	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.2	0.0	1.6	3.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	1.1	0.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	4.5	4.9	3.8	3.8	3.7	3.6	4.0	3.6	3.3	4.4	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.9	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.4	26.8	0.0	1.4	0.0	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 17.8"	"Cell type enriched"	"Detected in single"	46	"Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	17.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 486.4"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.5	0.0	0.6	0.3	2.0	0.7	0.8	1.0	16.6	0.6	1.3	1.5	3.1	0.6	2.4	3.7	1.1	0.7	0.6	486.4	61.5	1.7	0.4	0.6	0.5	3.2	5.3	10.5	0.6	0.5	0.6	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.4	0.2	10.9	1.0	0.5	0.8	4.1	0.1	0.3	0.8	0.4	0.9	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.7	0.8	0.7	0.6	0.6	0.5	0.6	0.4	0.5	0.9	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450787-47463702	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	13.4	15.5	9.7	20.3	9.8	21.4	13.6	10.0	14.6	11.8	13.0	17.7	18.4	10.4	22.6	24.1	11.3	13.7	27.2	9.5	12.2	45.3	12.7	13.5	30.4	9.9	10.3	10.2	10.4	26.8	13.4	19.0	10.0	10.6	18.1	13.5	8.4	10.0	8.8	17.5	19.0	15.0	10.4	18.1	14.3	24.1	10.3	21.6	21.3	12.6	25.4	16.8	11.8	10.3	32.6	17.6	15.2	7.8	31.6	44.8	21.1	47.8	31.5	30.7	41.5	29.9	37.4	51.7	39.0	45.3	69.4	17.0	49.4	39.1	55.0	30.8	22.1	29.8	17.7	23.2	43.0	73.6	36.8	38.7	51.6	29.2	32.3	28.5	39.5	33.7	22.5	20.6	75.8	18.1	44.1	59.4	10.4	21.8	22.8	21.8	34.7	11.2	88.1	26.3	29.8	15.2	19.9	16.1	39.6	26.5	29.5	48.0	32.7	43.6	41.8	39.2	57.9	21.6	27.6	42.1	47.3	95.2	32.2	114.3	58.2	68.9	44.6	80.4	48.1	48.1	40.5	44.9	74.0	43.4	37.5	43.2	29.0	57.4	89.4	34.3	51.2	71.4	9.7	9.8	10.0	14.6	9.5	12.2	9.9	10.3	10.0	10.4	10.3	10.3	31.3	22.4	16.5	3.3	41.6	22.6	11.4	60.5	21.6	18.2	12.8	16.6	46.1	18.6	32.6	29.5	4.2	86.6	39.1	20.9	107.6	42.8	68.4	43.0	21.6	26.7	21.0	14.5	5.5	46.3	116.3	28.6	16.8	19.2	33.0	11.3	22.5	12.7	90.9	6.7	7.3	19.4	42.7	54.4	42.1	18.9	54.3	50.7	12.4	4.7	82.0	37.2	72.1	2.5	5.3	25.1	23.8	40.6	22.9	8.6	28.0	231.8	57.4	23.8	19.7	16.9	29.9	141.5	59.0	37.3	30.0	105.8	53.9	36.9	28.8	10.2
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 85.6;retina: 55.5"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	85.6	6.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYAA2		ENSG00000276076	"Crystallin alpha A2"	A0A140G945	21	6560714-6564489	"Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	136	"kidney: 125.7;liver: 42.1;retina: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	207	"Hep G2: 37.5"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"		Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	125.7	42.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTXN3		ENSG00000205279	"Cortexin 3"	Q4LDR2	5	127649044-127658630	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 79.8"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 201.3"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"													NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"								"unprognostic (7.32e-2)"	"unprognostic (9.88e-2)"		"unprognostic (1.19e-1)"				"unprognostic (1.29e-1)"	"unprognostic (6.20e-3)"					0.0	0.0	3.1	0.0	4.2	0.0	0.0	1.9	10.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	4.8	79.8	0.0	0.1	0.0	8.3	11.8	0.0	0.0	0.2	5.3	0.0	10.2	0.5	0.0	0.2	0.2	0.0	12.9	0.0	0.0	0.0	2.6	0.0	0.0	0.1	5.3	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	4.2	1.9	10.2	5.1	4.8	8.3	11.8	10.2	2.6	5.3	3.6	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	23.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	201.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CUBN	"gp280, IFCR, MGA1"	ENSG00000107611	Cubilin	O60494	10	16823966-17129811	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 140.4"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 257.7;Proximal tubular cells: 325.0"	"Cancer enriched"	"Detected in some"	15	"renal cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.8;ASC TERT1: 3.0;SK-MEL-30: 2.8;WM-115: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004133, HPA043854"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004133: AB_2732398, HPA043854: AB_2732510"	"unprognostic (1.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.61e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.24e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.93e-1)"	0.7	0.8	0.8	0.4	0.9	0.4	0.8	0.8	0.7	1.2	1.3	0.5	0.2	0.7	3.1	0.2	2.1	0.3	0.6	0.8	0.8	140.4	0.1	0.6	0.8	2.5	1.7	2.5	0.5	0.6	2.2	2.6	2.4	1.1	0.2	3.0	0.7	0.4	0.3	0.8	28.0	0.4	1.7	0.9	0.4	2.0	1.0	1.7	3.8	0.5	0.7	0.4	0.7	0.6	0.0	0.0	1.5	14.8	0.5	3.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.6	1.5	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.1	0.0	0.1	1.6	0.1	0.2	0.3	0.1	0.5	0.0	0.0	0.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.9	0.8	0.7	0.8	0.8	2.5	1.7	2.4	1.7	1.0	0.6	3.2	0.0	1.5	23.8	3.7	0.5	0.4	0.2	0.6	2.9	0.6	0.6	1.7	0.0	3.2	5.5	2.1	0.0	3.3	0.1	13.7	0.0	37.3	3.1	2.2	5.7	0.0	0.0	8.4	0.2	0.0	2.3	0.0	2.2	0.0	2.2	1.4	0.0	0.1	0.0	9.0	3.7	0.0	0.3	0.4	31.8	2.8	3.1	7.2	7.5	0.1	6.5	1.0	9.0	5.5	0.1	5.0	1.2	1.6	0.4	257.7	325.0	3.5	4.0	0.0	19.0	1.6	1.1	0.9	0.1	0.9	0.1	2.9	1.2	1.2	0.2
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 15.2;thyroid gland: 5.7"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 22.1;monocytes: 22.8;Proximal tubular cells: 36.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 13.6;RH-30: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.67e-3)"	0.3	0.9	0.3	0.7	0.3	0.8	0.8	0.3	0.4	0.2	0.3	0.4	0.4	0.2	0.6	0.4	0.2	0.5	0.1	0.3	0.3	15.2	0.6	0.5	0.9	0.3	0.3	0.2	1.6	1.0	0.4	0.3	0.3	0.3	0.6	3.3	0.5	0.2	0.1	0.6	0.5	0.1	0.3	0.2	0.5	0.4	0.3	0.2	5.7	0.0	0.7	2.2	0.2	0.5	2.8	0.4	0.0	0.3	0.2	0.4	1.1	0.1	3.1	1.0	0.3	3.7	1.0	2.0	0.1	0.4	0.3	3.3	0.5	5.9	3.1	0.6	0.4	0.9	0.0	1.0	0.3	1.2	2.5	0.5	1.9	0.8	13.6	1.2	0.4	2.6	1.3	1.2	0.4	0.4	0.4	1.1	1.3	2.8	2.3	0.8	22.6	1.7	0.5	0.3	0.7	0.8	2.0	0.4	0.1	0.1	1.7	2.3	0.2	0.2	1.6	1.1	0.4	1.4	1.2	0.4	1.2	2.6	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.0	0.0	0.7	3.0	5.2	1.3	1.1	0.6	0.7	5.1	2.7	0.7	2.8	1.9	0.0	2.1	0.1	0.0	0.6	1.9	2.0	0.9	1.1	0.5	0.5	0.0	0.0	0.3	22.1	0.4	0.6	0.0	1.7	4.5	0.4	0.4	0.3	2.3	0.0	0.2	0.6	0.0	0.3	0.8	0.0	0.0	1.5	0.0	0.0	22.8	0.6	0.0	0.0	0.1	5.4	0.1	0.4	1.7	1.4	0.5	36.9	0.6	5.2	0.0	1.5	1.1	0.3	0.7	1.3	2.7	0.1	0.5	0.4	0.9	0.6
CYS1		ENSG00000205795	"Cystin 1"	Q717R9	2	10056780-10080944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 124.6;pancreas: 33.6"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 32.9;Collecting duct cells: 51.5;Distal tubular cells: 70.5;Muller glia cells: 48.0;Proximal tubular cells: 54.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"RPTEC TERT1: 111.5"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.48e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (2.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.20e-2)"	3.1	1.6	6.0	1.2	5.7	0.0	1.9	5.3	7.8	8.4	15.5	11.7	2.5	7.8	3.6	3.9	6.3	9.1	6.1	5.5	5.5	124.6	1.0	6.1	1.1	6.9	6.0	12.4	33.6	1.7	7.2	0.1	5.6	4.9	1.8	2.2	2.9	7.2	1.0	1.5	3.4	5.9	6.4	2.9	3.9	1.0	5.2	0.5	5.6	2.1	2.1	3.5	6.6	5.9	0.0	0.3	0.0	0.0	0.5	2.6	0.1	0.4	1.6	0.2	0.1	0.2	0.0	0.0	0.4	4.4	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	111.5	0.0	0.0	0.5	0.4	0.3	0.0	1.3	2.0	0.2	0.0	6.0	3.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.7	5.3	7.8	5.5	5.5	6.9	6.0	5.6	6.4	5.2	5.9	0.9	6.4	1.1	1.0	1.0	0.5	0.1	0.6	0.0	10.3	0.5	5.5	7.3	32.9	0.0	51.5	0.0	0.0	0.2	0.0	70.5	7.0	0.1	0.3	0.9	0.6	0.0	0.0	2.9	1.1	0.6	8.8	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	0.0	3.4	1.0	0.0	2.8	0.0	48.0	0.0	3.0	0.6	0.4	0.0	4.5	0.1	0.3	0.0	54.1	0.0	1.9	0.0	0.5	3.9	0.0	1.4	0.0	0.1	0.0	0.3	0.1	0.0	0.1
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870592-6877936	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 1746.1;pancreas: 747.8;salivary gland: 1975.0"	"Cell type enriched"	"Detected in many"	6	"Distal tubular cells: 13300.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Group enriched"	"Detected in many"	4	"amygdala: 1.2;cerebellum: 1.5;hypothalamus: 1.0;midbrain: 2.4;thalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 43.3"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		2500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	11.1	0.7	1.2	1.5	0.0	5.3	41.5	1.5	0.4	305.4	0.3	20.7	5.1	6.2	16.4	190.6	21.2	54.9	1.3	0.0	1.0	1746.1	248.4	5.7	0.0	0.0	2.4	0.5	747.8	6.9	12.7	2.1	0.2	37.9	11.5	1.9	1975.0	24.5	2.9	217.6	8.7	0.3	0.0	0.3	33.3	0.4	3.0	3.0	3.6	0.0	9.0	11.6	152.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.5	0.0	2.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.1	0.3	0.0	2.7	1.2	43.3	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.4	0.0	1.0	0.0	2.4	0.2	0.0	3.0	0.2	0.7	3.2	4.5	0.0	6.8	90.1	641.5	210.5	134.9	0.4	46.9	26.9	0.1	1976.0	57.2	982.1	0.0	11.8	0.4	117.6	13300.4	1860.0	0.0	339.5	223.6	8.8	15.7	0.0	0.0	295.4	0.9	19.0	1.5	1529.3	0.0	0.0	3.3	319.3	3.6	0.0	0.0	8.6	46.8	4.4	7.3	0.1	17.4	17.0	7.2	0.0	15.3	0.6	0.0	0.0	0.0	156.9	91.2	0.0	1.2	537.6	59.1	218.9	9.5	0.7	0.0	1.4	14.3	0.0	0.0	237.0	537.6	3.7	13.8	0.0	15.4	257.0
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912883-110013766	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 110.2;pancreas: 89.5;skeletal muscle: 29.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.9;Breast myoepithelial cells: 8.1;Cardiomyocytes: 8.2;Distal tubular cells: 7.9;Excitatory neurons: 8.5;Inhibitory neurons: 11.2;Muller glia cells: 26.2;Skeletal myocytes: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;SK-BR-3: 11.6;U-251 MG: 3.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA	209000	680000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.0	0.0	1.0	0.1	1.0	0.2	14.7	0.2	0.8	0.0	0.2	0.8	0.0	0.4	2.4	0.7	0.3	1.0	2.8	0.9	2.0	110.2	0.0	0.5	0.0	1.4	0.9	0.0	89.5	0.2	0.4	0.0	1.5	1.4	1.1	13.6	15.7	0.4	29.6	0.7	0.2	0.5	1.2	0.1	0.0	0.1	0.7	0.0	3.0	17.4	0.0	0.4	0.1	1.8	0.2	0.2	1.9	0.0	0.0	0.1	0.0	0.4	1.1	0.5	0.4	0.1	0.0	0.0	6.4	0.6	1.6	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.6	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.1	0.6	0.1	0.0	0.0	2.3	0.0	0.4	0.1	0.1	0.5	0.4	0.2	0.0	0.0	0.0	11.6	0.4	1.2	2.8	0.0	0.0	0.9	1.3	0.0	3.6	0.0	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.0	1.0	0.2	0.8	0.9	2.0	1.4	0.9	1.5	1.2	0.7	1.8	0.1	0.0	0.0	3.3	0.0	1.0	0.2	0.1	0.0	1.0	12.9	8.1	8.2	0.0	0.5	0.0	0.0	0.0	0.2	2.0	7.9	0.2	5.6	0.2	0.1	0.6	0.0	0.0	8.5	5.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.7	11.2	0.1	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.3	26.2	0.0	1.5	0.3	1.0	0.4	0.0	0.0	1.1	0.1	1.2	1.0	1.2	0.0	8.2	0.2	0.5	0.4	0.0	1.4	0.0	0.1	0.1	1.6	0.3
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Adipocytes: 409.0;Endothelial cells: 261.7;Hepatic stellate cells: 175.3;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA		470000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	46.3	20.2	6.7	9.6	7.1	0.2	38.2	7.1	11.2	37.1	7.8	10.3	6.8	27.9	9.9	12.7	19.2	31.4	38.5	6.3	7.5	79.7	7.5	48.4	6.6	8.1	7.0	6.9	6.2	19.2	9.6	0.8	9.0	12.7	8.1	1.5	9.2	25.6	18.5	9.0	8.3	38.8	7.0	3.5	8.2	2.3	9.4	8.7	43.6	40.2	4.9	24.9	13.9	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	7.1	7.1	11.2	6.3	7.5	8.1	7.0	9.0	7.0	9.4	7.4	409.0	6.4	6.0	0.3	14.0	16.6	0.5	0.1	6.2	0.1	2.1	3.0	14.1	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.0	0.1	0.7	0.6	0.6	261.7	0.0	8.0	1.3	0.0	0.0	16.2	0.0	0.3	0.0	0.1	175.3	1.1	0.2	0.0	0.2	0.0	0.0	5.5	21.4	1.3	1.2	1.7	16.0	111.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	2.6	1.0	0.0	0.2	0.0	0.4	0.0	5.8	21.4	0.2	0.5	1.1	14.6	0.3	2.4	0.7	0.0	1.0
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;kidney: 36.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 3.7"	"Region enriched"	"Detected in some"	10	"cerebral cortex: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.1	0.1	0.0	1.3	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.8	0.0	0.7	0.1	0.0	0.0	0.0	1.3	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	55.2	0.0	0.1	0.0	1.2	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	35.7	0.0	0.0	0.0	0.0	0.0	1.5	5.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70646824	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 7.5;heart muscle: 6.5;kidney: 9.0;skeletal muscle: 4.9"	"Group enriched"	"Detected in some"	4	"Melanocytes: 33.8;Plasma cells: 13.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 0.6;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.2;U-266/84: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	7.5	0.0	0.3	2.4	6.5	0.0	0.0	9.0	0.5	0.3	0.0	0.0	0.0	0.0	3.6	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.2	0.2	0.0	0.1	1.7	0.6	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.1	2.8	0.0	3.7	0.0	0.0	0.0	0.0	3.9	1.0	4.4	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.6	0.3	0.1	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	13.4	0.0	0.0	4.1	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in many"	41	"OE19: 6565.0;SK-BR-3: 3115.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	13.0	5.4	16.1	12.1	20.5	1.6	56.0	14.3	13.1	37.6	23.3	68.2	63.6	25.2	26.6	102.4	64.2	31.0	57.0	13.3	16.0	73.5	31.1	36.2	4.8	22.4	22.7	23.9	37.6	81.7	17.3	27.0	17.1	55.6	48.5	8.1	68.7	50.5	20.7	91.0	67.3	25.0	18.5	6.9	49.7	11.7	15.4	7.4	56.5	15.0	28.0	40.0	52.9	16.4	38.7	45.7	50.4	31.7	59.3	41.2	67.7	27.2	44.9	58.6	48.9	34.4	102.7	2.9	54.6	62.7	31.5	117.6	2.8	61.2	26.9	5.2	38.6	1.8	36.0	56.3	35.3	0.9	1.0	41.0	56.6	36.2	21.9	56.2	24.4	1.9	6.2	2.4	43.3	59.4	7.1	3.0	90.7	6565.0	11.7	3.9	20.5	5.4	58.9	118.9	9.4	2.6	51.5	3115.9	16.9	62.2	88.1	2.2	2.9	30.2	37.7	37.7	17.6	5.3	3.3	3.6	3.0	0.9	98.5	1.1	0.2	0.4	5.0	0.1	0.3	0.6	0.2	1.4	0.2	0.6	0.5	1.4	1.2	0.4	0.1	0.1	0.2	1.7	16.1	20.5	14.3	13.1	13.3	16.0	22.4	22.7	17.1	18.5	15.4	16.4	3.9	41.7	40.1	12.7	2.2	14.0	19.0	37.1	17.6	4.6	62.7	34.9	20.7	32.9	43.8	136.1	12.5	12.0	5.1	111.0	7.9	30.9	0.3	48.7	13.9	6.1	15.6	1.3	0.9	25.5	84.8	15.7	53.5	61.3	0.0	20.3	11.7	10.7	4.0	6.7	1.0	47.5	42.7	2.2	3.1	1.0	18.3	1.7	10.6	1.0	1.2	24.1	26.8	2.0	1.0	32.5	54.8	23.0	1.1	34.9	121.7	19.5	42.0	5.8	0.0	13.1	12.7	6.8	5.7	43.5	18.9	22.7	2.8	4.4	75.4	31.3
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977867-55022671	"Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 19.9;thyroid gland: 17.3"	"Cell type enriched"	"Detected in some"	8	"Endothelial cells: 142.4"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 302.2;TIME: 568.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB047364	Approved				"Secreted to blood"	NA	NA	1540000	340000	"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB047364: "	"unprognostic (4.70e-2)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.3	4.2	0.4	0.7	0.7	0.6	0.5	0.2	1.1	2.0	0.8	0.2	0.7	3.6	0.4	0.2	0.2	1.3	3.6	0.3	1.3	19.9	2.6	11.3	1.2	0.5	0.5	0.7	2.3	6.0	2.2	0.4	0.3	3.5	0.0	0.1	6.3	3.7	0.2	0.1	0.8	0.7	0.8	0.9	0.3	0.6	1.6	0.2	17.3	0.2	0.6	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	79.8	9.5	4.1	1.0	0.0	0.0	0.1	7.4	5.7	2.3	0.0	0.0	1.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.7	0.4	8.5	302.2	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	568.0	4.7	13.7	39.2	21.3	0.1	0.0	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.4	0.7	0.2	1.1	0.3	1.3	0.5	0.5	0.3	0.8	1.6	0.4	6.3	0.0	0.6	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	16.1	0.0	0.1	0.1	142.4	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	2.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.5	1.7	0.1	0.3	0.0	0.1	0.1	0.6	1.1	0.0	0.7
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"		19	45212370-45245407	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"kidney: 19.0;thyroid gland: 17.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 19.1;K-562: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: AB_2684431"																		4.3	8.3	0.3	2.1	0.6	1.6	2.9	0.5	0.4	4.0	1.6	2.7	2.4	4.9	0.4	1.9	2.8	2.3	2.3	0.4	0.3	19.0	2.7	2.7	1.1	0.7	0.5	0.9	2.7	3.3	5.0	0.4	0.5	5.2	0.7	0.1	1.8	2.2	0.9	2.1	3.2	1.9	0.3	8.3	2.9	3.3	0.4	0.4	17.9	0.3	0.5	3.2	2.4	0.7	0.1	0.3	2.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	2.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	19.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	16.6	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.0	0.1	0.3	0.6	0.8	1.5	0.2	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.4	0.4	0.3	0.7	0.5	0.5	0.3	0.4	0.7	15.3	0.0	1.3	0.7	0.7	0.4	0.3	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	17.7	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.4	51.4	0.3	0.0	0.0	1.1	0.6	0.0	1.6	0.0	0.0	1.8	2.8	0.0	0.0	0.1	0.2	2.1	0.5	0.7	0.0	0.0	1.9	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.6	0.4	6.2	0.2	0.9	0.0	0.1	21.2	0.0	0.3
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609181-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 66.3;kidney: 174.5"	"Group enriched"	"Detected in some"	15	"Proximal enterocytes: 478.5;Proximal tubular cells: 294.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"CACO-2: 78.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved					NA	NA		10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.6	0.3	0.5	0.6	1.5	0.2	0.1	1.6	0.9	0.0	5.9	2.4	2.4	0.1	0.0	0.3	0.0	0.1	3.0	0.6	0.5	174.5	16.7	0.0	5.3	2.7	2.8	0.3	0.6	0.0	0.1	0.0	1.5	0.1	1.3	0.3	0.5	0.0	1.0	0.1	66.3	0.0	0.4	0.8	0.7	0.6	2.2	0.2	0.4	0.0	1.8	0.1	0.0	0.6	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	78.9	0.9	0.0	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.7	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.5	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	1.6	0.9	0.6	0.5	2.7	2.8	1.5	0.4	2.2	0.6	0.0	0.0	0.0	3.6	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	9.3	13.7	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.4	16.8	0.0	0.3	0.0	14.3	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	25.0	0.0	0.0	0.0	478.5	294.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.1	18.1	0.0
FAM167B	"C1orf90, DIORA-2, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247222-32248856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 44.0"	"Group enriched"	"Detected in many"	14	"Adipocytes: 68.5;Endothelial cells: 102.5;Hepatic stellate cells: 200.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.6;EFO-21: 12.0;SK-MEL-30: 30.9;U-2197: 29.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"		"HPA029398: AB_10602807, HPA062074: AB_2684677"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	19.9	19.7	4.3	4.1	3.8	0.2	10.0	3.8	6.3	14.3	4.3	7.4	2.8	12.9	0.5	4.0	10.3	4.2	11.0	3.8	4.5	44.0	10.7	20.5	2.7	4.5	4.1	4.1	8.4	4.3	14.4	4.2	4.5	16.5	2.1	1.4	4.7	5.9	3.0	2.4	8.1	5.8	4.4	1.9	7.5	0.9	5.1	0.8	19.9	1.1	1.5	13.2	7.7	4.3	0.9	1.8	0.6	0.0	1.2	1.1	0.0	4.3	9.6	1.9	2.7	0.1	0.9	0.2	12.0	7.3	2.2	1.4	0.3	0.0	0.6	0.1	0.0	0.0	4.6	0.5	0.4	0.0	0.1	1.0	0.7	1.4	0.4	2.6	3.5	0.6	0.0	0.1	0.2	0.6	0.2	0.0	0.3	0.2	4.1	0.9	0.0	1.2	1.2	0.4	1.8	0.4	2.8	0.2	30.9	0.8	0.5	0.1	3.2	0.8	0.9	29.9	0.1	0.1	0.3	0.7	0.3	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.7	0.2	4.3	3.8	3.8	6.3	3.8	4.5	4.5	4.1	4.5	4.4	5.1	4.3	68.5	0.0	1.1	0.3	3.2	0.3	0.5	0.2	0.0	0.4	2.8	2.8	0.4	0.0	0.1	5.5	0.0	0.1	2.7	1.3	0.0	0.5	0.0	1.3	3.5	102.5	0.0	8.0	0.0	0.8	0.2	3.7	1.5	1.0	0.0	0.2	200.3	1.7	0.6	0.0	0.1	1.3	0.0	8.5	2.2	0.0	2.8	1.4	1.8	2.8	0.0	0.0	2.1	0.5	0.4	0.2	1.2	1.2	0.6	0.6	0.0	0.1	1.3	0.5	0.0	0.6	1.6	0.0	0.3	0.3	1.0	0.3	2.1	0.9	0.7	0.3
FBN3	KIAA1776	ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149592	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.4;salivary gland: 4.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 2.4;Inhibitory neurons: 3.4;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 3.7;NTERA-2: 12.3;REH: 18.6;SuSa: 4.5"					"Not detected"	"Not detected"			HPA049482	Uncertain				"Secreted to extracellular matrix"	NA	NA		2400000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.0	0.1	0.3	0.6	2.4	0.1	1.4	0.0	0.5	0.6	0.1	0.0	0.0	0.7	0.0	0.6	0.9	0.1	0.0	4.0	0.0	0.3	0.2	0.1	0.1	0.5	0.0	0.1	0.5	0.6	0.5	1.9	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.3	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.3	0.6	0.5	0.6	0.6	0.5	0.6	0.6	0.0	6.4	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"kidney: 38.1;lymphoid tissue: 26.2"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 32.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 2.4;renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056505	Enhanced					NA	NA		5300000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.1	7.9	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	26.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1
FGF9		ENSG00000102678	"Fibroblast growth factor 9"	P31371	13	21671073-21704498	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 10.7;retina: 8.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Excitatory neurons: 36.7;Horizontal cells: 40.4;Inhibitory neurons: 54.7;Muller glia cells: 138.8"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 3.7;ovarian cancer: 1.2;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;HEK 293: 1.4;JURKAT: 2.1;RPMI-8226: 2.1;RPTEC TERT1: 3.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067007	Enhanced	Approved			"Secreted in other tissues"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"			"HPA067007: AB_2732755"	"unprognostic (6.59e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.42e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.38e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (1.70e-6)"	"unprognostic (5.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.92e-2)"	2.4	4.0	1.1	0.1	1.4	0.2	0.2	5.8	4.7	1.5	0.2	0.8	0.7	1.6	0.2	0.2	0.4	0.4	2.7	1.3	1.9	10.7	0.0	0.9	0.1	3.7	1.6	1.0	0.5	0.1	2.2	0.1	4.3	0.3	1.2	8.2	0.3	0.5	0.5	0.1	1.8	0.3	1.2	0.1	0.8	0.5	3.0	0.1	0.1	0.5	0.0	1.2	0.8	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.6	2.1	3.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	5.8	4.7	1.3	1.9	3.7	1.6	4.3	1.2	3.0	2.1	0.9	9.6	5.6	12.1	1.8	1.7	0.2	0.6	0.0	14.4	0.7	2.7	25.7	0.0	1.3	3.7	0.0	0.1	3.2	1.7	39.2	0.4	9.4	13.1	2.6	1.6	18.6	0.0	36.7	0.0	0.0	3.9	0.0	26.6	0.0	1.2	0.0	0.0	0.1	40.4	54.7	2.7	0.0	0.0	1.6	2.9	0.6	0.5	1.8	1.9	1.6	138.8	3.1	9.5	1.7	0.2	0.5	0.0	1.9	0.1	10.9	1.1	0.0	5.9	0.0	1.0	0.7	6.3	6.2	0.1	1.4	0.3	3.2	0.1	7.5	0.1
FIGNL2		ENSG00000261308	"Fidgetin like 2"	A6NMB9	12	51817899-51848718	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.1;parathyroid gland: 2.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 17.4;BEWO: 11.4;NTERA-2: 7.0;SuSa: 12.7"	"Not detected"	"Not detected"													NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.36e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.78e-6)"	"unprognostic (7.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-2)"	0.5	0.0	0.7	0.2	0.7	0.0	0.2	1.0	0.9	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.7	0.8	2.1	0.5	0.3	0.3	0.8	0.6	0.0	0.1	2.2	0.4	0.7	0.3	0.2	0.1	0.4	0.7	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.4	0.5	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	17.4	0.0	0.2	0.1	11.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	1.7	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	7.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.5	2.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	1.0	0.9	0.7	0.8	0.8	0.6	0.3	0.2	0.9	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322985-14337614	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	5.0	3.7	2.3	0.8	3.0	0.0	2.3	6.4	5.3	3.2	0.9	1.6	11.8	2.3	3.1	1.6	2.4	5.0	0.6	5.3	1.3	23.2	7.0	17.7	0.1	0.0	1.3	10.6	1.2	8.2	1.0	1.8	0.8	8.2	0.8	1.6	1.2	14.0	2.0	6.3	2.3	1.4	0.6	0.7	9.7	1.2	2.3	7.3	5.2	0.7	0.3	7.9	2.1	1.8	0.0	12.2	27.5	0.0	0.0	0.0	0.0	2.7	0.8	0.1	0.0	15.3	5.6	0.0	0.9	0.6	0.0	8.0	0.0	8.3	0.1	0.0	1.8	0.0	0.4	0.3	2.4	0.0	0.0	4.6	51.3	0.0	9.7	0.0	0.1	0.2	0.0	0.2	5.3	0.4	3.7	0.0	8.9	6.2	0.1	0.1	0.2	0.0	17.3	3.6	0.5	5.7	0.0	0.0	9.2	15.5	0.5	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.0	0.0	0.2	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	6.4	5.3	5.3	1.3	0.0	1.3	0.8	0.6	2.3	1.8	0.3	218.0	156.5	2.3	0.5	8.7	168.3	26.1	55.8	23.9	4.4	6.5	1.2	24.3	73.1	22.0	6.2	0.5	0.0	2.2	13.7	23.6	0.2	0.7	1.7	1.9	11.3	0.0	27.2	14.9	0.0	8.7	37.8	0.7	5.1	5.0	2.9	8.5	0.2	6.7	39.3	2.5	2.0	0.3	0.7	0.5	3.7	1.3	5.4	1.9	1.6	0.6	0.0	26.2	3.9	10.0	3.0	0.4	0.1	24.9	3.5	49.2	13.4	3.3	0.0	25.0	1.8	0.0	0.1	5.9	16.6	0.0	0.8	1.4	1.5	18.3
FMO1		ENSG00000010932	"Flavin containing dimethylaniline monoxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 199.0"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 97.9;Proximal tubular cells: 196.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078132	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	5.1	5.6	0.1	0.5	0.1	0.0	10.0	0.1	0.3	6.3	0.3	0.4	0.1	3.1	0.1	3.5	4.2	5.2	0.7	0.1	0.1	199.0	2.9	1.5	0.4	0.1	0.1	5.0	2.4	1.1	1.8	2.3	0.1	0.4	0.2	0.0	5.4	0.7	0.1	10.4	20.2	4.2	0.1	0.0	0.9	1.6	0.1	7.4	2.3	0.8	10.8	2.5	1.7	0.1	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.0	0.0	0.0	0.3	3.0	3.2	0.5	0.0	12.5	0.0	0.5	1.1	10.0	2.8	0.0	3.7	0.0	0.3	0.0	0.0	13.7	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	18.7	0.0	0.0	0.0	3.2	0.0	0.3	0.4	0.0	0.1	2.9	0.0	0.0	0.0	1.5	10.8	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	2.6	0.0	0.1	97.9	196.9	0.0	0.0	6.6	0.5	4.7	0.0	0.1	1.4	2.3	0.8	1.0	2.6	1.4	0.1
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448118-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA065273: AB_2685452"	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	28.3	7.8	13.6	5.4	25.8	2.1	33.0	13.6	13.8	18.0	13.8	17.3	20.6	16.8	18.6	8.9	13.4	14.5	20.0	12.0	15.4	36.1	13.3	16.8	3.1	14.6	19.1	13.9	17.3	20.8	10.5	17.2	14.2	15.6	17.5	12.4	43.1	11.5	17.4	12.7	20.2	12.3	15.9	2.8	23.7	15.0	14.4	6.5	31.8	21.4	4.0	14.9	13.2	12.7	29.7	16.2	83.4	46.8	17.6	12.4	92.8	14.6	9.9	10.8	15.0	19.9	9.2	0.1	29.4	14.3	29.0	14.9	20.3	16.7	15.4	18.5	15.2	15.8	23.5	29.9	8.8	2.8	0.3	23.0	27.2	10.2	14.8	28.2	52.1	18.1	6.2	0.1	25.8	13.8	11.6	1.2	63.7	50.5	16.4	24.4	63.7	7.8	47.5	44.6	32.6	47.0	45.4	88.0	25.8	97.3	33.5	4.0	52.1	25.2	31.7	0.6	10.2	9.1	7.5	0.2	2.5	0.4	17.5	7.3	0.1	0.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.0	1.5	0.2	0.1	13.6	25.8	13.6	13.8	12.0	15.4	14.6	19.1	14.2	15.9	14.4	12.7	130.0	109.0	42.1	48.0	4.3	26.5	61.5	27.5	18.2	13.3	62.9	59.1	42.6	40.0	60.9	62.5	4.2	37.6	2.2	35.4	56.7	77.9	12.1	61.1	30.0	49.8	67.0	36.6	41.0	48.4	35.7	20.5	50.0	91.7	16.4	19.6	25.0	21.0	11.8	69.0	110.8	33.0	14.2	4.7	22.7	19.7	8.1	10.6	39.2	80.6	7.1	18.8	0.0	55.3	4.2	55.8	34.5	3.8	1.0	56.0	43.6	50.8	53.8	10.0	26.3	5.9	49.9	23.4	37.2	22.0	25.7	17.1	4.1	10.2	38.4	75.6
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 44.0;salivary gland: 11.4"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.4	1.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXI2	FLJ46831	ENSG00000186766	"Forkhead box I2"	Q6ZQN5	10	127737185-127741183	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1.9;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;Distal tubular cells: 3.9;Squamous epithelial cells: 1.4;Urothelial cells: 1.7"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"			"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.12e-3)"	"unprognostic (4.71e-4)"	"unprognostic (6.78e-3)"	"prognostic favorable (4.23e-7)"	"unprognostic (6.31e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.65e-2)"	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.3	1.9	0.2	0.1	0.3	0.0	0.2	3.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.1	0.5	0.1	0.2	0.1	0.5	0.2	0.0	0.3	0.3	0.0	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.7
FRAS1	"FLJ14927, FLJ22031, KIAA1500"	ENSG00000138759	"Fraser extracellular matrix complex subunit 1"	Q86XX4	4	78057323-78544269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.8;thyroid gland: 12.0"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 204.9;Inhibitory neurons: 377.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 35.9;Hep G2: 21.9;RH-30: 20.1;SiHa: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051601	Approved				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051601: AB_2681547"	"unprognostic (1.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (4.69e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.09e-2)"	2.0	0.6	3.4	0.5	5.8	0.0	0.7	0.0	7.9	2.1	4.0	3.5	0.3	2.0	1.9	1.7	1.0	0.9	1.5	3.5	3.3	7.4	0.3	3.4	0.1	3.1	3.3	0.2	5.4	0.6	2.4	5.8	3.0	2.3	1.3	2.2	1.0	0.7	2.7	1.3	1.0	1.4	0.6	0.7	0.9	0.6	13.8	2.6	12.0	2.2	0.2	0.5	1.4	4.9	4.6	6.9	2.7	0.0	7.0	2.9	4.8	1.1	4.1	0.6	0.4	5.4	9.8	0.0	8.2	35.9	0.0	1.3	3.8	2.1	0.1	0.0	3.8	4.2	8.5	21.9	0.8	0.0	0.0	14.1	2.3	0.0	5.2	5.4	0.1	0.3	0.0	0.0	4.1	0.2	0.1	0.0	8.6	3.6	1.3	0.0	20.1	0.0	8.7	9.9	5.0	9.7	21.6	6.7	1.3	12.3	0.0	0.0	0.0	0.0	4.5	2.9	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.8	0.0	7.9	3.5	3.3	3.1	3.3	3.0	0.6	13.8	4.9	0.5	32.1	0.0	9.1	0.1	1.9	2.2	2.5	10.2	10.8	0.8	1.8	7.3	22.8	9.2	29.5	0.0	28.0	0.0	0.8	3.9	7.6	2.1	5.5	1.0	2.0	1.2	0.0	204.9	1.7	1.4	5.3	4.1	13.5	0.0	0.1	1.1	0.2	4.4	0.0	377.7	1.0	0.0	0.0	0.7	2.8	0.6	0.4	1.8	20.6	0.0	0.6	0.0	10.1	5.5	2.7	2.5	0.0	0.0	1.8	1.4	4.3	2.5	2.7	0.0	1.5	3.4	0.8	1.2	10.4	1.3	15.6	0.1	2.8	2.4	0.4
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix 2"	Q5SZK8	13	38687077-38887131	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 7.7;thyroid gland: 4.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.2;Astrocytes: 46.0;Cholangiocytes: 15.7;Endometrial ciliated cells: 18.6;Glandular and luminal cells: 48.6;Oligodendrocyte precursor cells: 15.6;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.6;MCF7: 7.8;RT4: 7.2;SK-BR-3: 6.3;SuSa: 29.7;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA028831	Uncertain		Approved	Cytosol		NA	NA		1500000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.2	0.1	0.3	0.0	1.1	0.0	0.2	0.2	0.9	0.3	0.1	0.5	0.1	0.5	0.2	0.0	0.4	0.8	0.0	0.6	0.0	7.7	2.0	2.2	0.0	0.0	0.4	0.7	2.7	0.0	0.3	1.4	0.0	1.8	0.1	0.3	0.0	0.7	2.8	0.1	0.2	0.3	0.0	0.1	0.9	0.3	0.0	0.2	4.9	3.6	0.0	0.2	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.3	0.0	0.2	0.0	1.4	0.1	2.3	7.2	0.2	0.1	0.0	6.3	0.3	29.7	1.1	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.9	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	27.2	46.0	0.0	0.6	0.1	0.7	0.0	0.2	0.4	0.5	2.7	15.7	1.4	1.8	0.0	5.9	0.0	0.3	5.9	3.2	0.5	18.6	4.5	0.6	0.0	0.0	0.5	0.2	0.4	0.4	0.0	48.6	0.0	0.5	0.0	1.3	0.8	0.0	9.1	0.1	2.0	0.3	0.0	0.1	0.0	0.2	0.0	3.7	0.0	3.3	0.0	15.6	9.7	1.0	0.1	0.0	0.0	0.0	0.0	24.8	2.9	0.3	0.0	3.1	0.7	0.2	0.9	0.0	0.1	1.9	0.5	2.9	0.1	0.1
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3645.4"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Group enriched"	"Detected in some"	25	"MOLT-4: 2255.4;RPTEC TERT1: 4711.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 27.7"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	2.0	0.9	0.7	1.4	0.6	3.3	1.2	1.4	1.7	1.0	0.0	2.1	1.4	1.5	1.2	0.8	1.8	353.1	1.2	0.8	0.0	3645.4	23.8	4.4	8.9	0.0	0.1	2.4	612.6	0.2	1.6	0.8	0.0	1.7	0.8	1.1	835.6	0.7	0.3	1.0	1.6	2.2	0.0	3.1	2.8	0.6	0.0	74.8	1.0	0.6	4.5	1.8	0.9	0.4	0.0	118.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	3.5	0.0	0.2	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.2	83.6	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.9	140.3	0.0	0.0	0.2	0.3	2255.4	0.0	1.2	0.0	0.0	0.6	0.0	4.6	4711.9	0.0	1.9	0.0	0.0	2.9	0.2	0.2	0.8	0.3	0.8	0.0	1.3	0.5	0.0	1.0	0.3	0.2	0.1	0.2	0.0	0.0	1.2	0.0	1.0	0.0	1.0	0.2	1.8	14.8	0.2	0.3	5.1	4.3	0.0	9.6	0.0	3.8	1.7	2.1	0.7	0.6	1.4	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.0	33.6	1.1	0.1	0.8	0.6	0.2	0.1	0.5	1.2	1595.6	0.1	435.9	0.0	0.1	0.7	0.0	2952.4	892.8	21.8	1.6	4.1	2.2	15.1	2.7	0.0	10.0	0.1	3.5	0.5	41.3	0.0	0.6	4.2	3.9	3.6	0.0	0.0	0.3	16.2	4.5	4.1	25.9	9.3	24.8	0.0	0.0	8.8	0.5	1.0	0.0	0.0	23.2	0.0	7.5	0.4	0.2	0.0	3423.7	0.1	3.3	6.6	1.6	3.8	0.3	0.3	0.2	0.9	0.3	27.7	1.2	0.1	0.0
FXYD4	CHIF	ENSG00000150201	"FXYD domain containing ion transport regulator 4"	P59646	10	43371636-43376335	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	43	"kidney: 297.7"	"Cell type enriched"	"Detected in some"	107	"Collecting duct cells: 5039.3"	"Group enriched"	"Detected in many"	5	"renal cancer: 10.7;urothelial cancer: 20.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"SuSa: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058421	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA058421: AB_2683714"	"unprognostic (2.92e-3)"	"unprognostic (5.25e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-1)"		"unprognostic (2.32e-1)"		"unprognostic (2.00e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	1.5	0.0	2.6	0.0	0.0	1.5	2.7	0.0	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.4	2.0	297.7	0.0	1.1	0.0	1.6	2.2	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	5.6	2.7	1.3	0.0	0.0	0.0	1.4	0.0	6.9	0.8	2.2	0.0	0.0	0.4	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	1.5	2.7	1.4	2.0	1.6	2.2	1.7	1.4	2.2	2.7	0.0	6.4	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	5039.3	0.0	0.5	0.0	0.5	46.9	0.0	2.6	6.4	2.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	9.2	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	11.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.2	0.1	0.1	8.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.4	0.3	0.1	1.0	1.4
FXYD6-FXYD2		ENSG00000255245	"FXYD6-FXYD2 readthrough"		11	117820163-117876667	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.5;salivary gland: 4.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MOLT-4: 6.5;RPTEC TERT1: 7.3"									"HPA068838, HPA075209"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane, Vesicles"		"HPA068838: AB_2686047, HPA075209: AB_2732285"																		0.3	0.2	0.4	0.0	0.4	0.0	0.2	0.5	0.5	0.4	0.2	0.9	0.1	1.0	0.8	0.1	0.6	0.9	0.6	0.4	0.4	7.5	0.2	0.4	0.0	0.3	0.3	1.3	1.9	0.0	0.3	0.2	0.3	0.3	0.0	0.0	4.5	0.1	0.2	0.1	0.3	0.3	0.3	0.9	0.3	0.3	0.3	0.4	0.3	0.2	0.1	0.4	0.2	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	11.0	0.0	0.0	0.0	0.0	97.8	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	2.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	15.8	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GAL3ST3	GAL3ST2	ENSG00000175229	"Galactose-3-O-sulfotransferase 3"	Q96A11	11	66040765-66049161	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.7;thyroid gland: 17.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.9;Cardiomyocytes: 3.6;Cone photoreceptor cells: 10.4;Excitatory neurons: 3.7;Horizontal cells: 5.0;Inhibitory neurons: 4.7;Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 15.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;ovarian cancer: 5.5;thyroid cancer: 10.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 6.5;SH-SY5Y: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"							"prognostic unfavorable (6.53e-6)"	"unprognostic (1.24e-1)"			"unprognostic (3.30e-1)"		"unprognostic (1.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.29e-1)"	0.0	0.0	5.3	0.0	7.7	0.0	0.0	4.8	5.7	2.9	0.1	0.0	0.0	3.9	0.1	0.0	2.6	0.0	7.1	4.8	2.1	5.3	0.0	0.0	0.0	2.0	2.6	0.2	0.6	0.3	4.1	0.0	1.6	0.8	0.0	5.7	0.0	1.6	0.3	0.1	0.0	2.8	1.5	0.0	0.0	2.1	2.8	0.0	17.1	0.3	0.0	0.0	0.3	3.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.7	4.8	5.7	4.8	2.1	2.0	2.6	1.6	1.5	2.8	3.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	7.5	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		27000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	3.9	1.0	10.6	5.9	0.8	2.0	4.5	1.3	3.6	0.3	0.5	0.3	0.3	11.8	1.2	2.2	0.3	2.9	3.2	41.3	1.3	0.6	2.2	1.7	6.7	0.1	3.1	4.0	5.9	0.0	0.8	1.6	0.1	0.6	1.2	0.0	0.1	2.1	3.3	0.7	1.8	2.4	0.5	2.5	10.9	0.4	0.9	0.4	4.8	2.3	1.3	3.3	23.6	28.6	0.0	0.0	0.0	0.0	0.0	7.9	4.1	4.9	0.6	0.0	0.0	22.1	7.8	0.4	0.0	0.0	1.0	1.0	0.8	0.6	2.8	12.1	0.0	0.0	0.0	18.2	0.0	0.1	4.5	0.0	17.0	0.2	0.0	0.6	0.0	19.0	0.0	10.7	0.1	0.0	12.6	0.0	0.0	15.5	0.0	32.3	41.3	35.3	24.4	18.3	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	19.6	0.0	0.5	1.9	6.2	0.1	0.0	11.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.9	10.6	2.0	4.5	2.9	3.2	1.7	6.7	0.8	1.8	10.9	3.3	2.2	0.0	0.0	1.0	1.4	2.8	4.1	5.3	21.6	0.3	0.6	2.4	1.1	0.0	6.2	9.2	0.0	0.0	0.0	0.3	13.7	2.9	5.7	0.0	0.1	1.2	0.0	0.0	29.1	0.4	0.0	1.1	0.5	0.4	0.0	0.0	8.2	0.2	0.1	0.0	79.2	0.9	2.0	0.6	0.3	12.0	0.0	0.4	0.0	2.8	0.0	0.2	0.0	4.0	8.7	2.6	0.0	0.0	3.1	14.2	21.9	45.5	1.1	0.4	6.6	0.4	2.2	3.4	6.9	9.2	0.9	0.0	0.4	0.2	1.8	5.1
GALNT9	GALNAC-T9	ENSG00000182870	"Polypeptide N-acetylgalactosaminyltransferase 9"	Q9HCQ5	12	132196372-132329589	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;kidney: 9.4;thyroid gland: 13.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.7;Collecting duct cells: 27.6;Excitatory neurons: 37.1;Inhibitory neurons: 13.1;Proximal tubular cells: 8.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.9;ovarian cancer: 0.5;renal cancer: 1.6;thyroid cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-87 MG: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075016			Approved	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA075016: AB_2686729"	"unprognostic (1.13e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.69e-2)"	9.3	1.2	8.3	0.1	11.9	0.0	0.1	19.9	22.5	3.9	0.0	1.5	0.2	0.8	2.3	0.1	1.9	0.0	0.8	11.2	2.9	9.4	0.2	0.5	0.3	6.1	4.4	1.3	0.1	0.2	8.4	0.0	5.9	1.0	0.0	0.6	0.2	0.3	0.1	0.1	0.5	0.0	1.0	0.9	0.6	0.7	9.6	0.1	13.0	0.0	0.0	0.5	0.8	11.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	11.9	19.9	22.5	11.2	2.9	6.1	4.4	5.9	1.0	9.6	11.0	0.0	0.0	0.6	2.6	0.0	0.0	0.5	0.0	0.0	7.7	0.1	0.0	1.6	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	1.3	0.0	0.0	37.1	0.0	0.0	2.7	0.0	0.8	1.3	0.0	0.0	0.0	0.2	3.3	13.1	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	5.6	0.0	1.7	0.0	2.0	2.9	0.1	0.0	1.9	0.0	0.6	0.0	8.2	0.0	3.3	0.0	0.9	0.6	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.8
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 371.8;urinary bladder: 175.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	960000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	34.8	11.7	1.3	1.5	1.4	0.4	24.9	1.0	2.3	18.9	40.9	29.2	4.5	13.6	2.2	4.8	5.5	19.9	4.5	4.3	1.3	371.8	88.6	46.9	0.6	2.0	1.7	4.7	112.3	25.9	12.3	86.9	1.5	105.3	24.4	1.2	12.5	4.6	5.5	6.4	12.3	1.9	1.2	11.4	75.5	1.6	2.5	0.3	11.2	0.5	1.7	175.4	19.2	1.6	1.8	95.6	9.4	3.5	22.3	18.5	416.5	33.1	17.9	1.2	18.8	4.2	29.6	0.4	58.8	3.0	97.0	0.7	0.0	12.2	4.7	0.2	2.2	0.9	9.2	225.5	564.9	0.1	35.7	48.8	140.1	90.7	58.6	0.7	99.5	0.0	152.4	0.7	22.9	23.5	0.1	0.8	5.4	34.4	52.5	0.2	3.7	0.2	69.9	94.6	0.9	1.0	0.4	5.5	127.9	35.1	2.6	0.4	213.1	0.0	7.4	1.8	1.5	1.5	4.0	0.4	51.9	0.1	27.8	0.0	0.7	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.1	1.3	1.4	1.0	2.3	4.3	1.3	2.0	1.7	1.5	1.2	2.5	1.6	6.6	35.3	62.4	0.0	1.8	1.3	350.6	366.1	0.0	0.1	54.2	15.5	0.7	47.1	1160.8	259.3	0.0	60.6	0.4	176.0	33.2	316.9	0.0	166.8	35.4	31.9	84.8	0.0	0.1	381.9	263.4	52.9	224.8	261.8	29.2	0.2	2.5	7.0	33.8	0.0	0.1	357.6	453.7	1.6	3.7	0.0	0.9	14.1	3.6	0.0	9.9	0.5	1.0	0.0	0.0	440.4	146.6	1.5	1.3	780.2	22.9	85.7	681.4	0.6	0.0	9.5	46.7	0.7	0.5	1.3	1.7	4304.7	5.5	3.4	291.0	3294.2
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689784-7695775	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"kidney: 2.9"	"Cell type enriched"	"Detected in some"	25	"Granulosa cells: 30.2"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"NTERA-2: 452.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"			"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	2.9	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	452.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	77.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"kidney: 75.5"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 133.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	5.8	6.0	3.4	3.8	4.1	1.6	5.0	3.9	4.7	2.6	3.5	7.6	8.7	3.2	2.1	2.7	3.0	2.9	1.6	3.1	4.0	75.5	16.7	3.0	3.4	4.4	4.1	2.8	15.2	3.0	1.5	3.0	3.9	3.4	4.9	6.8	8.9	3.1	2.3	4.8	6.1	2.4	4.3	4.1	7.1	6.6	3.8	3.6	3.5	4.2	5.8	3.4	2.5	4.7	14.2	1.7	11.3	12.2	9.4	14.3	4.9	8.8	2.3	1.5	3.8	0.2	12.6	1.4	4.9	6.4	0.2	0.7	1.8	2.6	0.5	20.1	7.6	6.0	1.1	0.7	13.4	8.6	19.1	17.3	9.8	0.2	0.8	0.1	5.7	6.6	3.1	0.3	2.3	0.9	1.4	1.1	0.6	27.4	3.8	0.9	2.8	1.8	14.1	2.4	133.3	5.0	2.8	6.2	6.6	10.5	5.9	28.0	5.5	0.0	0.1	3.0	2.4	7.3	4.4	0.5	0.7	6.4	6.2	0.0	4.1	0.8	5.8	5.9	5.5	3.9	4.8	6.4	3.3	4.3	2.9	4.3	0.0	7.0	6.2	2.4	5.4	3.4	3.4	4.1	3.9	4.7	3.1	4.0	4.4	4.1	3.9	4.3	3.8	4.7	3.2	0.0	1.5	7.5	7.2	2.7	3.0	1.1	5.2	1.7	4.4	3.2	0.9	1.5	2.1	7.3	14.6	13.4	2.6	4.6	7.9	8.7	4.7	2.6	2.1	3.4	7.8	1.7	2.7	10.0	11.8	3.6	3.1	4.2	5.7	4.1	4.2	14.0	12.1	1.7	3.2	4.7	2.0	9.8	1.4	10.3	2.8	6.2	0.0	4.7	10.0	6.8	19.6	3.5	8.0	9.1	4.5	3.8	2.1	2.3	10.5	152.0	0.1	3.3	6.6	4.3	1.8	22.5	10.9	3.9	2.0	4.4	6.1	12.4	7.7	2.5
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 8.7;thyroid gland: 8.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Early spermatids: 5.6;Late spermatids: 18.7;Proximal tubular cells: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HeLa: 3.5;Karpas-707: 1.3;U-2197: 8.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	1.5	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	1.0	0.1	0.0	8.5	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.3	0.3	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	3.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"kidney: 10.5;thyroid gland: 8.2"	"Group enriched"	"Detected in some"	10	"Alveolar cells type 1: 3.2;Early spermatids: 5.3;Late spermatids: 12.1;Spermatocytes: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 1.5;U-2197: 1.0"									"HPA045635, HPA047534"	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.5	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	10.5	0.1	2.2	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.2	2.3	0.1	0.0	8.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 127.2;Proximal tubular cells: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 382.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		930000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	18.8	38.4	26.9	17.3	28.8	8.1	20.9	26.2	35.2	26.7	27.7	19.7	29.5	28.7	51.9	13.6	18.4	22.3	17.3	28.1	30.8	76.4	16.6	17.6	22.7	27.0	27.7	31.8	11.3	27.9	20.5	22.2	29.3	22.2	21.9	17.7	14.6	28.3	26.4	14.8	22.5	29.2	27.0	30.9	14.5	18.8	29.7	24.9	27.8	25.7	19.8	33.3	17.1	30.7	42.6	61.0	23.2	115.8	77.1	51.9	54.6	32.6	78.7	84.7	95.8	91.3	49.2	0.2	72.9	23.6	382.3	44.0	109.9	98.0	74.8	32.9	46.5	31.3	33.1	65.5	137.2	86.4	39.2	63.5	56.9	54.5	144.8	63.2	91.6	80.6	37.3	110.1	93.0	27.2	66.8	9.8	88.0	62.8	121.4	25.5	76.3	94.3	81.8	114.8	20.6	54.0	65.0	67.8	127.9	67.5	54.6	26.5	43.3	50.9	33.3	76.9	47.5	61.2	126.9	47.1	74.2	29.3	45.0	0.3	48.6	7.1	37.2	59.1	77.9	19.4	30.0	34.2	51.7	11.1	35.3	38.8	12.7	15.8	56.3	29.6	27.6	40.2	26.9	28.8	26.2	35.2	28.1	30.8	27.0	27.7	29.3	27.0	29.7	30.7	10.5	9.6	14.9	10.7	8.2	6.0	40.8	20.9	21.1	11.6	12.6	17.8	12.6	12.8	20.1	18.4	8.4	26.7	11.1	6.9	35.2	29.3	1.1	5.8	19.8	14.6	15.0	9.9	11.5	14.2	48.6	22.8	7.7	9.6	12.0	30.8	15.4	7.4	127.2	6.7	12.7	6.2	12.2	60.2	10.7	3.6	19.9	48.5	14.2	12.2	23.5	40.5	15.5	7.1	11.5	21.6	7.1	26.7	7.8	32.9	19.4	102.3	8.0	7.9	0.0	10.4	11.7	10.4	17.0	17.6	7.4	29.7	16.6	64.8	9.1	34.7
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 11673.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 20125.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 605.6;thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 20.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.7"	"Cell line enriched"	"Detected in many"	12	"ASC diff: 7677.4"	"Region enhanced"	"Detected in all"		"hypothalamus: 239.5"	"Low region specificity"	"Detected in all"			CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	6200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	4524.7	443.8	57.8	75.4	68.3	7.9	3188.6	62.7	73.8	917.6	578.2	741.2	88.3	416.0	90.7	568.6	1038.4	136.4	2362.4	68.2	117.5	11673.5	986.3	2471.8	133.2	317.7	104.5	517.8	257.0	112.4	793.7	592.2	136.6	557.5	93.4	4204.9	481.4	140.0	847.9	669.7	720.6	61.0	67.5	555.7	641.1	80.4	135.8	26.8	3627.5	458.9	44.9	1196.7	891.7	70.3	2.2	10.0	8.5	2.7	7677.4	6.7	9.2	3.5	0.8	7.9	2.4	177.5	3.9	1.1	214.1	5.6	3.2	2.8	39.6	433.2	6.0	6.1	2.5	1.9	4.3	195.0	294.7	0.5	4.3	649.1	41.2	0.2	1.0	10.6	11.3	1.2	1.2	0.3	11.0	31.4	0.5	1.2	13.8	0.8	0.2	1.0	5.2	1.7	74.1	4.3	11.3	11.4	1.2	31.6	1.9	33.6	43.5	2.1	2.5	2.3	19.6	3.7	1.0	2.7	15.6	2.5	7.0	3.0	0.6	0.0	4.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	0.0	1.6	57.8	68.3	62.7	73.8	68.2	117.5	317.7	104.5	136.6	67.5	135.8	70.3	353.6	9.6	33.7	1.0	106.8	18.5	86.9	94.8	1.2	26.3	31.7	5.5	639.8	18.6	58.3	649.2	43.8	713.8	2.2	2.3	1772.6	5.5	2.9	48.1	71.1	144.6	45.6	24.0	4.0	48.2	1191.3	514.0	50.0	627.9	11.4	274.9	735.3	228.4	151.5	16.8	0.4	5.9	91.6	47.9	86.7	17.5	446.7	160.2	23.2	3.7	0.7	5019.8	0.0	0.0	0.3	9.9	13.8	41.0	2.2	141.8	0.5	20125.9	39.1	86.8	683.7	131.6	264.6	7.1	10.3	13.9	21.6	1767.7	68.3	1.0	1.3	34.3
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.5"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 40.3;kidney: 60.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 12.9;spinal cord: 22.6;white matter: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1"	"Region enriched"	"Detected in single"	102	"pons and medulla: 10.1"	"Group enriched"	"Detected in some"	168	"medulla oblongata: 8.1;spinal cord: 25.4"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	10.2	7.4	0.2	4.4	0.1	0.2	4.6	0.3	0.2	18.3	0.0	16.1	1.0	4.3	40.3	0.3	13.4	0.3	0.7	0.1	0.0	60.2	0.8	6.2	0.4	12.9	0.0	0.3	1.2	1.3	0.1	2.6	0.8	2.0	6.1	0.0	0.2	21.1	1.7	1.2	14.0	2.3	22.6	3.0	9.3	1.1	0.1	0.0	0.7	0.5	0.0	3.8	2.2	6.3	5.2	11.9	0.0	6.2	5.3	5.5	0.1	0.0	0.0	0.0	0.0	6.5	7.7	0.0	28.2	14.2	2.0	0.1	1.4	0.4	0.0	0.2	80.3	7.1	23.8	0.0	7.9	0.6	18.0	6.9	0.2	11.4	0.2	4.3	5.4	0.5	4.7	0.1	15.7	0.3	0.0	0.3	0.0	20.0	4.7	0.0	13.1	0.7	53.2	2.6	0.0	0.0	4.4	0.0	8.2	0.1	2.1	2.5	30.1	1.0	6.0	5.0	22.2	0.0	0.0	0.1	0.9	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	12.9	0.0	0.8	22.6	0.1	6.3	10.6	0.0	0.0	0.0	0.4	0.8	0.5	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	136.1	0.0	0.2	0.0	18.1	113.5	0.1	1.0	80.7	5.5	10.6	7.7	0.4	0.0	2.0	2.9	3.0	0.0	56.4	0.0	0.0	4.2	0.0	1.7	0.0	0.0	9.0	0.0	18.6	3.1	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.8	0.0	0.0	0.6	9.5	2.8	0.0	0.0	0.0	0.9	6.4	4.8	6.2	0.0	1.1	0.3	1.2	0.0	11.0	1.2
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Proximal enterocytes: 84.2;Proximal tubular cells: 224.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	8.9	12.0	18.8	6.1	24.5	5.8	8.7	20.6	26.8	4.3	22.7	9.5	26.3	5.3	13.3	8.3	12.9	6.4	5.8	19.1	22.6	50.9	70.5	7.3	11.0	20.3	20.8	5.5	13.8	14.8	9.0	3.0	20.6	8.4	9.2	10.9	8.8	9.5	2.3	7.1	26.9	4.4	20.5	7.9	8.9	3.7	20.8	38.9	13.2	2.6	9.5	5.2	3.9	21.1	4.3	10.4	1.7	1.8	4.6	6.9	7.8	3.4	8.6	3.5	2.8	2.9	5.3	5.8	5.2	5.8	3.5	8.4	1.3	2.0	3.6	11.9	1.6	2.1	4.6	12.7	19.4	1.5	2.8	4.3	3.3	7.2	7.2	6.2	7.9	16.0	1.9	7.1	4.8	26.8	3.7	1.4	1.6	18.1	6.0	4.6	4.2	3.3	9.6	5.5	6.9	8.6	7.5	6.5	7.6	2.5	6.0	8.1	7.4	1.6	1.3	14.3	6.1	9.0	10.4	1.0	7.3	2.4	2.8	100.7	13.0	19.1	30.5	24.1	25.4	39.3	26.0	24.7	18.1	26.7	20.2	27.2	2.8	33.1	47.6	20.9	52.2	24.8	18.8	24.5	20.6	26.8	19.1	22.6	20.3	20.8	20.6	20.5	20.8	21.1	6.2	12.8	8.7	14.7	9.3	6.8	3.2	7.3	4.0	8.9	10.0	8.4	9.9	10.0	8.8	5.5	0.0	8.0	11.3	8.4	80.3	11.3	0.4	34.6	2.0	5.6	7.3	2.5	4.7	16.1	4.6	8.0	4.6	7.0	20.8	10.2	3.3	44.3	11.1	10.1	5.6	12.8	12.2	11.6	7.5	2.0	4.4	8.2	12.4	11.2	19.8	38.0	24.7	8.0	11.4	5.4	21.7	4.1	12.1	4.6	84.2	224.4	28.3	3.5	0.0	8.8	5.9	1.4	1.5	5.4	5.8	3.0	13.7	9.9	11.2	4.2
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	190000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	833.0	374.9	99.4	151.1	124.0	44.2	583.2	112.7	149.7	640.3	1299.1	473.1	105.6	653.2	260.4	115.3	618.1	405.7	1117.2	132.7	143.8	1298.6	283.2	532.4	133.1	185.2	138.7	359.1	270.1	77.2	246.0	66.6	146.4	506.0	83.2	4.7	193.7	659.0	185.6	193.6	259.6	334.9	136.8	436.9	267.4	259.2	187.9	48.9	995.3	91.8	81.9	546.4	494.0	132.6	1.3	4.8	1.1	0.0	134.8	50.4	4.7	693.6	643.1	59.2	19.0	2.8	0.1	0.3	433.7	33.5	35.3	70.2	0.7	111.1	15.7	1.3	5.4	2.5	78.7	0.5	207.7	17.1	17.9	234.7	55.8	96.8	26.2	1471.3	138.2	0.6	0.5	0.9	142.8	0.0	0.5	74.5	5.9	0.0	1.3	13.4	0.4	2.8	682.7	0.0	1.0	1.8	130.2	9.5	0.0	276.3	1.8	64.6	1009.4	60.5	46.4	7.8	114.8	41.1	0.4	1.4	159.2	58.3	1.8	2.0	3.9	21.7	0.1	4.1	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.3	10.8	4.5	0.4	0.1	1.7	99.4	124.0	112.7	149.7	132.7	143.8	185.2	138.7	146.4	136.8	187.9	132.6	2254.8	112.2	20.2	164.9	16.2	238.5	127.2	300.5	24.5	5.9	27.7	53.5	148.2	20.0	90.6	2087.4	22.9	6.6	76.9	1.4	516.5	2455.3	75.9	1235.5	702.2	2740.1	1.2	82.7	0.7	15.1	8.3	1435.9	29.0	381.3	15.8	1205.0	3079.4	16.4	26.5	0.0	3.7	1.0	61.1	101.9	375.7	335.4	11440.4	70.4	944.5	151.8	41.8	17.1	345.0	11.6	0.8	84.6	1.5	11731.6	11.0	113.3	0.0	692.2	731.0	12.5	8184.6	155.0	4434.0	36.6	38.6	9.9	179.1	5.7	51.3	759.1	2.5	64.0
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846568-53865794	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;kidney: 59.8;liver: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	0.9	2.0	20.2	2.3	21.4	0.5	5.7	22.7	28.9	18.1	16.6	6.8	5.8	5.1	0.7	1.7	3.3	2.4	2.7	19.4	20.2	59.8	33.3	3.8	2.5	18.7	19.9	1.5	7.8	1.1	4.2	0.9	19.0	2.4	6.9	4.8	4.9	0.6	1.3	2.2	5.9	0.8	18.9	1.2	3.6	2.5	23.2	0.3	2.9	0.2	0.7	0.8	1.3	23.6	1.5	3.1	4.5	3.4	0.1	0.0	7.1	3.1	0.1	0.1	0.0	20.2	1.4	4.6	1.0	1.0	1.7	0.8	12.2	0.0	0.0	1.6	3.5	6.0	6.1	59.5	0.0	5.6	3.2	0.0	0.0	0.0	0.0	3.8	0.0	1.6	4.9	2.1	0.1	4.2	0.9	2.3	12.1	46.2	2.6	1.7	1.9	5.3	1.4	5.3	6.4	3.7	10.1	2.4	1.9	3.3	9.2	2.0	2.5	3.0	3.3	2.6	3.9	4.7	5.6	2.9	2.7	3.3	1.7	1.3	0.2	0.0	0.2	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.9	0.1	20.2	21.4	22.7	28.9	19.4	20.2	18.7	19.9	19.0	18.9	23.2	23.6	0.2	0.0	4.1	48.3	0.2	0.3	2.0	0.0	0.0	0.1	8.2	4.4	4.1	17.2	1.3	0.0	0.0	1.4	0.3	4.3	9.8	4.8	1.0	0.5	1.0	0.2	29.2	0.0	0.5	1.6	1.0	0.6	4.6	1.7	2.5	0.4	0.4	13.1	0.1	0.0	2.5	8.7	2.0	0.0	1.1	0.7	1.2	1.2	0.0	1.9	0.0	4.4	0.0	37.7	4.3	1.8	3.0	0.4	0.0	4.4	2.9	78.0	0.0	0.1	0.0	0.3	0.5	0.4	1.0	0.0	0.1	0.4	0.9	0.0	10.2	0.6
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	17.5	29.8	5.3	9.9	5.4	0.4	17.3	6.0	6.1	14.8	5.2	25.4	30.4	21.3	11.7	24.1	24.5	17.9	13.2	5.0	10.9	68.9	2.2	65.8	3.0	7.5	6.6	12.8	15.9	17.7	21.1	26.7	11.9	19.5	15.5	4.4	19.4	15.7	9.0	30.8	26.7	15.6	4.2	11.1	24.5	2.1	7.8	5.9	43.5	4.1	6.2	46.7	17.1	4.0	181.8	234.9	1.4	7.5	4.3	17.5	37.3	83.4	177.9	123.1	93.2	5.3	276.2	0.4	507.9	59.5	400.4	126.8	2.2	647.2	73.9	22.9	3.5	0.1	56.8	1.6	105.1	0.3	5.0	21.6	313.5	123.2	540.7	572.8	91.6	9.1	0.1	2.6	236.0	52.9	0.7	0.5	5.5	81.2	141.0	0.4	12.1	13.7	562.0	311.1	9.7	3.9	89.8	12.2	205.0	56.2	21.1	2.4	200.8	541.8	169.4	5.6	329.5	8.1	14.2	5.9	920.8	1.9	570.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	5.4	6.0	6.1	5.0	10.9	7.5	6.6	11.9	4.2	7.8	4.0	8.5	54.5	30.1	3.6	3.4	57.4	63.5	63.5	48.3	18.0	17.1	32.0	5.3	27.1	26.2	77.3	25.0	2.8	1.3	91.2	0.0	111.9	0.5	26.4	3.1	14.7	14.5	0.0	24.3	105.1	3.2	5.3	47.4	20.7	3.8	3.4	8.9	0.3	1.1	3.3	20.0	25.1	16.2	1.2	8.2	0.6	1.8	2.0	17.8	8.4	4.3	3.1	2.1	3.0	0.8	245.6	26.7	4.1	4.5	72.6	69.6	4.4	21.7	16.2	13.1	5.6	23.4	0.5	1.6	17.0	23.2	1.8	3.8	0.9	44.7	104.2
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358285	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.6;pancreas: 1.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.7;Glandular and luminal cells: 2.7;Proximal tubular cells: 1.1;Spermatocytes: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;EFO-21: 4.1;Hep G2: 5.3"									HPA036021	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	4.6	0.9	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	3.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.8;thyroid gland: 52.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Endometrial ciliated cells: 23.9;Excitatory neurons: 15.6;Glandular and luminal cells: 16.3;Inhibitory neurons: 18.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 75.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;CAPAN-2: 7.2;HDLM-2: 7.0;HMC-1: 20.3;K-562: 7.0;SK-BR-3: 14.0;T-47d: 12.0;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	0.8	1.3	3.1	2.8	1.9	0.7	3.5	17.3	75.8	6.2	0.0	0.8	0.6	2.8	2.6	1.6	23.2	0.5	2.4	12.5	0.0	17.8	4.4	4.6	2.6	20.0	3.4	0.4	5.7	14.1	21.1	1.2	11.4	4.4	0.5	8.0	3.0	8.1	1.3	2.9	3.3	0.7	3.1	5.7	1.2	3.6	15.0	2.5	52.1	0.1	1.9	2.0	1.5	20.2	0.0	0.5	0.0	1.2	0.0	0.0	3.8	0.1	0.0	0.0	0.0	7.7	7.2	0.7	0.9	0.0	0.5	1.1	0.2	0.0	0.0	7.0	1.7	0.0	0.0	2.0	0.0	0.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.0	0.0	2.7	0.1	0.0	0.9	1.1	3.3	0.0	0.1	0.0	0.5	0.3	0.0	1.2	1.7	14.0	0.0	0.1	12.0	2.4	0.2	0.0	8.2	0.0	0.0	0.0	0.1	0.5	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	1.9	17.3	75.8	12.5	0.0	20.0	3.4	11.4	3.1	15.0	20.2	0.3	0.0	0.5	3.3	2.4	0.8	1.0	0.2	0.0	8.8	4.4	2.5	2.7	1.5	2.4	20.2	8.4	2.3	0.2	0.2	0.0	1.6	0.3	23.9	1.2	0.7	4.2	0.0	15.6	1.4	0.9	0.2	0.5	16.3	0.0	0.1	1.1	2.4	2.8	1.7	18.3	0.1	4.1	7.3	1.9	0.6	0.6	6.3	0.0	3.7	3.2	0.8	0.0	2.0	1.9	0.3	0.1	0.0	0.3	1.3	0.0	3.3	1.1	6.2	0.0	0.1	1.1	1.3	1.2	0.4	0.6	2.3	0.4	0.0	0.1	0.9
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	117	"kidney: 198.0"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 195.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	39	"RPTEC TERT1: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.2	0.1	1.0	0.1	1.6	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.5	0.1	198.0	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.1	0.3	0.5	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.6	0.0	0.0	0.1	0.0	195.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 241.6;thyroid gland: 129.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.7	0.5	0.8	20.7	0.7	14.1	2.8	0.9	6.7	12.7	0.5	0.9	1.5	0.5	11.0	8.5	1.2	30.4	0.8	0.8	0.6	241.6	2.8	42.2	1.2	0.9	0.6	0.3	57.8	0.7	0.4	4.6	1.8	2.6	0.4	0.5	25.5	14.6	0.5	3.0	0.7	2.4	0.3	11.7	40.5	1.8	5.4	1.9	129.5	3.0	1.9	25.1	8.1	1.1	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	0.8	0.7	0.9	6.7	0.8	0.6	0.9	0.6	1.8	0.3	5.4	1.1	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin cysteine rich BMP regulator"	Q6ZWJ8	7	128862042-128910719	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 17.0"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 53.3;Early spermatids: 23.1;Late spermatids: 28.7;Proximal enterocytes: 55.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.3;HMC-1: 5.1;U-87 MG: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	1.5	0.1	0.0	0.2	0.0	0.0	0.3	1.8	0.1	0.9	0.0	0.1	0.4	0.0	0.0	1.6	0.5	1.0	0.1	0.0	0.0	17.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.4	2.2	0.1	0.2	1.0	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.5	0.2	0.0	0.2	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	9.3	0.2	1.3	0.0	0.1	0.6	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.8	0.1	0.0	5.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.9	12.8	3.4	0.3	1.9	0.0	0.9	0.0	1.2	3.0	0.6	0.9	0.8	0.0	3.7	53.3	2.1	0.2	0.9	2.1	0.0	0.3	23.1	2.1	1.3	0.8	2.4	0.0	0.4	0.2	4.1	2.0	3.1	2.9	2.5	0.2	2.2	0.3	1.0	3.3	2.6	5.3	0.0	1.3	0.0	28.7	1.2	3.1	0.0	0.0	0.1	0.4	2.1	0.0	0.2	4.3	1.9	0.4	1.9	0.3	55.9	6.4	0.0	1.3	0.0	7.3	1.7	6.3	3.7	2.1	0.0	1.4	2.2	0.5	9.2	4.1
KIAA1191	"FLJ21022, p33MONOX, p60MONOX"	ENSG00000122203	KIAA1191	Q96A73	5	176346062-176361807	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044701, HPA048145"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA044701: AB_2679053, HPA048145: AB_2680283"	"unprognostic (7.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.39e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (5.02e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.73e-2)"	41.7	44.3	40.6	26.7	43.8	30.8	46.0	33.4	43.2	50.9	44.3	46.3	49.6	49.4	52.5	61.2	66.8	42.9	86.7	45.1	47.4	199.3	70.4	47.9	29.2	39.1	39.6	90.0	57.3	87.0	33.1	38.2	45.1	55.2	44.5	58.6	72.3	64.8	70.9	44.2	51.0	55.1	32.7	34.0	62.0	12.8	46.3	36.6	60.8	63.2	37.5	49.7	34.3	33.9	61.5	63.4	105.1	142.7	95.6	72.8	82.6	86.8	86.2	96.6	106.1	118.2	60.2	24.0	111.9	105.5	145.2	53.8	67.6	157.6	113.1	125.0	81.4	27.9	41.4	63.1	111.0	24.0	47.2	73.9	115.2	83.2	70.8	109.6	120.7	39.1	43.1	51.2	108.6	81.7	34.7	14.5	47.1	65.6	81.2	25.2	66.1	21.1	92.6	60.0	82.8	91.6	92.3	45.7	103.6	94.6	66.9	27.1	106.5	88.4	40.2	65.7	107.5	33.7	49.7	27.7	69.0	46.5	71.3	33.8	23.8	32.9	28.7	28.6	32.1	25.1	27.3	27.6	23.1	18.3	28.4	29.7	10.4	27.4	29.0	18.2	40.2	28.6	40.6	43.8	33.4	43.2	45.1	47.4	39.1	39.6	45.1	32.7	46.3	33.9	26.8	54.5	41.0	16.6	31.3	34.0	40.6	29.1	39.3	31.3	40.8	35.6	61.2	34.3	35.9	33.1	25.0	25.0	35.8	38.7	93.9	37.2	2.5	27.5	24.5	30.2	43.2	17.4	19.6	27.4	13.7	29.6	28.1	35.6	17.7	20.6	26.0	45.8	15.8	48.8	22.7	28.3	30.5	21.4	27.1	7.9	31.1	19.8	21.4	12.2	29.5	33.5	13.4	12.5	16.0	37.9	37.5	38.4	28.6	45.0	50.1	304.3	35.1	30.8	13.1	23.8	26.0	7.2	6.0	38.7	31.7	33.4	30.3	20.0	30.6	47.5
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 162.3;pancreas: 85.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020192, HPA024127"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Plasma membrane"		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	2.2	1.1	2.1	0.0	25.3	0.4	3.6	11.4	2.8	7.8	25.5	4.2	1.0	0.2	8.0	24.7	0.2	2.0	0.9	162.3	27.7	1.6	0.5	0.6	1.1	0.7	85.4	0.8	0.6	1.1	1.0	7.0	4.2	0.1	3.6	4.8	0.0	1.4	16.1	0.4	0.4	0.2	11.0	2.4	1.3	1.3	31.8	0.0	0.1	0.2	0.3	0.8	0.0	4.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.6	0.2	0.0	5.2	0.0	0.6	0.0	0.2	0.1	0.2	0.0	0.9	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0	0.0	0.4	0.1	17.2	0.6	0.0	0.0	0.1	44.8	0.2	6.6	0.1	0.0	0.9	0.0	0.2	4.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	0.4	3.6	2.0	0.9	0.6	1.1	1.0	0.4	1.3	0.8	0.1	0.0	4.4	0.0	1.3	0.0	0.9	0.6	0.0	0.0	20.3	10.8	0.4	105.8	0.0	90.1	0.0	0.1	0.0	7.9	80.3	43.3	7.0	8.3	1.5	0.3	64.1	0.0	0.7	11.8	9.3	0.4	14.8	15.6	0.0	0.0	0.0	10.2	0.3	0.0	0.3	22.0	0.0	0.3	0.0	14.7	0.6	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.7	21.3	0.0	0.0	2.2	60.3	79.1	0.0	0.0	0.0	0.0	0.3	3.2	7.9	0.0	0.0	0.5	0.9	0.3	28.9	0.5
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480930-18485974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 8.4;kidney: 19.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 5.7;Collecting duct cells: 9.2;Endometrial ciliated cells: 4.4;Gastric mucus-secreting cells: 5.6;Hepatocytes: 7.6;Proximal tubular cells: 9.9;Respiratory ciliated cells: 5.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.4;CAPAN-2: 10.4;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.5;RT4: 9.5;T-47d: 10.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.88e-4)"	0.5	0.0	0.0	0.0	0.0	0.0	4.5	0.7	0.1	2.3	8.4	0.6	0.4	0.0	0.2	1.3	0.8	1.0	0.0	0.5	0.0	19.5	4.7	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.4	0.7	0.0	1.7	1.1	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.2	0.1	0.0	1.6	0.0	0.0	3.2	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	10.4	0.0	5.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.1	0.0	0.2	0.0	0.0	11.5	9.5	2.8	0.0	0.0	0.8	0.0	1.0	10.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	1.7	0.4	1.2	5.7	2.2	9.2	0.0	0.1	0.0	0.3	1.9	2.0	0.4	4.4	0.3	0.1	0.0	0.0	0.0	2.2	0.1	0.1	5.6	3.0	0.0	0.1	0.0	7.6	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	1.1	0.0	9.9	5.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6
LAMTOR3	"MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3"	ENSG00000109270	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3"	Q9UHA4	4	99878336-99894428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026858	Supported					NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026858: AB_1853523"	"unprognostic (7.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.75e-9)"	"unprognostic (5.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-2)"	16.9	25.7	14.6	16.4	15.4	32.5	24.9	17.3	26.7	20.8	14.5	24.9	23.5	23.3	39.5	30.1	19.2	19.4	24.3	15.4	15.8	38.1	21.7	17.5	20.4	15.2	16.4	24.3	17.3	36.4	18.9	22.5	15.5	28.3	26.2	23.3	24.6	17.1	21.0	23.8	23.8	19.1	13.6	16.6	21.3	15.6	15.7	20.1	33.9	20.2	21.0	23.8	21.6	14.8	19.9	6.4	26.1	17.5	36.2	35.1	20.2	18.9	18.6	18.3	15.0	15.0	39.0	17.3	18.6	19.5	17.8	9.3	26.1	23.9	25.4	20.5	14.0	12.0	13.1	28.3	35.0	36.1	34.1	23.1	48.9	13.8	15.4	26.9	20.7	12.9	30.4	21.1	35.2	20.4	30.5	35.4	16.1	42.8	10.7	20.2	14.9	19.5	55.2	22.9	20.2	25.2	12.2	40.6	41.0	26.3	20.9	29.3	20.5	14.2	16.7	24.0	14.8	26.5	30.6	33.8	30.0	20.6	20.5	43.5	17.6	38.5	9.8	26.8	12.9	11.4	12.1	11.1	19.0	9.3	14.0	14.1	58.6	18.8	28.4	13.3	13.5	13.8	14.6	15.4	17.3	26.7	15.4	15.8	15.2	16.4	15.5	13.6	15.7	14.8	38.8	57.7	33.7	8.8	35.6	49.6	60.7	77.8	68.3	28.0	53.9	46.1	35.9	24.3	44.2	35.0	12.5	48.8	30.3	95.7	135.0	50.9	12.0	38.3	29.8	27.6	36.1	46.7	15.2	32.6	55.8	37.4	43.8	61.3	41.8	23.9	22.9	25.2	77.8	18.5	13.7	48.9	52.9	41.5	89.8	9.4	40.0	56.9	37.4	3.7	60.7	50.7	38.1	8.5	12.7	43.9	102.5	42.5	30.7	63.9	53.9	130.2	30.3	26.3	19.7	30.9	30.9	72.6	40.2	86.6	64.6	78.4	32.6	22.8	43.3	78.8
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.5	0.2	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LRATD2	"BCMP101, FAM84B, NSE2"	ENSG00000168672	"LRAT domain containing 2"	Q96KN1	8	126552443-126558478	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 43.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.9;Cardiomyocytes: 6.8;Cytotrophoblasts: 5.4;Endothelial cells: 4.0;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 78.5;AN3-CA: 104.6;MCF7: 112.1;PC-3: 72.5;SuSa: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050782, HPA062115"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA050782: AB_2681235, HPA062115: AB_2684686"	"unprognostic (2.46e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (2.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.75e-5)"	6.1	2.5	6.1	3.2	7.1	3.0	16.3	7.1	5.2	7.3	25.4	7.6	13.1	7.3	6.8	19.5	8.3	8.1	4.0	5.2	7.1	27.3	8.2	12.0	3.8	8.9	7.5	2.9	16.3	9.2	4.5	7.5	6.9	8.3	8.2	19.1	43.7	6.8	2.5	7.2	7.4	4.6	7.0	3.2	17.6	2.1	5.8	3.2	7.4	5.2	6.3	6.4	5.8	12.6	78.5	9.8	5.8	104.6	0.0	0.0	6.9	1.1	2.7	0.8	1.2	3.0	44.9	0.0	48.5	0.2	8.4	34.3	3.1	14.7	1.3	0.1	63.0	0.0	0.2	0.5	1.4	0.1	1.6	0.6	20.3	0.0	9.0	17.6	6.3	19.7	0.1	0.0	0.5	112.1	2.6	0.0	5.3	65.7	72.5	0.0	2.3	0.8	41.8	32.5	29.7	0.0	2.4	34.9	32.4	162.9	52.0	0.7	0.0	0.3	9.4	0.1	2.0	1.3	0.2	0.1	0.9	5.0	19.6	1.7	0.0	1.5	1.4	0.0	1.4	0.3	1.8	2.7	0.0	0.8	2.0	2.1	0.1	1.1	0.0	0.0	2.6	0.9	6.1	7.1	7.1	5.2	5.2	7.1	8.9	7.5	6.9	7.0	5.8	12.6	20.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	1.5	0.0	0.0	0.0
LY6L		ENSG00000261667	"Lymphocyte antigen 6 family member L"	H3BQJ8	8	143080457-143083001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;kidney: 1.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"prostate cancer: 2.8"	"Region enhanced"	"Detected in single"		"thalamus: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"																				"unprognostic (5.25e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.5"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 161.4"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted in other tissues"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.9	1.6	3.1	1.2	3.3	0.9	2.1	6.0	4.3	3.6	1.8	2.3	1.2	2.3	1.8	1.3	2.3	0.8	2.0	3.0	2.6	23.5	5.8	1.9	1.6	3.2	2.8	2.4	1.6	0.2	2.0	0.7	3.2	3.3	1.1	2.6	1.7	0.7	2.1	1.7	2.8	0.9	2.6	4.7	1.7	5.5	3.1	2.4	2.6	0.4	1.3	2.5	2.3	4.1	0.3	2.3	1.7	2.8	3.9	2.2	1.9	0.9	1.0	0.9	1.5	0.4	2.0	0.5	1.5	0.4	0.2	1.0	2.3	0.3	1.1	1.6	1.4	1.3	2.0	0.7	0.7	0.4	3.1	1.8	2.4	1.4	0.6	2.0	0.5	3.0	0.7	1.5	1.0	0.5	1.2	4.0	0.4	1.2	2.1	2.9	1.0	0.8	3.9	0.9	1.0	0.6	0.3	0.7	0.6	2.0	0.3	0.4	1.3	1.2	1.4	2.0	1.0	1.7	1.0	0.3	0.3	2.4	0.5	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	3.1	3.3	6.0	4.3	3.0	2.6	3.2	2.8	3.2	2.6	3.1	4.1	0.6	0.0	0.0	3.6	1.5	0.0	0.2	0.6	0.0	1.0	0.8	0.8	0.5	1.5	1.5	1.8	2.1	0.3	0.5	0.5	21.5	0.7	10.8	0.2	0.3	0.5	0.0	0.0	4.6	0.2	0.2	0.4	0.0	0.2	4.5	0.8	1.1	0.5	0.3	0.0	4.2	0.3	0.0	0.3	0.3	4.8	0.3	1.4	0.0	2.8	0.8	0.2	0.0	2.0	5.6	0.6	0.1	0.4	0.0	0.6	0.2	161.4	0.2	0.6	0.0	0.1	0.5	2.4	1.1	0.0	0.0	0.5	0.6	0.3	0.4	0.2
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528962-31530232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"kidney: 81.8"	"Group enriched"	"Detected in some"	44	"Distal tubular cells: 401.1;Proximal tubular cells: 414.8"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	81.8	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.3	0.4	0.1	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	401.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029817	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1;salivary gland: 68.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 162.1;SK-MEL-30: 201.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004880	Approved				"Intracellular and membrane"	NA	NA		41000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	10.0	1.7	2.3	3.8	1.7	2.3	7.4	2.1	3.8	8.1	27.2	4.0	2.4	6.8	0.7	2.9	8.6	1.6	7.5	2.5	1.9	35.1	1.6	1.9	1.9	0.6	2.8	1.2	4.6	10.3	2.9	1.5	0.4	4.1	2.1	0.3	68.7	5.5	1.1	16.4	9.9	1.2	0.5	1.1	1.7	3.4	6.5	2.9	3.1	1.0	1.6	3.2	7.3	2.0	162.1	34.6	0.4	1.2	4.8	6.0	4.0	2.8	1.5	5.2	6.3	9.8	23.6	4.5	33.3	5.6	4.5	49.6	1.8	0.1	2.3	7.4	10.8	5.6	7.9	4.1	30.5	0.8	30.8	33.0	4.3	4.3	0.4	0.2	0.8	8.9	4.3	30.5	3.1	9.8	9.3	0.0	3.6	6.9	22.5	13.4	5.3	2.0	0.8	1.5	3.1	11.3	32.5	2.8	201.4	3.8	9.5	4.8	1.2	1.2	26.8	5.5	19.9	5.3	46.0	4.5	3.9	9.5	0.2	0.0	0.1	0.0	0.2	0.2	0.8	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	2.3	1.7	2.1	3.8	2.5	1.9	0.6	2.8	0.4	0.5	6.5	2.0	0.8	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	21.1	20.6	0.0	0.0	1.8	14.7	0.0	0.2	1.0	0.0	0.0	28.3	0.0	3.2	6.1	0.6	0.0	0.0	0.0	5.7	0.3	3.7	0.0	4.4	0.0	3.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	66.4	0.0	0.0	1.7	0.0	0.0	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	63.6	100.6	41.9	31.1	52.7	118.7	54.5	39.5	53.2	62.9	53.1	45.2	28.3	46.3	70.5	67.8	42.4	32.9	42.0	44.9	41.7	140.8	16.5	49.2	36.1	44.7	43.4	48.6	39.7	68.1	44.7	36.8	40.3	45.6	31.1	38.6	49.8	28.0	77.4	51.5	39.2	33.1	47.1	54.7	44.3	11.0	46.5	56.9	52.7	52.9	44.1	49.5	57.5	48.2	50.8	41.8	95.3	77.0	99.5	156.2	36.1	85.7	103.8	58.8	68.5	30.4	79.9	92.4	64.8	132.6	53.3	33.0	61.1	71.4	71.2	70.5	72.0	41.1	34.1	120.6	75.1	35.8	81.0	111.6	76.6	54.3	81.1	119.4	111.4	97.8	61.8	57.6	112.3	60.2	93.7	71.2	87.6	60.8	64.0	124.8	80.8	82.7	116.3	44.5	61.8	116.0	66.1	53.1	195.0	65.6	44.5	16.7	75.0	96.9	43.9	62.2	49.5	72.8	102.8	71.4	107.6	80.8	66.3	111.0	75.7	33.4	11.4	14.3	13.5	18.3	19.0	21.1	42.5	20.6	20.4	16.2	36.1	17.0	12.0	14.3	20.4	28.8	41.9	52.7	39.5	53.2	44.9	41.7	44.7	43.4	40.3	47.1	46.5	48.2	82.4	19.2	26.1	32.3	66.9	71.8	89.5	143.8	51.2	52.6	77.7	61.7	53.6	34.3	81.3	86.5	45.9	79.4	94.3	49.6	281.8	119.5	7.8	56.4	68.9	89.2	84.9	146.9	48.2	122.9	124.2	67.6	42.8	64.7	47.7	70.0	98.6	11.2	95.8	45.4	37.8	80.4	101.7	181.7	103.3	6.3	63.3	124.2	104.9	40.3	270.1	92.9	109.2	34.2	28.3	114.9	51.5	65.1	58.0	149.4	81.1	414.2	50.4	43.7	65.7	48.9	108.8	17.1	25.1	74.7	77.0	139.1	111.4	57.4	80.5	142.9
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 66.7;stomach 1: 132.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.3;Collecting duct cells: 9.2;Distal tubular cells: 13.7;Endometrial ciliated cells: 9.9;Glandular and luminal cells: 40.5;Proximal tubular cells: 7.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"amygdala: 11.4;basal ganglia: 8.4;cerebral cortex: 18.4;hippocampal formation: 14.1;white matter: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 59.8"	HPA055407	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA055407: "	"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	2.2	0.4	11.4	1.1	8.4	0.0	2.7	0.6	18.4	8.5	0.0	13.8	1.9	1.0	9.2	1.4	2.5	16.8	0.9	14.1	0.0	66.7	0.2	6.8	0.4	0.0	0.0	0.6	1.4	0.4	1.5	6.2	0.0	1.4	18.2	14.0	17.1	0.6	0.3	5.1	1.4	0.8	0.0	0.6	132.6	0.5	0.0	0.6	0.4	0.7	1.3	0.7	0.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	8.4	0.6	18.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.3	6.4	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	2.9	0.0	0.0	6.2	9.2	0.0	0.5	0.7	0.0	13.7	1.4	0.0	9.9	6.0	2.5	0.0	0.0	0.0	6.2	0.1	0.5	0.0	40.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	7.7	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"kidney: 700.9"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 4564.6"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.9;Hep G2: 5.7;Karpas-707: 12.8;U-266/70: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039451, HPA039562"	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favorable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.8	0.5	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	5.3	0.0	0.2	0.2	700.9	0.4	0.0	0.7	0.2	0.2	0.0	1.2	0.0	0.1	0.1	0.3	0.5	0.0	0.1	0.3	0.1	0.0	0.3	0.2	0.0	0.1	0.2	1.1	0.2	0.2	0.2	14.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.1	2.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.6	0.4	0.0	0.2	0.2	0.0	0.0	24.9	0.0	0.2	0.4	5.7	2.8	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	12.8	0.0	1.2	0.0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.6	0.1	0.1	0.3	0.0	0.0	0.6	0.5	0.1	1.4	0.0	0.0	0.5	0.1	0.1	7.8	0.7	0.3	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.0	1.7	0.0	13.0	0.8	0.9	0.1	0.0	0.6	0.7	0.8	0.1	1.5	0.0	99.3	0.0	0.0	0.3	0.3	424.6	0.0	0.0	0.1	0.2	0.2	1.2	0.0	0.0	0.9	0.1	0.3	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	23.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	4564.6	0.0	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.3	7.8	0.0	0.1	0.9
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67240713-67336061	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.4	8.7	13.9	6.3	20.9	5.6	10.6	17.6	16.5	8.8	26.6	12.7	20.4	6.3	21.1	13.6	7.3	7.9	7.4	11.9	17.4	31.4	19.6	12.3	4.8	18.2	18.2	6.1	8.7	19.6	7.2	9.8	18.3	16.2	12.0	17.2	18.4	12.7	18.0	8.4	20.7	7.2	18.1	6.6	9.4	8.8	17.5	10.3	25.1	13.6	6.1	9.0	8.4	27.5	156.4	24.4	24.1	18.5	13.3	12.3	20.6	46.4	23.6	33.2	21.6	23.8	45.9	12.7	21.5	37.8	11.0	31.0	13.9	26.1	50.2	5.5	9.5	11.8	23.6	16.8	15.5	4.5	8.5	13.1	10.0	17.9	23.7	24.2	19.0	13.5	12.6	4.7	53.9	20.4	14.4	5.0	7.7	22.2	16.2	12.2	37.1	15.2	30.1	36.8	13.2	9.4	28.2	27.0	15.5	21.1	28.6	9.2	29.2	41.4	87.2	13.8	19.9	7.8	7.6	19.3	27.2	10.1	14.7	0.1	0.5	0.8	0.4	1.0	0.3	1.1	0.5	0.6	0.8	0.4	1.1	0.6	0.0	2.2	0.7	0.6	0.3	0.4	13.9	20.9	17.6	16.5	11.9	17.4	18.2	18.2	18.3	18.1	17.5	27.5	13.2	64.1	28.9	37.2	8.8	21.0	26.0	14.6	22.2	8.5	22.4	12.8	24.7	11.5	21.1	22.0	43.8	23.1	5.2	47.2	13.7	21.7	5.9	29.5	15.0	17.7	5.4	6.7	24.8	26.9	11.3	17.3	18.3	46.2	5.1	15.8	17.2	20.7	17.6	3.3	34.7	21.2	12.2	11.9	13.4	4.5	8.1	9.2	3.6	22.5	6.6	23.4	3.1	41.2	129.8	26.7	32.5	11.3	13.1	30.1	54.3	33.5	14.9	34.3	6.6	17.7	22.2	22.4	36.1	29.2	17.3	17.5	7.7	7.5	22.4	38.7
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 281.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 747.4;Prostatic glandular cells: 568.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846"	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.06e-5)"	67.6	72.5	53.9	33.8	56.1	15.6	46.1	53.0	118.1	42.7	85.9	81.6	22.7	37.1	50.7	31.3	37.9	24.8	57.3	55.4	60.8	281.0	50.6	37.8	46.7	54.7	56.5	41.7	22.2	24.2	39.4	51.8	55.6	33.1	36.5	25.6	26.2	41.6	96.1	53.5	39.0	36.7	58.9	28.6	51.3	44.8	63.3	38.3	97.5	76.8	49.8	50.6	33.7	57.8	70.8	56.6	211.0	77.2	74.1	72.9	71.4	79.5	185.4	68.7	70.0	181.8	134.9	105.6	51.7	104.0	92.8	28.7	124.6	106.0	73.4	193.5	65.4	89.6	34.3	47.8	35.4	45.2	31.7	35.0	107.8	127.2	116.5	104.2	47.4	45.2	116.5	28.0	140.7	66.0	73.4	104.1	136.9	135.4	122.1	99.6	37.4	101.5	307.4	60.4	187.5	50.0	84.5	46.2	103.6	112.6	87.3	58.7	24.3	62.8	36.6	115.4	46.3	132.5	125.8	96.3	204.2	118.4	62.8	67.0	53.8	60.4	90.3	53.7	66.6	74.9	67.0	81.4	56.1	48.4	83.8	87.3	46.8	115.7	57.5	101.4	74.0	79.6	53.9	56.1	53.0	118.1	55.4	60.8	54.7	56.5	55.6	58.9	63.3	57.8	45.1	22.4	40.9	32.3	83.9	266.8	229.8	226.6	126.9	40.5	78.9	125.9	59.8	28.6	75.8	252.0	10.4	195.2	103.0	56.3	747.4	41.1	83.1	85.2	88.6	58.0	91.5	45.4	25.7	36.7	237.0	111.7	32.6	58.6	137.7	184.5	25.7	95.7	126.5	8.4	57.9	211.0	75.3	36.4	207.6	73.1	28.0	104.8	101.4	32.8	164.0	37.9	108.1	45.2	6.2	52.8	138.5	102.7	102.0	568.4	61.0	159.2	66.0	26.5	118.3	26.9	104.8	90.4	136.5	71.0	331.0	182.4	124.2	49.8	99.9	335.6
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657731-56660698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 585.6;kidney: 573.8;liver: 562.0;thyroid gland: 1183.2"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 10399.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 55.6;classical monocyte: 30.2;gdT-cell: 47.0;MAIT T-cell: 41.8;memory B-cell: 25.7;memory CD4 T-cell: 48.9;memory CD8 T-cell: 80.3;naive CD4 T-cell: 49.4;naive CD8 T-cell: 85.5;T-reg: 89.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.4;NB-4: 238.9;NTERA-2: 137.1;RPTEC TERT1: 754.6;THP-1: 131.9;U-937: 126.2"															NA	NA		160000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	45.7	60.4	375.3	29.9	386.7	10.2	16.5	415.0	585.6	8.1	339.9	158.4	82.2	8.6	2.7	10.6	19.8	19.1	7.9	359.9	376.2	573.8	562.0	11.5	23.4	417.6	407.6	2.8	312.3	5.0	23.2	4.0	396.9	70.5	123.0	52.5	18.4	14.0	2.8	8.5	222.2	16.5	379.1	20.5	88.3	4.5	406.8	6.3	1183.2	1.8	14.5	14.8	6.0	361.3	4.9	7.4	0.0	0.2	0.4	0.3	10.0	6.1	15.6	5.6	9.5	2.0	29.5	0.1	19.3	1.3	8.8	26.5	51.5	6.0	5.8	143.4	7.1	8.9	1.4	2.6	3.7	0.2	100.9	1.5	1.7	6.1	1.7	2.5	0.8	2.1	0.4	0.1	0.3	14.7	0.4	238.9	137.1	1.2	12.9	0.0	0.6	4.4	754.6	5.3	75.1	8.3	6.1	2.4	2.6	19.8	3.5	131.9	0.0	0.0	1.7	0.9	0.7	0.4	0.0	0.0	87.5	126.2	1.1	55.6	30.2	8.9	47.0	2.8	41.8	25.7	48.9	80.3	8.2	10.7	49.4	85.5	4.8	8.1	1.4	3.3	89.2	64.1	375.3	386.7	415.0	585.6	359.9	376.2	417.6	407.6	396.9	379.1	406.8	361.3	25.9	0.0	9.3	18.6	55.4	8.5	28.1	18.6	18.2	0.0	42.0	77.1	9.5	181.6	15.1	327.4	0.0	6.7	27.5	652.8	1119.2	194.4	0.6	376.6	79.5	16.8	170.9	95.6	0.1	123.2	379.6	22.5	57.1	946.3	11.4	77.8	48.9	1365.5	29.6	0.0	0.0	631.0	4.1	70.3	9.4	1.9	31.4	115.6	92.5	2.8	53.4	0.0	27.8	1.0	0.3	126.5	1252.2	5.3	65.9	107.0	2028.8	10399.1	22.6	0.0	6.6	26.4	41.6	3.2	1.5	3.9	8.0	19.4	68.6	6.9	851.3	19.2
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.0;intestine: 1.2;kidney: 2.1;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720884-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.5;kidney: 69.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	6.7	5.1	4.3	1.3	5.0	0.9	7.9	7.0	6.7	23.0	3.0	30.0	3.0	5.0	4.5	58.5	20.0	6.4	6.3	3.6	3.4	69.7	21.1	7.9	0.8	4.1	2.7	11.8	16.1	2.0	16.5	0.5	4.0	20.9	7.2	8.1	40.3	1.1	7.0	8.0	14.7	0.8	1.4	6.1	9.8	8.5	4.2	0.8	16.2	1.0	1.4	21.0	26.0	5.0	0.9	0.0	0.2	0.7	0.4	0.0	0.7	0.0	0.2	0.0	0.1	0.0	3.7	0.1	0.7	0.0	0.2	1.5	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.1	0.7	3.9	0.1	1.0	0.1	1.1	0.1	3.6	1.3	0.4	0.0	28.1	0.2	0.5	0.2	0.0	0.0	0.2	0.8	1.0	0.1	1.3	1.7	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.0	7.0	6.7	3.6	3.4	4.1	2.7	4.0	1.4	4.2	5.0	0.9	35.3	16.7	16.6	0.5	1.8	10.0	6.4	0.6	19.9	3.2	1.5	0.7	14.3	43.7	22.0	35.5	0.1	0.2	53.2	1.9	55.5	0.1	3.5	1.3	1.7	13.8	5.3	7.5	9.9	0.1	1.8	13.3	6.2	1.3	5.3	3.3	7.3	0.5	11.8	7.7	7.3	152.5	1.0	0.8	0.4	5.3	1.1	3.6	1.0	0.0	4.7	0.0	5.0	3.0	12.2	16.9	6.4	1.7	14.2	16.9	3.3	66.5	20.5	0.0	8.8	3.3	1.3	1.3	4.3	1.8	0.0	1.7	1.0	15.2	84.4
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261479-3278461	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favorable (6.62e-6)"	"unprognostic (1.27e-2)"	360.1	441.4	172.7	232.6	179.2	301.8	377.8	181.2	233.2	317.9	206.8	436.4	420.1	265.9	482.9	509.1	297.0	278.9	312.6	185.2	186.5	559.9	406.1	426.9	272.3	186.2	180.1	231.7	224.3	418.7	189.7	405.2	184.9	244.1	439.6	103.9	364.9	273.0	269.7	342.1	403.5	248.4	180.4	274.1	321.4	152.9	183.3	303.8	340.5	214.7	314.8	404.3	347.9	181.5	565.6	294.1	253.8	247.3	726.9	598.1	437.1	839.9	719.9	751.9	769.3	611.7	439.0	282.5	360.1	1154.6	576.7	277.3	424.3	967.7	748.6	166.1	180.7	285.0	297.2	482.8	744.0	645.0	428.0	533.6	879.0	512.7	320.4	659.9	1128.1	283.3	247.8	266.3	971.9	1146.7	372.0	450.3	170.1	666.5	249.7	181.0	320.2	228.5	1572.8	995.6	208.1	217.4	836.3	497.2	524.7	403.6	429.2	379.3	1422.8	736.3	1111.3	654.0	1036.9	148.1	153.2	342.8	448.2	256.9	586.8	1484.7	500.6	1513.2	643.7	666.4	548.3	436.8	619.3	701.5	582.0	360.0	501.2	582.5	1141.6	485.2	799.0	797.2	742.7	1294.1	172.7	179.2	181.2	233.2	185.2	186.5	186.2	180.1	184.9	180.4	183.3	181.5	846.5	807.7	516.2	16.3	279.4	634.5	889.6	2141.6	412.6	82.6	394.7	556.9	755.3	444.7	1157.4	542.6	25.0	1084.6	470.9	1301.7	1048.7	1453.7	164.3	617.3	362.5	674.4	243.9	269.7	21.9	1470.9	1082.5	447.4	290.0	705.2	446.8	372.9	683.9	292.2	614.1	65.6	20.4	590.3	990.7	375.7	450.1	225.0	446.4	448.1	345.1	52.5	911.6	185.7	461.4	14.1	21.6	2199.0	1180.2	433.3	121.6	814.9	1459.2	1477.9	891.9	94.5	355.0	269.5	542.6	240.0	208.9	486.5	568.4	1402.6	532.9	671.1	568.9	1097.6
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640723-73642422	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 732.4"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 2565.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"Hep G2: 10.7"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.1	0.3	1.1	0.1	0.5	0.1	0.2	0.1	0.7	0.2	0.0	1.1	4.6	0.1	0.0	0.0	1.2	0.6	0.1	0.8	0.8	732.4	82.7	0.2	0.0	0.6	0.3	1.3	0.2	0.0	0.6	0.0	0.1	0.2	0.1	1.8	0.1	0.1	0.0	0.0	7.2	0.1	0.4	1.1	0.6	0.5	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.1	0.7	0.8	0.8	0.6	0.3	0.1	0.4	1.0	0.8	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	36.8	0.0	0.0	0.0	0.3	187.9	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.9	51.1	0.0	0.0	0.0	1.1	0.0	1.0	0.4	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	61.3	2565.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.6	0.1
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040661, HPA040679"	Approved		Approved	"Nuclear speckles,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Microtubules	"Nuclear speckles, Mitotic spindle"	"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	1.5	3.1	1.7	3.3	1.9	1.7	2.4	1.4	1.9	2.5	3.8	2.4	3.0	1.5	3.2	2.5	3.9	2.0	1.0	1.4	1.6	9.1	5.2	3.3	5.8	2.0	1.7	1.9	4.5	2.9	4.4	2.6	1.7	4.0	2.2	0.6	3.7	2.6	0.5	3.1	4.2	1.2	1.6	5.8	3.4	3.8	1.9	2.7	7.2	0.4	5.0	2.6	2.2	2.3	2.1	3.4	3.5	2.8	1.9	2.1	10.9	0.9	2.1	1.3	1.7	5.4	5.0	13.1	3.5	2.8	2.5	3.8	5.2	4.8	1.3	3.5	6.4	2.9	5.8	10.1	3.3	1.8	3.7	4.8	1.8	2.5	5.8	1.8	0.9	1.9	4.3	1.3	1.5	4.7	1.9	3.4	3.3	3.7	1.0	4.9	2.3	5.9	7.0	5.7	6.4	1.5	3.0	6.3	1.6	4.7	9.3	2.4	0.8	1.3	2.2	1.6	1.0	1.5	1.8	8.9	2.0	1.6	3.1	3.3	0.9	1.2	0.7	0.5	0.8	2.8	0.6	0.7	0.1	4.2	0.7	1.0	0.4	1.3	1.1	14.8	0.5	0.8	1.7	1.9	1.4	1.9	1.4	1.6	2.0	1.7	1.7	1.6	1.9	2.3	2.7	9.6	19.3	3.9	22.9	2.8	9.2	8.3	7.4	2.8	10.1	14.1	1.7	12.8	11.6	25.8	8.4	17.6	19.1	14.9	7.9	5.8	9.5	12.8	6.0	2.9	10.3	7.0	0.7	6.0	9.2	3.9	6.1	15.2	26.6	3.2	3.3	9.4	3.9	1.7	0.5	14.4	10.2	5.0	2.7	2.0	3.4	4.4	3.6	2.8	4.0	2.6	3.1	1.5	1.6	3.9	17.2	2.6	7.2	8.6	13.4	4.3	14.3	1.8	0.0	11.7	3.0	19.9	11.4	8.8	1.6	11.1	4.9	7.8	15.9	4.2
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575686	"Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;kidney: 16.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 279.0;Inhibitory neurons: 175.8;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	NA	NA		160000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051535: AB_2681524"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.3	0.1	4.5	0.1	5.5	0.0	0.0	0.0	8.2	0.3	0.0	0.2	0.0	0.3	1.6	0.6	0.1	0.4	0.0	10.2	2.0	16.6	0.0	0.4	0.0	2.4	1.9	0.1	0.0	0.0	3.5	0.0	2.5	5.1	0.3	0.8	0.4	2.5	0.0	0.6	0.1	0.1	0.0	0.1	0.6	1.0	1.5	1.2	0.0	0.3	0.7	0.1	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.7	0.0	0.0	0.1	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.5	0.0	8.2	10.2	2.0	2.4	1.9	2.5	0.0	1.5	4.2	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.7	0.0	0.0	1.8	0.0	0.8	0.0	0.0	5.9	0.0	28.8	0.8	0.1	0.0	0.0	0.0	279.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	175.8	0.0	0.0	0.0	0.0	22.3	0.3	0.0	0.0	13.1	0.0	0.0	0.0	323.2	7.6	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.2
NEURL2	"C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3"	ENSG00000124257	"Neuralized E3 ubiquitin protein ligase 2"	Q9BR09	20	45888625-45891208	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 26.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 13.1;Proximal tubular cells: 17.3;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;Hep G2: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043402, HPA059842"	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA043402: AB_2678464, HPA059842: AB_2684139"	"unprognostic (6.26e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.58e-1)"	14.1	9.1	1.8	2.6	3.0	1.3	6.9	4.0	3.1	5.2	4.5	7.3	4.3	6.2	3.0	2.6	7.4	2.9	8.9	2.0	2.1	26.7	8.2	3.9	1.5	2.4	2.3	9.4	4.4	3.8	4.1	3.1	2.3	4.4	2.2	4.2	5.5	2.7	18.1	4.7	6.5	4.0	2.0	5.9	5.0	2.5	2.1	7.6	5.8	8.9	1.3	7.9	4.3	3.2	0.9	0.7	1.9	1.6	3.1	1.3	1.6	1.2	1.4	1.3	0.6	8.2	5.2	1.0	1.7	0.9	2.3	2.7	1.6	0.0	0.8	0.6	1.4	0.6	6.4	8.5	3.9	0.6	1.4	2.9	1.1	1.3	0.5	2.0	1.0	1.6	0.8	2.1	0.7	3.2	1.0	0.6	0.9	0.5	2.9	1.7	1.4	0.5	0.8	0.7	4.2	3.0	1.7	4.1	5.2	0.4	3.1	1.7	2.0	1.5	1.3	1.2	1.2	6.0	1.3	0.2	1.7	0.8	1.4	0.0	0.6	1.8	0.4	0.3	0.2	2.8	0.7	0.6	0.2	1.0	1.5	1.3	0.2	1.0	0.2	0.3	0.5	0.3	1.8	3.0	4.0	3.1	2.0	2.1	2.4	2.3	2.3	2.0	2.1	3.2	1.7	0.0	0.0	2.0	2.3	0.1	2.1	1.0	2.8	3.5	2.2	3.4	5.7	0.0	0.4	0.0	4.2	0.7	0.5	5.0	7.9	3.2	2.8	0.8	2.3	2.7	3.0	1.3	1.4	2.0	0.9	3.3	3.1	0.9	0.0	7.8	5.7	5.7	13.1	0.0	2.3	2.3	0.0	5.1	0.3	8.6	5.3	1.2	0.0	1.0	1.5	2.5	2.1	2.0	1.4	2.9	0.7	3.8	2.2	2.3	6.7	17.3	0.5	3.4	13.1	3.2	6.1	0.0	0.3	1.8	1.1	0.5	0.7	11.0	2.1	1.7
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 68.1;choroid plexus: 20.3;kidney: 52.2"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 80.8;Oligodendrocyte precursor cells: 76.4;Proximal tubular cells: 264.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.9;MOLT-4: 42.8;SK-MEL-30: 9.3;SuSa: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029876	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	0.1	0.8	41.3	0.2	41.0	0.1	0.1	28.7	68.1	2.3	20.3	1.7	0.3	0.4	0.4	0.0	0.3	0.1	0.0	45.7	44.7	52.2	0.0	0.1	0.0	39.1	40.3	0.1	0.1	0.0	2.4	2.8	39.9	0.1	0.1	3.1	0.1	0.1	0.0	0.4	0.4	0.0	37.5	0.1	0.3	2.2	40.3	1.2	0.8	0.1	0.0	0.1	0.6	36.1	0.1	2.0	7.5	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	1.3	0.8	0.0	3.9	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	42.8	0.0	5.2	0.0	0.1	7.8	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.1	9.3	29.5	0.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.5	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	41.0	28.7	68.1	45.7	44.7	39.1	40.3	39.9	37.5	40.3	36.1	0.0	0.0	0.0	23.8	1.9	0.3	0.0	1.7	0.0	2.6	0.0	0.1	0.3	0.0	0.1	11.0	0.0	3.3	0.0	0.0	5.9	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.6	3.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.3	1.5	0.0	1.0	0.0	80.8	0.0	76.4	0.1	4.2	0.0	0.0	0.0	0.0	0.0	264.8	0.1	1.9	0.0	0.0	0.3	0.4	6.0	0.0	0.0	2.3	0.8	0.1	0.0	0.1
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324353-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 138.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 164.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 14.3;HUVEC TERT2: 27.7;TIME: 70.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.8	0.7	0.7	0.7	1.2	0.2	3.8	0.7	1.2	1.5	0.0	1.2	0.2	4.9	0.4	0.4	1.3	2.4	7.6	0.4	0.6	138.0	0.3	1.5	0.2	1.0	0.7	0.8	0.3	3.6	0.9	3.1	0.9	1.0	0.3	17.1	3.0	1.3	1.7	1.4	0.6	3.4	0.8	0.4	0.5	0.3	0.7	0.1	2.1	3.5	0.5	1.4	1.1	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.5	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.1	14.3	27.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.1	0.0	0.0	0.3	7.1	0.4	0.0	70.6	0.2	5.0	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	1.2	0.7	1.2	0.4	0.6	1.0	0.7	0.9	0.8	0.7	1.7	4.4	0.0	0.0	2.9	1.0	0.6	0.1	0.4	0.0	7.5	0.2	0.3	1.0	0.0	0.0	11.0	6.2	2.2	0.2	0.1	15.6	0.0	0.8	1.0	1.4	5.9	0.0	0.0	30.0	0.0	0.8	9.2	0.0	3.0	0.0	0.6	2.5	0.1	0.2	0.0	21.1	0.0	0.0	0.0	0.5	0.7	0.3	1.3	0.0	6.5	0.1	4.5	0.0	7.1	28.4	0.1	0.0	1.2	0.3	0.1	0.0	164.0	0.0	27.1	0.0	1.2	1.0	0.6	0.7	0.1	0.3	2.5	1.1	0.1	0.0	0.1
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2 stomatin family member, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"kidney: 255.0"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 20.2;Early spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NTERA-2: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB037267, HPA049486"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 52.3;placenta: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Cytotrophoblasts: 123.1;Hofbauer cells: 481.5;Kupffer cells: 148.8;Microglial cells: 125.5;Proximal tubular cells: 141.0;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 423.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 423.2;monocytes: 128.4"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	12.7	5.8	16.7	19.2	20.8	18.9	5.5	19.3	22.9	4.3	11.1	6.9	2.8	1.7	29.9	10.0	3.3	13.0	2.6	12.7	15.6	52.3	20.8	14.5	32.5	19.6	20.1	1.4	2.8	3.3	1.7	45.2	18.9	2.3	9.1	1.9	4.2	6.2	1.7	8.4	4.4	7.5	15.8	28.7	5.0	5.1	27.0	6.2	2.6	2.8	14.7	15.5	5.1	22.0	3.4	0.6	1.0	0.0	2.8	2.8	0.9	1.1	2.1	1.2	0.6	0.0	1.4	9.0	1.5	0.0	0.0	1.3	1.9	2.4	0.3	0.0	1.5	14.2	0.4	0.1	1.5	5.4	8.1	2.2	9.1	0.2	0.0	0.1	0.1	10.1	10.9	13.8	2.1	1.1	0.3	3.5	11.0	7.0	1.1	1.4	0.7	11.0	0.2	7.4	3.1	4.6	5.0	0.3	4.7	1.1	2.9	8.7	0.2	1.1	2.4	0.7	0.1	9.8	12.7	9.0	2.4	9.5	3.6	25.5	128.4	104.1	5.5	118.2	4.8	1.8	4.5	4.9	7.6	6.3	3.5	4.9	423.2	0.3	96.6	1.5	8.1	65.4	16.7	20.8	19.3	22.9	12.7	15.6	19.6	20.1	18.9	15.8	27.0	22.0	2.9	0.0	5.5	170.1	4.9	6.1	4.0	8.6	1.8	7.6	1.5	4.4	2.9	2.8	4.8	7.3	2.1	123.1	2.2	2.3	19.6	1.2	19.1	0.4	0.6	3.5	1.8	45.5	7.5	2.4	6.1	2.5	3.1	0.2	5.7	0.5	72.8	3.9	481.5	6.7	13.5	1.4	6.1	148.8	11.5	27.0	0.9	91.7	10.6	125.5	40.1	2.8	5.2	22.1	21.0	1.3	0.3	0.4	0.7	1.6	0.9	141.0	1.7	2.8	0.0	1.7	1.7	16.5	8.9	16.5	7.1	107.4	3.1	3.4	1.6	4.3
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NPR3	"ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC"	ENSG00000113389	"Natriuretic peptide receptor 3"	P17342	5	32689070-32791724	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 107.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8;Granulosa cells: 97.9;Proximal tubular cells: 143.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 19.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 35.3;fHDF/TERT166: 22.8;HeLa: 81.4;HSkMC: 50.0;U-138 MG: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052702	Supported		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA052702: AB_2681922"	"unprognostic (8.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.46e-3)"	"prognostic favorable (5.43e-6)"	"unprognostic (6.00e-4)"	"unprognostic (5.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.38e-2)"	21.3	3.4	1.4	0.8	1.2	4.5	3.8	0.9	1.7	8.0	5.6	5.3	0.7	4.1	2.0	5.3	4.7	4.3	27.3	1.3	2.0	107.8	4.8	11.1	0.9	1.5	1.4	1.7	1.3	1.3	0.6	9.5	1.3	6.3	1.1	2.6	1.1	8.9	5.8	5.0	1.4	3.0	1.1	9.6	1.0	1.7	1.3	4.9	13.0	9.5	2.0	1.8	4.5	2.0	0.3	4.3	0.2	0.4	2.4	35.3	0.1	10.0	1.9	0.6	0.6	0.0	0.2	0.0	0.2	22.8	0.7	0.0	4.9	0.1	1.2	0.1	0.0	0.4	81.4	0.0	7.1	0.1	0.2	50.0	0.6	2.6	6.9	2.3	0.3	0.1	0.1	0.6	3.3	0.6	0.0	0.5	0.1	0.0	11.9	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.5	13.3	0.1	0.3	0.2	0.0	0.3	21.5	0.3	1.8	0.3	0.2	0.1	0.0	3.5	0.1	0.3	0.1	0.3	0.2	0.3	0.1	0.2	0.4	0.3	0.2	0.0	0.5	0.4	0.5	3.3	0.4	0.0	0.4	0.1	0.1	1.4	1.2	0.9	1.7	1.3	2.0	1.5	1.4	1.3	1.1	1.3	2.0	3.9	16.0	4.9	1.0	0.8	5.4	0.1	1.6	24.5	11.6	0.2	1.1	27.3	0.0	1.7	9.2	0.0	0.0	0.2	0.1	52.8	0.1	1.4	4.5	8.5	11.9	0.0	13.9	0.4	0.0	0.1	2.6	0.0	16.5	3.8	97.9	15.7	1.6	0.1	3.3	11.4	0.0	0.0	0.3	0.0	3.2	11.1	1.3	0.0	0.0	0.2	1.7	0.0	1.0	0.3	0.0	0.1	12.8	1.4	1.9	0.0	143.4	3.7	1.5	6.6	0.3	6.6	0.1	1.2	23.0	1.3	0.1	1.3	16.5	0.0	0.3
OR2T10		ENSG00000184022	"Olfactory receptor family 2 subfamily T member 10"	Q8NGZ9	1	248590487-248597700	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"kidney: 5.0"	"Cell type enriched"	"Detected in single"	8	"Proximal tubular cells: 4.9"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052019	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052019: AB_2681696"													"unprognostic (8.58e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796540-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	2.6	1.2	3.6	6.8	4.2	4.1	3.9	2.8	5.9	10.2	3.8	5.9	9.3	2.2	0.8	7.6	5.1	5.0	2.6	3.9	4.4	16.0	1.2	8.6	11.3	3.8	3.7	5.2	1.9	14.1	2.0	3.9	3.5	2.2	6.0	1.3	3.7	2.5	3.3	10.3	7.6	3.7	3.1	6.8	8.5	2.8	4.5	8.3	9.8	2.0	14.4	13.3	6.5	5.1	40.2	10.7	7.8	14.4	17.3	34.5	17.5	44.5	49.3	20.4	32.1	27.0	52.0	22.2	6.2	47.8	26.9	34.6	23.6	33.4	31.4	13.5	9.8	5.3	16.4	20.4	24.5	15.3	113.8	17.0	27.2	26.7	31.8	26.0	31.0	19.0	28.4	30.1	34.9	0.0	9.4	18.7	15.3	38.1	13.7	7.5	21.6	9.1	20.4	28.2	1.6	16.1	30.3	21.5	6.7	23.0	11.1	1.5	37.1	9.1	17.9	49.4	33.7	20.7	32.8	55.6	19.5	24.7	102.0	5.8	1.9	1.5	8.5	1.7	7.3	3.3	5.3	5.6	3.3	1.6	1.8	3.5	0.4	7.7	1.2	2.3	9.5	2.5	3.6	4.2	2.8	5.9	3.9	4.4	3.8	3.7	3.5	3.1	4.5	5.1	2.2	0.0	26.1	123.1	18.3	12.1	8.0	8.8	21.6	0.3	3.8	4.4	5.5	5.7	22.2	25.8	0.0	8.4	13.2	3.8	3.9	3.5	0.3	24.6	2.3	3.6	1.8	11.1	176.1	3.9	2.1	3.1	19.4	31.9	0.0	0.4	3.6	0.5	10.8	0.0	272.2	1.7	20.3	12.7	9.3	0.3	0.6	13.2	16.0	94.6	7.8	4.8	14.4	44.2	3.6	24.4	4.5	0.0	91.7	5.2	3.3	0.5	53.1	0.2	0.0	3.4	4.6	0.5	5.0	16.5	8.0	4.0	18.5	20.3	4.5	16.5
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132190147-132295315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 324.2;U-87 MG: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		13000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	17.4	11.7	11.9	16.1	12.1	2.4	12.3	11.4	28.4	29.5	42.2	28.7	22.6	31.1	76.7	19.6	29.6	19.9	40.6	14.4	17.2	80.0	10.5	31.5	2.5	11.4	14.3	8.6	70.7	10.9	19.9	35.1	19.1	10.8	32.7	7.8	32.5	17.1	13.0	16.7	26.8	52.6	10.0	8.7	20.5	9.7	16.8	11.3	20.7	22.9	8.3	22.9	22.3	12.2	57.0	34.9	11.2	57.2	149.2	173.7	61.1	261.9	223.7	108.9	265.0	78.9	50.3	1.5	71.8	283.3	120.5	70.2	33.2	136.5	172.7	41.5	11.9	0.6	48.1	49.0	324.2	0.0	33.9	104.6	193.1	128.8	117.4	162.7	59.1	0.1	21.2	3.6	134.0	23.2	0.2	0.5	3.0	53.7	27.2	0.9	3.6	9.8	31.1	11.0	5.4	15.8	67.7	22.3	47.9	84.1	28.4	3.7	88.9	171.7	63.5	51.0	57.1	24.4	28.1	11.8	323.4	0.4	48.3	0.0	0.4	0.0	0.8	0.3	0.7	0.0	0.4	0.1	0.2	0.0	0.0	0.1	1.0	0.9	0.0	0.3	0.0	0.2	11.9	12.1	11.4	28.4	14.4	17.2	11.4	14.3	19.1	10.0	16.8	12.2	13.0	35.3	10.3	7.5	1.1	16.8	43.6	115.6	23.9	11.6	9.5	9.5	13.3	8.6	36.9	11.0	22.9	2.6	0.3	43.2	5.9	68.3	1.4	26.7	96.9	12.2	15.0	0.0	7.7	71.8	70.2	61.6	12.8	28.0	5.7	11.1	9.3	7.8	7.6	0.0	7.7	18.6	32.6	1.3	5.5	2.0	8.1	4.4	30.2	2.8	2.6	6.8	0.0	1.5	1.2	81.9	41.0	5.3	3.0	19.6	41.4	44.6	71.9	5.2	26.3	109.4	47.6	23.0	29.1	6.8	9.8	7.5	4.8	10.4	13.8	15.3
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731580-50756795	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Glandular and luminal cells: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 29.0;MCF7: 51.7;T-47d: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	1.9	1.1	1.6	0.8	2.0	2.3	3.5	3.7	1.8	1.7	8.4	2.5	3.6	1.4	8.2	3.1	3.8	2.5	0.8	2.7	1.8	16.1	4.4	5.4	1.0	1.8	2.1	1.1	4.6	4.3	1.4	3.9	1.6	1.2	2.3	8.9	1.8	1.7	3.9	2.9	3.2	0.8	1.8	1.1	5.7	2.7	2.0	0.9	3.7	0.9	2.1	1.7	1.5	2.4	5.4	6.2	1.7	3.7	1.1	0.4	8.0	0.4	0.6	0.9	0.7	29.0	12.7	2.4	5.4	0.1	3.8	4.3	2.6	3.9	1.5	1.2	1.5	1.3	2.1	11.5	1.2	0.9	1.3	0.1	1.9	0.5	1.6	1.7	0.1	2.3	3.1	1.6	0.1	51.7	2.5	2.3	3.0	9.0	2.3	1.4	1.7	2.3	12.9	5.9	1.1	1.6	4.1	9.6	3.0	7.2	48.8	1.3	0.2	0.5	3.2	0.5	1.0	1.9	1.3	2.0	1.3	0.9	1.1	1.6	0.2	1.5	1.4	0.3	1.5	1.1	1.4	1.4	0.3	1.3	2.2	1.4	1.1	1.6	0.6	1.3	0.9	0.4	1.6	2.0	3.7	1.8	2.7	1.8	1.8	2.1	1.6	1.8	2.0	2.4	0.4	189.1	50.4	2.9	4.5	63.0	58.9	17.0	30.7	14.4	60.3	15.0	4.3	37.1	31.1	90.1	54.2	35.5	4.0	68.6	41.1	26.2	4.0	110.1	14.4	1.7	14.9	0.4	11.5	24.4	15.0	4.7	55.5	179.2	1.3	1.8	1.8	20.1	3.7	5.0	10.6	26.7	22.4	0.8	4.2	2.5	1.8	3.5	16.0	1.9	1.2	12.3	2.1	1.5	4.6	57.5	39.7	0.7	6.3	43.6	29.3	102.0	30.0	62.7	6.6	1.2	4.8	16.6	9.4	34.7	68.3	48.4	6.3	1.5	27.3	102.7
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.6;kidney: 85.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.4	5.4	0.2	0.0	0.0	1.8	29.6	0.0	8.4	0.0	0.0	0.5	0.4	85.3	0.1	0.0	0.0	6.8	1.6	0.2	0.4	5.9	0.8	0.0	3.3	0.2	0.0	1.2	0.0	11.5	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.4	0.5	0.4	6.8	1.6	3.3	6.3	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 267.9;thyroid gland: 565.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.0	1.4	0.6	0.9	0.5	1.7	0.1	1.1	14.5	1.7	1.8	0.6	8.8	32.9	2.2	37.5	3.6	2.1	1.0	1.9	267.9	1.2	1.6	1.7	5.2	1.3	1.7	1.0	1.4	1.4	1.9	3.0	1.1	0.9	1.5	1.9	26.1	0.5	1.8	2.4	0.8	3.7	0.8	1.4	2.4	2.3	0.5	565.5	0.3	1.0	2.1	1.0	1.9	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.4	0.9	0.1	1.1	1.0	1.9	5.2	1.3	3.0	3.7	2.3	1.9	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	20.9	4.8	24.2	1.0	28.6	0.4	14.0	4.8	24.6	17.4	0.0	5.6	2.0	26.4	6.3	2.0	28.7	4.3	23.7	25.5	32.5	15.6	2.3	5.2	1.2	20.5	15.9	4.2	7.9	0.8	12.5	23.8	18.8	19.0	1.2	22.5	10.5	11.9	0.7	2.0	3.3	17.7	9.9	0.8	5.5	3.0	36.7	0.3	124.7	0.8	1.0	4.0	4.9	17.2	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	24.2	28.6	4.8	24.6	25.5	32.5	20.5	15.9	18.8	9.9	36.7	17.2	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	6.0	2.6	3.6	1.8	4.6	1.5	3.6	6.9	5.2	2.0	7.7	3.8	5.4	2.6	3.4	3.7	3.4	2.0	1.8	3.6	4.3	9.2	8.6	3.4	2.6	6.2	4.6	7.4	4.5	6.1	3.0	4.0	6.8	3.8	4.1	5.0	3.6	2.6	2.5	2.1	3.2	2.1	3.5	2.0	3.0	3.8	5.7	2.5	9.3	4.1	3.0	2.1	2.2	4.3	9.8	11.7	7.1	14.1	18.7	9.6	8.9	5.0	19.2	11.3	17.0	23.9	6.7	13.5	6.9	6.9	10.8	12.1	20.8	11.3	10.9	3.2	10.5	6.8	5.9	15.9	10.1	8.8	11.5	7.4	8.3	16.1	16.6	12.3	4.9	14.9	13.3	9.5	10.3	6.3	17.1	6.2	8.4	6.5	14.7	16.7	9.9	21.4	6.0	10.3	14.3	8.0	15.9	6.5	6.0	5.5	8.7	4.3	4.6	7.0	9.2	4.2	7.5	16.6	16.9	13.4	9.5	6.9	7.0	1.1	0.2	1.2	3.8	0.1	3.1	1.0	1.8	3.2	0.8	2.1	2.6	3.0	0.7	4.2	0.1	0.5	0.6	1.3	3.6	4.6	6.9	5.2	3.6	4.3	6.2	4.6	6.8	3.5	5.7	4.3	2.5	9.6	22.9	8.1	3.1	5.2	6.4	1.3	6.2	9.6	5.8	4.2	5.1	8.6	3.1	9.2	14.6	12.8	3.3	13.3	7.9	3.4	0.2	3.5	3.2	3.3	3.6	0.8	8.8	2.9	2.2	4.1	3.1	4.3	6.3	14.4	7.1	20.5	2.4	5.0	7.6	4.2	2.0	1.3	0.4	2.4	3.1	1.2	3.6	3.7	0.4	8.1	7.2	4.5	4.3	3.4	6.6	4.5	4.5	8.9	7.4	9.9	1.2	6.7	0.0	5.9	2.7	12.6	5.7	8.0	2.4	3.6	3.4	4.0	5.5	6.5
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1 ciliary IPT domain containing fibrocystin/polyductin"	P08F94	6	51615299-52087613	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 4.7;kidney: 13.6;pancreas: 9.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 60.1;Collecting duct cells: 46.0;Early spermatids: 293.6;Late spermatids: 83.1"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favorable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.1	1.1	0.0	0.0	0.0	13.6	1.5	0.0	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.3	1.4	60.1	0.0	46.0	0.0	0.1	0.0	0.1	1.9	18.2	293.6	0.2	0.0	0.3	0.0	0.0	3.2	0.9	0.1	0.1	2.6	0.4	0.0	0.0	0.0	3.7	0.1	0.0	2.8	0.0	0.0	0.0	0.0	83.1	2.1	0.5	5.4	0.0	0.0	3.1	0.0	0.5	0.7	2.6	0.0	0.4	0.0	0.4	0.0	23.3	0.0	0.1	0.0	0.0	0.1	15.0	1.7	0.0	0.0	0.0	0.3	0.0	0.1	0.8
PLAAT4	"HRASLS4, PLAAT-4, RARRES3, RIG1, TIG3"	ENSG00000133321	"Phospholipase A and acyltransferase 4"	Q9UL19	11	63536808-63546462	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 20.0;dendritic cells: 75.8;Extravillous trophoblasts: 19.0;Hofbauer cells: 26.6;Syncytiotrophoblasts: 30.1;T-cells: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 223.6;RPTEC TERT1: 114.4;SK-BR-3: 169.0;U-266/70: 81.7"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"				"prognostic favorable (1.35e-5)"	"prognostic favorable (4.00e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (6.26e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.64e-1)"	47.7	18.8	84.1	52.9	83.8	20.7	102.5	78.4	121.9	46.5	78.3	56.2	87.7	28.5	62.3	19.2	99.1	52.3	19.0	83.3	90.1	202.7	111.1	107.9	98.2	97.8	83.6	58.5	14.0	2.4	24.2	16.9	85.5	57.2	57.0	12.5	83.7	73.7	14.2	9.0	101.9	43.5	84.1	73.1	64.7	7.7	86.8	79.4	46.3	16.1	56.1	55.5	25.7	89.8	22.2	14.0	0.0	0.6	19.8	68.5	5.0	2.0	37.2	28.1	25.2	0.4	223.6	3.5	18.7	3.9	22.9	5.2	5.2	4.1	5.9	37.8	0.0	1.4	1.3	0.0	78.4	0.7	0.9	79.0	0.5	10.5	0.2	60.1	3.4	7.8	0.0	27.5	4.1	0.0	55.3	4.7	0.3	4.0	1.9	24.2	0.1	1.7	114.4	4.8	0.3	0.1	4.8	169.0	9.5	1.2	20.3	1.6	6.5	2.0	0.2	4.1	0.8	81.7	1.2	0.9	8.5	13.6	1.5	258.1	80.6	53.6	426.8	114.5	328.6	81.5	323.4	454.2	48.9	61.4	282.7	370.3	57.1	256.5	96.5	5.8	278.2	563.0	84.1	83.8	78.4	121.9	83.3	90.1	97.8	83.6	85.5	84.1	86.8	89.8	12.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	20.0	75.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	19.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	30.1	12.6	0.0	0.0	0.0
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028727-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;kidney: 15.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 3.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.0	0.1	9.7	0.0	12.8	0.0	0.7	7.1	12.7	0.1	5.2	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	10.4	9.3	15.6	3.6	1.4	0.0	10.2	9.1	0.0	0.3	0.0	0.1	0.0	9.8	0.2	0.1	1.5	0.3	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.1	0.6	10.9	0.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.8	7.1	12.7	10.4	9.3	10.2	9.1	9.8	9.6	10.9	11.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	37.2	0.0	12.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	39.0	0.0	1.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.8;Cone photoreceptor cells: 87.6;Endothelial cells: 181.1;Glandular and luminal cells: 121.3;Microglial cells: 92.8;Rod photoreceptor cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 295.8;NTERA-2: 509.7;SuSa: 640.8;TIME: 474.0;U-251 MG: 226.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		33000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	20.8	6.8	27.7	8.9	26.5	0.3	21.9	25.2	34.4	26.0	19.0	8.4	5.1	27.5	5.6	8.1	49.0	14.5	29.1	25.2	25.3	96.2	3.0	31.8	5.6	29.2	28.1	6.1	26.0	18.9	1.1	29.3	29.5	8.7	8.6	67.8	16.1	18.9	15.3	4.8	6.2	28.9	22.0	5.6	5.6	2.4	42.0	3.7	28.5	26.1	6.1	9.6	1.0	22.0	50.9	18.9	42.6	16.3	0.5	0.0	2.6	5.4	4.2	16.9	6.1	121.4	83.1	0.3	109.7	295.8	57.1	34.9	34.3	0.7	15.3	5.4	17.3	0.2	115.0	2.7	1.1	4.2	4.0	0.2	0.4	50.5	0.8	9.4	146.3	1.5	10.5	1.8	16.9	18.0	0.5	1.3	509.7	10.0	43.6	16.2	73.1	15.8	1.6	16.6	34.3	8.9	34.7	7.0	0.2	640.8	4.1	2.2	474.0	6.8	26.6	72.5	226.1	2.5	4.5	1.2	27.1	20.1	48.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	26.5	25.2	34.4	25.2	25.3	29.2	28.1	29.5	22.0	42.0	22.0	165.8	6.4	9.9	3.6	2.4	5.2	0.9	14.0	0.6	9.7	33.3	20.7	22.9	4.3	25.4	27.6	87.6	0.8	1.0	1.0	0.0	4.6	0.8	44.8	13.0	181.1	2.4	2.7	9.4	18.3	0.4	9.2	1.1	121.3	2.5	2.2	65.0	1.0	0.4	5.0	3.3	12.9	4.1	0.9	9.6	1.3	4.7	2.6	5.4	92.8	0.7	10.6	0.0	7.1	3.1	42.7	0.8	0.4	4.3	3.6	0.7	0.8	10.3	188.4	0.0	6.3	8.4	0.3	1.1	1.3	3.1	0.7	3.3	1.9	2.7	5.8
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104853287-104858574	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 45.6;epididymis: 32.4;kidney: 58.8;seminal vesicle: 15.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal tubular cells: 27.4;Proximal tubular cells: 13.2"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 59.6;AN3-CA: 53.9;HEK 293: 21.2;RPTEC TERT1: 57.3;SH-SY5Y: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			1.5	0.1	22.5	0.1	36.9	0.0	0.3	34.6	36.2	0.0	0.0	0.7	0.0	0.0	32.4	0.0	0.0	0.0	0.1	26.3	18.9	58.8	0.0	0.0	0.0	31.0	35.5	0.1	0.0	0.0	0.1	0.0	25.3	0.2	0.2	0.3	1.3	15.2	0.0	1.7	0.1	0.0	22.7	0.0	0.6	0.2	30.6	0.2	0.0	0.0	0.1	0.0	0.0	45.6	0.0	0.0	59.6	53.9	0.6	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	6.5	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	6.4	1.4	0.0	57.3	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	36.9	34.6	36.2	26.3	18.9	31.0	35.5	25.3	22.7	30.6	45.6	0.0	0.0	0.0	1.0	0.5	0.8	0.1	0.0	0.0	3.8	0.0	0.6	1.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	13.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	51	"SuSa: 287.4"	"Not detected"	"Not detected"							"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.1	0.3	1.2	1.0	1.0	1.5	1.2	1.5	1.2	6.3	0.4	4.9	4.3	2.3	2.4	1.8	7.1	2.1	3.3	1.0	0.7	16.5	8.0	3.7	1.0	1.3	0.8	0.5	13.0	0.0	0.3	0.2	1.1	7.6	1.1	0.7	0.8	2.4	1.0	2.2	8.0	0.3	0.2	2.0	10.1	1.3	1.3	0.2	0.9	0.3	0.3	10.2	2.0	1.9	3.6	1.8	0.4	0.7	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.3	0.3	5.6	0.1	0.4	2.9	0.7	3.1	0.0	0.6	1.4	0.6	3.3	2.5	0.2	0.9	0.8	0.3	0.6	0.3	0.9	0.2	0.0	0.7	0.1	1.0	1.0	0.2	0.3	1.0	2.9	0.6	0.1	0.8	0.6	0.7	4.8	3.8	0.6	0.1	1.0	0.2	0.3	287.4	0.6	0.4	0.0	0.7	0.5	1.8	0.3	1.3	1.3	1.6	0.5	1.3	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	1.2	1.0	1.5	1.2	1.0	0.7	1.3	0.8	1.1	0.2	1.3	1.9	1.0	0.0	1.1	0.0	0.9	5.2	2.7	5.3	2.8	0.5	0.7	0.8	0.4	10.0	2.3	9.2	2.1	0.0	0.1	9.2	0.0	6.7	0.0	27.9	5.9	1.2	1.2	0.0	0.2	6.6	0.1	0.7	11.2	67.8	0.0	0.1	0.4	2.4	0.1	0.0	0.1	6.4	2.0	0.0	1.5	0.2	0.0	0.7	1.8	1.0	0.7	0.1	1.0	0.5	0.1	12.6	12.5	0.7	0.2	5.6	10.1	2.0	1.6	1.0	0.0	1.4	1.2	0.1	0.8	0.8	3.8	0.1	0.8	0.0	4.1	4.3
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667864-119681624	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.8	16.9	11.9	13.9	13.1	44.0	15.3	12.8	13.2	25.3	12.6	34.8	32.5	16.8	16.3	21.4	17.2	14.5	12.2	11.7	13.0	53.3	17.3	25.3	18.1	14.6	13.5	14.3	33.4	18.9	10.7	27.6	14.1	11.9	33.4	19.4	16.0	15.6	12.6	10.6	22.7	17.0	12.7	24.1	29.0	21.4	13.1	19.7	20.8	10.5	23.9	15.1	10.7	15.7	11.4	30.8	22.1	21.5	17.8	16.7	29.7	18.3	22.7	28.2	20.4	39.9	24.0	36.6	21.8	23.6	12.6	15.2	22.6	32.1	24.9	22.4	36.5	57.8	17.1	51.5	35.6	26.7	66.0	22.4	29.9	24.4	29.7	30.0	21.2	54.5	89.4	13.5	21.6	33.0	60.4	35.4	32.3	16.5	50.1	33.9	20.8	22.7	32.7	33.7	18.7	31.8	22.1	8.6	25.3	26.7	27.2	34.1	25.0	16.9	20.2	13.3	17.8	45.8	45.7	26.8	16.5	19.7	25.5	50.6	28.5	70.3	28.5	32.6	34.4	47.1	30.0	31.0	30.8	39.5	32.3	29.7	34.7	42.0	38.6	27.8	36.1	36.4	11.9	13.1	12.8	13.2	11.7	13.0	14.6	13.5	14.1	12.7	13.1	15.7	20.6	48.1	49.7	3.3	11.9	3.3	6.5	15.3	15.4	16.2	10.0	6.3	5.3	8.6	16.6	22.0	4.2	18.4	7.5	27.0	46.9	8.3	1.2	12.7	7.7	13.2	19.7	34.5	7.1	30.2	10.9	8.6	12.8	15.4	12.0	18.5	5.3	7.1	12.3	21.9	6.2	15.3	14.2	7.0	5.2	2.2	5.6	9.6	3.6	8.4	10.3	13.4	11.3	7.5	7.6	11.7	17.9	6.4	6.4	5.2	16.2	38.2	12.7	17.9	6.6	4.8	8.2	25.6	13.2	13.7	4.3	15.1	9.9	26.3	23.7	8.3
PRR5-ARHGAP8		ENSG00000248405	"PRR5-ARHGAP8 readthrough"		22	44702233-44862706	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 4.9;Collecting duct cells: 5.5;Pancreatic endocrine cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 2.1;HEK 293: 2.7;MCF7: 2.1;U-266/70: 6.8"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (1.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.28e-8)"	"unprognostic (8.64e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.45e-1)"	0.5	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.3	0.2	0.2	0.7	0.5	0.1	0.1	0.6	0.6	0.5	0.0	0.1	0.1	1.5	0.2	0.4	0.2	0.1	0.2	0.0	0.8	0.4	0.5	0.2	0.1	0.8	0.3	0.0	0.7	0.8	0.0	0.6	0.4	0.0	0.0	1.0	0.4	0.1	0.1	0.0	1.4	0.0	0.2	0.3	0.3	0.1	1.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.3	0.0	0.0	2.1	0.3	0.0	0.1	0.0	0.0	0.7	0.5	1.4	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.6	0.1	0.7	0.2	0.0	0.0	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	3.2	1.5	4.9	0.0	0.4	1.0	0.2	0.0	0.0	0.6	0.3	0.1	0.0	0.8	5.5	0.0	0.7	0.1	0.6	1.9	1.9	0.0	0.6	0.1	0.0	1.2	0.0	0.9	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.9	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.3	0.1	0.2	0.5	0.9
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"kidney: 30.9"	"Cell type enriched"	"Detected in some"	70	"Collecting duct cells: 198.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.9	1.4	0.4	0.5	0.7	0.0	0.4	0.3	2.2	1.2	0.9	0.5	0.3	0.5	0.0	0.8	1.0	0.0	0.1	0.3	1.0	30.9	0.3	2.4	0.0	0.4	0.3	0.1	0.3	0.1	1.4	0.0	0.5	0.7	0.0	0.0	0.3	0.0	0.1	0.1	1.4	0.4	0.1	6.5	3.0	0.2	0.5	0.0	0.5	0.0	0.0	1.1	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	3.2	0.3	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.3	2.2	0.3	1.0	0.4	0.3	0.5	0.1	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.3	0.9	2.8	0.0	198.6	0.0	0.1	1.3	0.3	0.0	0.1	0.1	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.2	2.5	1.1	1.4	0.0	0.4	0.4	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.8	0.0	0.8	0.1	0.1	0.0	0.4	2.5	0.3	0.9	0.3	0.0	0.0	0.6	0.8	0.2	0.4
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877721-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 586.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1"	"Group enriched"	"Detected in many"	4	"renal cancer: 18.8;testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	32.5	72.2	45.0	1.1	43.8	0.0	20.2	45.7	60.8	43.8	38.0	10.3	1.2	19.1	2.7	3.7	20.3	3.5	33.0	42.6	43.5	586.8	84.6	25.6	2.4	46.5	44.9	22.2	7.6	1.2	5.9	16.0	46.7	12.4	0.6	0.7	2.7	3.5	7.7	9.8	9.6	2.6	44.5	54.4	7.6	10.3	46.2	0.4	6.5	2.2	0.4	12.3	20.3	43.3	0.0	0.2	0.2	0.2	15.9	1.9	0.2	0.4	0.2	0.3	0.2	0.4	0.0	0.0	1.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	15.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.3	2.1	0.0	0.1	0.1	5.3	0.0	116.9	0.0	0.2	0.7	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	43.8	45.7	60.8	42.6	43.5	46.5	44.9	46.7	44.5	46.2	43.3	4.6	0.0	0.0	17.3	2.5	1.3	0.1	0.0	0.6	1.5	2.9	0.4	5.0	2.8	0.0	33.1	0.0	0.6	0.1	0.0	95.9	0.0	11.6	0.6	20.5	4.1	0.0	8.0	1.6	0.5	60.8	9.6	0.0	0.6	0.0	0.1	17.2	0.7	2.0	1.7	2.8	0.0	0.0	1.3	2.8	32.5	5.9	2.1	0.0	1.9	0.0	3.2	0.0	1.0	0.3	0.3	0.0	2.2	0.0	0.0	0.0	324.8	0.0	1.7	138.1	6.5	21.7	0.9	2.7	0.0	0.9	0.8	2.0	0.3	0.0	0.1
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase receptor type Q"		12	80402178-80680273	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.1;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	3.2	0.0	0.3	0.0	2.0	0.0	0.4	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.1	1.6	0.2	1.1	0.2	0.4	7.1	0.0	2.3	0.9	1.0	0.7	0.3	0.3	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.1	2.7	0.3	0.2	2.9	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	3.9	0.8	1.2	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.4	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.7	0.2	0.4	1.0	0.7	0.6	0.8	0.3	0.0	0.0	16.0	1.1	2.0	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.0	3.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.5	1.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775482	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	13.5	14.4	12.5	20.4	14.1	7.1	14.1	14.3	12.1	8.7	10.5	12.6	10.6	8.3	23.8	7.8	6.2	16.9	13.1	12.3	14.3	73.1	19.4	13.5	35.1	15.9	12.9	7.9	9.2	25.5	5.9	7.2	15.8	13.8	10.1	6.8	19.8	13.9	6.4	5.5	12.4	14.8	14.3	24.3	10.4	4.6	15.3	12.1	33.4	6.0	28.0	15.7	5.7	17.0	20.4	18.6	2.8	13.1	52.5	29.8	9.7	14.1	43.2	28.9	34.4	5.6	28.7	21.6	13.6	24.3	34.6	11.2	32.8	37.3	26.4	88.3	15.3	16.4	7.3	9.5	25.4	16.1	23.2	29.0	24.6	23.3	32.8	24.0	37.2	19.8	16.2	24.2	41.2	7.6	17.7	8.3	13.1	25.4	14.0	3.7	43.1	17.5	33.6	27.7	4.4	12.5	10.0	45.0	37.8	10.3	22.0	13.2	38.7	29.7	15.0	43.5	20.6	39.4	87.0	11.5	30.1	26.3	22.5	92.4	22.6	62.3	92.2	43.8	86.9	50.8	51.0	79.5	33.4	45.8	37.2	63.5	8.8	94.1	53.9	10.4	53.3	51.3	12.5	14.1	14.3	12.1	12.3	14.3	15.9	12.9	15.8	14.3	15.3	17.0	16.3	19.2	17.7	11.1	61.2	0.0	6.3	0.0	13.6	2.1	19.5	16.0	19.3	21.5	6.2	31.3	0.0	12.0	82.3	1.9	29.4	18.7	5.1	2.0	6.3	18.6	4.9	10.8	7.8	10.1	6.4	11.2	10.7	3.5	13.3	9.2	14.6	33.7	32.8	0.0	10.2	3.7	0.0	30.1	0.0	4.1	14.3	34.0	0.0	10.3	76.4	26.5	129.8	10.6	9.8	8.3	4.8	20.7	34.8	10.7	9.5	187.7	2.9	2.0	6.6	10.0	6.7	3.8	11.8	9.3	0.0	2.9	51.7	19.7	5.5	6.9
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 152.4;thyroid gland: 162.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 46.3;OE19: 162.8;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 231.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.6	80.8	74.0	2.6	118.6	0.8	4.4	24.6	91.9	7.5	0.0	19.7	12.4	1.9	1.9	7.5	4.2	24.9	9.5	76.2	34.5	152.4	36.1	14.2	1.0	35.8	22.0	1.6	106.2	57.1	37.9	2.1	32.8	12.8	17.3	27.3	88.7	0.8	0.2	3.5	21.7	0.7	15.8	1.2	110.8	3.6	32.4	0.5	162.8	0.3	0.9	4.0	3.4	67.3	6.2	46.3	0.5	3.6	0.0	0.0	0.8	0.0	0.1	0.1	0.0	4.3	6.4	0.1	4.6	0.2	30.2	7.9	4.4	0.3	0.1	1.0	2.3	2.2	4.3	22.1	0.7	0.0	6.6	0.3	3.1	0.0	0.0	0.0	0.0	22.1	29.6	1.1	0.0	15.6	7.7	0.7	2.8	162.8	7.0	4.3	1.2	1.1	10.2	3.4	52.1	9.3	7.7	27.4	8.9	1.8	2.7	5.2	0.1	0.0	3.1	0.0	0.1	0.6	0.1	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	118.6	24.6	91.9	76.2	34.5	35.8	22.0	32.8	15.8	32.4	67.3	0.0	9.6	29.3	10.4	0.5	1.3	1.1	1.1	0.6	64.1	8.5	5.6	5.1	25.8	4.5	14.7	0.0	0.2	0.1	4.3	72.4	25.1	0.8	3.1	0.6	0.4	6.7	4.0	82.0	28.8	1.4	1.0	17.3	8.0	0.0	6.2	0.4	8.5	0.3	92.5	45.8	112.6	6.1	0.6	0.3	0.3	0.0	0.6	16.0	3.7	0.6	11.5	0.0	51.8	18.6	15.3	17.2	0.0	0.2	5.0	6.0	13.5	1.2	7.3	0.0	0.0	0.7	1.0	3.6	0.5	1.1	1.5	0.3	2.5	7.7	2.6
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 162.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.8;Late spermatids: 28.4;Paneth cells: 5.6;Smooth muscle cells: 10.7;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;BJ: 2.0;HMC-1: 2.6;SK-BR-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000	10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	1.0	1.4	0.3	0.2	0.9	0.0	0.1	0.0	0.2	4.3	3.2	0.4	0.3	9.6	0.3	0.2	2.3	0.1	1.8	0.2	0.0	162.2	0.7	0.7	0.0	0.3	0.4	16.3	0.0	0.0	0.6	15.2	0.1	0.3	0.2	0.1	0.8	0.8	0.0	0.1	0.1	1.5	0.0	0.1	0.0	0.9	0.2	0.5	0.0	0.0	0.5	5.2	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.2	0.0	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.8	0.7	0.0	0.7	0.1	0.0	0.2	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	1.2	6.8	0.2	0.5	0.4	0.0	0.0	0.3	1.1	0.2	2.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	10.7	0.3	0.2	0.0	0.0	1.1	0.1	1.3	0.0	7.0
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RNF212B	C14orf164	ENSG00000215277	"Ring finger protein 212B"	A8MTL3	14	23185316-23273477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 27.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 42.9;Proximal tubular cells: 44.9;Spermatocytes: 94.6;Spermatogonia: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;Daudi: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053574	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053574: AB_2682195"	"unprognostic (2.88e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.45e-1)"	"unprognostic (7.33e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.39e-3)"	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	27.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	5.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.2	42.9	0.2	0.2	0.1	0.0	0.0	3.5	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	2.2	0.5	0.0	0.0	0.0	9.5	0.9	3.2	0.0	0.0	1.6	0.2	0.0	0.5	1.6	0.1	0.0	0.4	0.1	0.0	1.0	44.9	0.0	0.3	0.0	0.1	0.1	94.6	24.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.6;thyroid gland: 5.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3"	"Region enriched"	"Detected in many"	86	"olfactory bulb: 980.0"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 5.6"	HPA064184			Approved	Nucleoplasm		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.2	0.1	0.3	0.1	0.3	0.7	0.2	0.9	0.8	0.3	0.1	0.2	1.5	0.6	0.1	0.9	0.5	1.0	0.1	0.3	0.4	2.9	0.0	0.5	1.5	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.1	3.6	0.3	0.0	0.3	0.4	1.2	0.1	0.4	0.7	5.2	0.1	0.4	1.1	0.3	0.4	2.2	5.7	0.0	0.0	0.6	0.4	0.4	1.0	1.3	0.7	1.4	0.6	4.2	0.0	3.7	2.1	0.4	1.7	0.1	1.0	0.9	0.5	0.0	2.7	2.6	0.2	0.4	0.0	3.5	0.0	1.1	2.7	0.8	0.5	0.5	0.0	0.7	0.2	3.0	0.2	0.5	1.3	0.2	34.3	9.7	0.0	1.8	1.1	11.9	19.9	17.3	0.0	0.2	9.0	0.8	1.5	0.0	0.5	0.4	0.1	1.3	2.6	1.7	0.0	0.9	0.0	0.5	0.7	0.4	0.0	0.7	1.4	1.2	0.1	4.6	0.5	2.6	1.3	1.8	0.3	1.4	0.6	1.2	0.0	0.4	3.0	3.9	0.7	0.3	0.3	0.9	0.8	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	3.7	0.0	0.1	0.2	0.1	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	8.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.6	3.1	0.0	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.6	6.8	0.3	0.6
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 subunit alpha"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 157.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 114.0;Distal enterocytes: 230.9;Glandular and luminal cells: 189.8;Intestinal goblet cells: 180.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 6.8"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 300.5;HBEC3-KT: 202.4;hTCEpi: 85.3;RPTEC TERT1: 103.7;RT4: 114.1;SK-BR-3: 96.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	3.4	12.5	0.2	5.6	0.1	0.5	20.6	1.1	0.2	64.7	113.6	66.4	18.7	7.6	43.2	140.1	57.9	17.7	0.7	6.8	0.0	148.5	8.2	62.9	0.2	0.1	0.3	3.5	40.0	0.7	16.6	0.4	0.1	43.7	65.4	0.0	157.3	49.5	0.5	54.6	26.0	2.9	0.1	0.7	63.6	4.7	1.3	1.9	94.3	0.1	12.5	20.8	57.6	0.1	21.6	4.1	0.0	1.9	0.3	0.4	17.6	0.0	0.1	0.1	0.0	6.1	300.5	0.3	0.8	0.1	0.1	14.0	0.0	202.4	0.0	0.0	0.0	0.0	17.5	3.1	20.9	0.0	0.1	5.1	85.3	0.0	61.6	0.4	0.0	0.5	0.0	0.1	0.5	1.9	0.1	0.3	17.6	38.9	0.8	0.2	0.0	0.5	103.7	114.1	1.2	0.1	2.3	96.7	0.1	17.1	22.3	0.0	0.0	0.2	0.7	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	1.5	0.0	0.0	1.0	0.5	0.1	0.2	0.1	1.1	0.2	6.8	0.0	0.1	0.3	0.1	0.1	1.3	0.1	1.7	73.7	75.7	0.0	1.3	1.9	25.1	17.0	10.8	0.9	17.7	21.2	0.8	54.3	52.5	114.0	4.2	1.4	1.8	230.9	5.9	45.0	0.5	85.3	17.8	3.2	27.1	0.0	0.3	33.9	0.3	2.0	97.3	189.8	2.5	1.3	1.4	3.2	0.3	1.7	0.2	180.3	63.1	1.9	3.1	0.6	1.8	2.5	0.0	0.0	1.6	0.3	1.0	0.5	0.1	39.4	95.8	1.5	0.3	30.9	12.2	6.2	36.7	1.4	0.0	5.6	4.3	1.2	3.7	48.1	8.8	1.6	3.6	0.2	31.5	42.1
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 subunit gamma"	P51170	16	23182745-23216883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.4"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 90.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in single"	6	"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 46.8;RT4: 21.7"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Not detected"	"Not detected"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	0.7	0.2	0.4	0.0	0.3	0.3	2.3	4.4	0.2	16.0	0.2	10.3	0.0	1.8	0.7	9.9	0.4	0.0	0.0	0.8	0.2	42.4	0.0	7.4	0.0	0.2	0.2	0.0	3.2	0.0	3.8	0.5	0.4	13.8	1.2	0.2	17.7	3.4	0.0	9.7	0.4	0.1	0.0	0.0	10.1	0.1	0.1	2.0	5.7	0.0	1.2	1.4	15.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.9	0.0	0.0	0.1	0.0	21.7	1.5	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.4	0.2	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.3	0.4	19.2	4.2	0.0	0.0	0.4	4.7	8.8	19.9	0.0	0.8	1.3	0.8	0.0	17.4	90.1	0.0	0.2	0.0	3.4	0.0	2.0	0.0	9.8	1.1	0.1	0.0	0.0	0.2	1.7	0.0	0.4	15.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.1	0.0	0.1	5.3	0.0	0.2	1.9	0.0	0.0	0.0	0.2	0.1	0.1	4.4	0.3	0.1	0.2	0.0	0.4	1.8
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841289	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 149.7;Proximal tubular cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		370000	"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	81.2	22.9	18.9	11.1	19.4	13.4	48.9	18.8	22.3	28.2	22.0	23.8	43.8	24.5	11.5	19.2	26.5	12.0	31.9	18.5	20.6	68.6	37.2	17.4	12.9	19.9	19.6	25.4	26.4	25.4	31.5	12.9	18.8	28.5	10.4	6.5	33.8	19.7	38.1	22.1	36.7	10.2	20.1	34.0	21.5	10.6	19.4	12.0	39.9	25.0	10.1	22.2	23.3	20.1	28.0	43.8	12.1	11.0	33.7	25.7	36.6	13.7	27.6	20.6	21.0	32.5	33.2	15.3	27.5	7.1	11.0	14.7	3.9	24.6	6.9	37.6	29.7	15.5	33.8	29.2	12.0	7.9	12.7	25.7	18.1	12.8	9.8	31.5	23.5	35.6	5.4	18.2	28.9	25.4	24.6	12.8	6.0	12.1	17.5	32.7	9.0	62.4	16.9	12.9	8.9	37.6	8.0	17.3	17.8	8.3	37.9	14.5	10.7	18.2	20.8	5.6	6.6	70.2	9.8	7.7	52.1	13.2	4.2	24.5	19.9	43.4	24.6	21.1	24.1	24.8	20.4	24.2	25.7	25.3	31.7	17.8	5.4	29.3	10.8	30.1	23.0	16.5	18.9	19.4	18.8	22.3	18.5	20.6	19.9	19.6	18.8	20.1	19.4	20.1	21.9	38.5	29.9	15.0	18.7	15.7	31.5	41.8	20.5	12.0	24.5	25.7	19.3	15.7	35.9	16.5	10.4	43.1	12.4	33.2	74.3	27.7	3.9	16.9	10.0	24.6	22.3	7.2	12.4	61.0	9.3	25.7	17.3	12.4	16.5	22.1	24.3	26.7	22.7	20.2	10.5	33.6	48.8	11.1	13.7	2.8	33.2	12.8	42.7	7.5	13.9	28.8	26.8	11.1	6.0	33.3	36.5	16.6	30.9	14.1	149.7	332.7	40.9	16.8	6.6	19.1	16.0	5.2	16.7	21.9	11.5	33.8	21.6	23.9	40.7	27.0
SFXN2	SLC56A2	ENSG00000156398	"Sideroflexin 2"	Q96NB2	10	102714538-102743492	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.9;parathyroid gland: 12.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Hepatocytes: 21.2;Proximal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018150, HPA026834"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018150: AB_1856790, HPA026834: AB_1856791"	"unprognostic (1.70e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.98e-3)"	"prognostic favorable (2.28e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.77e-2)"	"prognostic favorable (6.52e-4)"	1.5	1.1	1.2	1.9	2.8	3.0	2.8	3.9	1.7	1.6	3.6	1.9	2.5	2.7	3.6	1.4	3.6	1.1	0.6	1.8	0.8	17.9	4.2	1.6	2.6	1.0	0.5	3.4	3.1	12.7	2.7	3.4	1.2	2.2	3.0	2.7	4.9	1.3	0.7	1.9	1.9	1.1	0.2	2.1	3.3	1.2	1.8	3.2	3.8	0.2	1.9	0.9	0.7	2.1	4.2	2.3	3.5	3.7	1.3	0.9	5.1	1.4	0.6	1.8	0.9	7.2	1.9	9.1	2.7	1.2	1.0	3.0	0.7	4.8	1.0	1.6	2.8	13.1	4.4	4.5	0.6	7.5	1.1	1.0	0.7	1.8	1.8	1.1	1.7	7.7	6.0	4.2	1.1	4.0	11.5	2.5	2.3	4.0	0.8	5.5	4.3	1.3	1.7	3.5	2.6	2.5	1.2	3.1	0.6	1.4	38.4	1.6	1.2	1.4	4.4	1.8	3.1	4.6	6.5	7.9	1.7	9.0	1.2	1.6	0.5	0.2	1.9	0.2	1.7	0.8	1.9	2.0	0.7	2.5	3.0	2.5	0.9	1.9	0.3	1.7	2.0	0.7	1.2	2.8	3.9	1.7	1.8	0.8	1.0	0.5	1.2	0.2	1.8	2.1	1.0	0.0	10.1	5.2	3.8	0.9	3.0	0.8	4.0	6.1	7.3	5.2	2.5	4.3	2.0	1.8	33.3	9.1	2.4	2.5	9.8	1.9	0.8	7.3	4.2	2.2	3.6	4.2	5.4	2.8	4.4	3.2	8.2	10.0	0.0	9.2	5.0	21.2	9.6	0.0	5.5	5.0	0.0	7.5	0.6	0.5	2.1	2.4	0.0	8.4	0.8	1.1	4.1	7.1	2.9	1.4	0.8	1.5	6.7	4.4	2.4	43.1	0.4	15.1	0.0	2.7	1.7	1.2	1.3	3.3	1.3	4.5	2.8	2.6	7.3	2.9
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306368-36329340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;thyroid gland: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.3;Late spermatids: 53.6;Proximal enterocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.4;HaCaT: 21.1;hTERT-RPE1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042212, HPA042456, HPA066168"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.1	0.7	2.4	2.5	1.1	1.3	10.8	0.2	6.8	4.4	0.0	3.4	14.0	2.2	1.4	6.9	1.2	2.0	2.0	0.8	0.0	8.8	0.8	3.9	2.0	1.1	0.2	3.5	0.5	0.3	1.7	3.1	1.0	6.7	3.7	3.2	13.4	1.4	0.8	17.4	20.9	1.1	0.0	2.2	2.0	6.8	0.8	0.7	27.8	0.3	3.0	1.3	7.2	0.2	11.2	0.3	2.0	2.2	0.5	1.3	14.4	6.1	0.9	2.8	1.3	7.1	4.3	2.2	5.5	1.6	0.3	21.1	1.4	3.3	2.1	0.9	2.1	2.1	4.8	5.3	1.1	1.2	3.2	0.9	3.0	1.9	1.4	21.7	1.0	4.3	0.4	2.6	1.6	7.3	1.4	1.1	1.2	2.6	2.4	2.3	0.3	1.2	3.7	1.8	4.4	2.1	1.1	11.0	3.4	10.3	0.7	0.3	3.2	1.6	1.2	4.3	1.0	3.3	1.0	2.2	3.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.4	1.1	0.2	6.8	0.8	0.0	1.1	0.2	1.0	0.0	0.8	0.2	1.1	0.0	2.0	0.3	1.7	3.1	1.7	3.0	1.8	6.9	6.2	4.3	1.4	0.0	1.9	5.5	0.0	2.9	1.9	15.3	1.9	0.6	14.2	2.5	2.0	1.6	0.0	0.0	1.6	0.4	2.2	1.9	4.6	7.7	1.3	2.6	1.1	0.3	7.7	11.8	1.2	2.9	2.0	6.1	7.7	53.6	1.2	5.0	3.6	0.0	2.2	1.2	1.0	0.0	0.2	4.3	5.8	2.6	2.9	2.6	14.9	1.1	2.3	1.2	0.0	0.7	2.1	2.6	1.2	2.4	3.1	5.7	1.3	3.2	1.6	1.3
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	8.4	3.5	4.0	8.7	4.3	4.6	5.6	4.1	5.6	2.9	5.2	2.8	0.9	2.1	0.7	8.4	3.0	5.4	3.6	3.6	7.3	19.2	9.6	9.0	9.1	10.5	6.0	1.2	6.3	0.7	2.5	3.0	8.5	4.7	1.0	1.3	4.6	2.7	1.5	2.7	4.9	2.0	9.2	14.1	6.0	0.6	8.4	28.0	4.6	0.7	4.5	4.4	5.8	11.8	3.9	6.1	0.1	0.0	0.0	0.5	4.1	0.4	0.2	0.5	0.8	3.2	2.2	5.2	5.2	0.0	0.8	2.0	0.0	12.4	0.0	14.2	0.2	0.0	6.1	5.7	4.3	0.1	0.8	0.2	15.3	0.3	9.9	0.5	25.8	3.2	0.8	7.3	0.4	4.1	41.8	3.4	0.0	2.3	5.1	3.1	0.7	1.6	0.4	1.0	0.1	3.1	1.7	0.4	26.8	1.0	0.0	1.0	14.2	0.0	3.0	19.0	0.2	0.0	1.0	4.7	0.2	1.9	4.1	0.0	9.9	1.3	0.7	8.8	0.9	4.9	1.7	1.1	7.7	6.8	0.9	0.7	0.3	0.3	12.3	17.7	2.5	4.3	4.0	4.3	4.1	5.6	3.6	7.3	10.5	6.0	8.5	9.2	8.4	11.8	12.6	0.0	5.8	1.3	18.1	0.8	10.5	6.9	0.6	1.0	0.8	1.4	3.3	4.3	4.1	25.8	0.0	2.1	18.2	2.5	7.9	3.6	0.5	0.9	0.3	12.6	1.2	3.2	0.2	5.6	3.4	1.6	32.6	2.2	17.2	0.3	27.5	8.6	22.7	23.5	0.1	2.5	14.2	33.7	16.7	1.5	0.6	35.7	0.0	17.8	15.6	13.3	7.2	0.5	0.1	9.3	4.5	0.7	17.1	8.3	0.1	17.2	2.0	0.9	0.0	0.6	1.2	0.0	0.3	2.5	0.6	3.0	11.7	2.5	1.8	15.3
SH3YL1	"DKFZP586F1318, Ray"	ENSG00000035115	"SH3 and SYLF domain containing 1"	Q96HL8	2	217730-266398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 223.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030926, HPA030927"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA030926: AB_10670148, HPA030927: AB_10669874"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-3)"	13.6	32.0	26.6	11.9	27.7	11.6	54.8	27.5	37.2	31.8	28.3	45.6	35.1	27.0	40.8	43.8	43.6	45.2	11.0	26.8	25.5	145.6	11.6	35.7	22.1	27.4	26.8	28.6	161.6	55.7	33.9	26.9	27.8	34.4	53.2	10.7	114.0	24.3	13.4	75.0	51.7	11.9	26.4	16.0	72.3	17.0	27.9	15.4	59.2	8.3	28.0	49.3	27.1	33.1	12.7	2.4	13.5	6.0	18.1	16.8	9.0	15.7	17.4	5.8	6.0	33.6	46.3	0.6	7.3	13.8	3.9	51.6	3.4	67.6	5.4	10.2	2.4	3.0	3.9	10.9	14.5	1.5	3.8	18.6	68.2	3.5	11.0	28.7	8.7	17.2	0.9	2.3	12.0	37.1	13.4	6.9	4.4	223.4	2.6	6.4	4.1	0.9	41.4	69.8	5.5	9.1	2.6	64.1	11.9	17.5	44.0	10.6	6.6	2.9	0.8	16.9	6.9	1.7	0.1	1.2	28.8	20.7	9.8	38.9	2.5	1.9	4.5	3.1	14.3	12.6	22.4	11.5	6.1	10.1	33.9	20.5	1.5	22.9	4.9	5.5	30.6	8.2	26.6	27.7	27.5	37.2	26.8	25.5	27.4	26.8	27.8	26.4	27.9	33.1	14.8	57.7	116.7	51.2	29.7	82.7	173.5	174.4	42.7	19.3	140.2	130.3	6.6	313.1	139.7	101.2	22.9	197.7	15.8	84.5	291.6	129.2	136.6	148.5	32.3	15.9	49.1	3.8	62.3	143.9	69.9	22.6	31.1	216.6	15.8	51.9	19.2	7.9	26.5	26.9	57.1	97.4	109.9	9.5	17.0	113.1	36.7	14.9	72.9	23.4	15.2	9.4	30.9	44.2	87.2	104.6	115.3	41.0	4.7	166.3	125.1	606.2	85.2	9.7	26.3	20.4	20.5	63.3	23.2	29.5	115.4	247.0	35.7	37.1	123.8	245.3
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397488-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.3;heart muscle: 15.5;kidney: 21.4"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 43.0;Fibroblasts: 19.4;Hepatic stellate cells: 55.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 7.6;renal cancer: 7.8"	"Group enriched"	"Detected in all"	4	"midbrain: 13.3;thalamus: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AN3-CA: 219.6;PC-3: 130.4"	"Region enriched"	"Detected in many"	23	"olfactory bulb: 51.7"	"Region enriched"	"Detected in many"	8	"spinal cord: 21.4"	HPA054754			Approved	"Lipid droplets,Cytosol"		NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.1	1.8	1.8	1.8	1.6	0.0	2.3	1.1	1.6	0.7	1.2	6.2	2.2	0.2	0.3	1.7	0.5	1.0	15.5	1.0	2.2	21.4	0.6	5.7	7.0	1.7	13.3	0.3	0.2	0.2	0.6	0.0	2.6	0.8	3.0	0.1	0.6	1.0	1.6	0.5	10.4	4.3	1.4	0.4	2.9	0.6	10.1	0.1	5.0	1.4	0.8	3.5	1.3	1.2	0.0	0.0	0.0	219.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.1	0.0	0.0	23.3	0.0	0.0	0.0	2.6	0.0	0.1	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	1.2	0.0	10.1	0.0	130.4	0.2	0.0	0.0	9.0	0.0	0.1	0.3	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.1	1.6	1.0	2.2	1.7	13.3	2.6	1.4	10.1	1.2	4.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	3.7	0.0	0.0	0.1	0.1	43.0	0.0	0.0	0.1	2.5	3.7	0.0	5.3	0.0	0.0	0.0	19.4	0.5	0.1	0.0	1.1	55.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.0	3.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	2.4	0.0	0.1	0.0	0.2	1.4	0.5	0.4	0.1	0.0	0.0	0.0	2.4	0.1	0.0
SIM1	bHLHe14	ENSG00000112246	"SIM bHLH transcription factor 1"	P81133	6	100385009-100464921	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;kidney: 9.9;skeletal muscle: 3.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 7.9;Ductal cells: 4.5;Skeletal myocytes: 7.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Group enriched"	"Detected in some"	5	"hypothalamus: 4.4;midbrain: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.7;BJ: 16.4;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 7.2;HDLM-2: 7.3;RPTEC TERT1: 18.4"	"Region enriched"	"Detected in single"	8	"hypothalamus: 5.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.1"	HPA024385			Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			1.7	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.4	9.9	0.3	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	9.7	0.0	16.4	23.7	7.2	6.7	0.0	0.0	0.0	0.0	5.2	1.5	0.0	0.0	0.0	6.1	7.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	0.0	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.2	0.0	0.1	0.0	0.0	7.9	4.5	1.8	0.1	0.1	0.1	1.8	0.0	0.1	1.2	0.1	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	7.6	0.3	1.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 705.6"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	705.6	0.4	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.6	0.5	0.6	0.4	0.2	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"kidney: 101.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Group enriched"	"Detected in some"	11	"BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.3	0.4	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	101.7	0.0	0.1	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.1	0.3	0.8	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	4.2	0.0	5.9	0.0	0.4	2.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	4.2	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 81.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 452.1"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053615, HPA062714"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	0.1	27.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	75.3	452.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.1	0.0
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683688	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.5;kidney: 3.2"	"Cell type enriched"	"Detected in many"	7	"Collecting duct cells: 77.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 4.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.9"	"Not detected"	"Not detected"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.5	1.1	0.2	0.2	0.2	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	3.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.2	4.9	0.2	0.1	0.2	0.7	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	6.4	9.6	5.2	0.7	0.6	0.9	0.3	0.0	1.1	0.4	0.3	0.9	0.0	1.9	77.3	2.1	0.3	0.6	0.3	0.0	0.0	1.3	0.2	0.3	0.9	0.0	0.0	8.8	0.0	0.5	2.4	0.0	0.3	3.8	0.1	1.1	0.0	0.4	1.7	10.6	0.5	0.0	0.3	2.0	1.4	0.6	0.8	1.8	2.8	0.2	0.9	1.0	6.6	1.0	0.1	1.2	0.7	0.1	0.5	4.9	0.2	1.5	2.0	0.0	0.4	0.2	0.3	0.4	0.0	0.1	0.8	1.0	0.2	0.2	0.5
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC16A5	"MCT5, MCT6"	ENSG00000170190	"Solute carrier family 16 member 5"	O15375	17	75087727-75106162	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 92.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Collecting duct cells: 88.3;Early spermatids: 42.2;Proximal enterocytes: 40.9;Respiratory ciliated cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.2;neutrophil: 34.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 34.9;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"A549: 65.9;OE19: 71.5;RPTEC TERT1: 68.8;RT4: 139.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (8.43e-3)"	"unprognostic (8.07e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	6.5	1.4	1.1	4.8	1.1	8.7	7.2	1.2	1.2	9.4	5.0	15.2	34.0	8.5	4.4	11.2	16.1	8.2	13.9	1.0	1.7	92.8	3.3	24.6	3.4	2.2	2.2	8.1	4.7	4.6	2.7	10.8	1.7	15.0	10.3	0.1	7.9	12.5	9.4	15.9	24.9	4.2	1.9	10.6	26.0	6.5	2.4	1.9	14.3	4.6	3.9	18.5	11.1	1.8	14.2	65.9	1.2	0.1	3.2	4.2	22.0	7.7	19.8	7.7	5.4	16.9	39.6	0.0	9.2	24.1	1.0	39.7	3.2	10.8	2.9	0.0	0.2	5.1	33.5	8.9	14.9	0.0	0.2	10.1	12.8	7.8	0.1	0.1	15.8	0.7	1.1	0.2	0.5	2.3	0.5	7.1	5.0	71.5	0.2	1.6	0.0	0.5	68.8	139.8	0.0	0.4	19.4	4.5	9.7	11.0	32.0	7.1	5.7	0.1	0.1	0.5	0.1	0.2	0.0	0.0	0.3	4.3	4.3	4.1	13.2	3.5	0.5	5.0	0.3	1.4	0.6	0.1	3.9	0.3	1.4	0.6	34.9	1.0	2.6	0.1	0.8	4.4	1.1	1.1	1.2	1.2	1.0	1.7	2.2	2.2	1.7	1.9	2.4	1.8	4.4	38.5	34.5	0.0	0.9	2.5	7.7	10.1	6.2	0.0	5.6	6.1	5.5	7.2	23.5	88.3	0.0	18.5	0.5	17.1	5.9	6.4	42.2	9.7	1.5	5.0	6.7	0.4	0.2	1.3	3.7	3.7	11.7	6.1	7.0	3.9	12.8	0.4	6.5	0.0	0.3	13.2	4.1	8.5	1.8	31.8	0.6	5.5	7.2	3.7	7.9	0.2	3.1	0.0	0.1	1.0	23.8	0.0	0.2	11.3	40.9	1.9	45.4	0.0	0.0	0.8	2.1	0.3	1.5	3.6	1.3	19.6	1.4	1.1	11.8	25.5
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782915-25832052	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"kidney: 169.3;liver: 49.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	647	"RPTEC TERT1: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050513			Approved	"Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	169.3	49.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 164.3"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 197.8"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	210	"RPTEC TERT1: 114.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.3	37.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	1.8	0.0	0.0	0.2	0.1	7.9	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	197.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555690-64572875	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	72	"epididymis: 10.6;kidney: 31.9;placenta: 33.4"	"Group enriched"	"Detected in some"	19	"Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;Hep G2: 1.0"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	654.0	0.0	0.0	5.9	0.0	1.2	0.0	0.2	1.7	0.0	0.0	0.0	0.4	22.5	3.4	0.0	0.0	0.0	0.0	0.4	0.2	50.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.3	0.3	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1520.6	0.2	0.1	0.2	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	204	"kidney: 109.4"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 173.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	109.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278757	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"kidney: 9.0"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 2.3;Inhibitory neurons: 1.8;Proximal tubular cells: 7.1"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035603, HPA035962"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"kidney: 153.9"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 92.0;Proximal tubular cells: 198.3"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.9"	"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	153.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.1	92.0	0.6	7.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	198.3	0.0	0.0	0.0	1.0	0.6	0.1	0.3	0.0	0.3	0.1	1.4	0.0	0.0	0.0
SLC22A24	"MGC34821, NET46"	ENSG00000197658	"Solute carrier family 22 member 24"	Q8N4F4	11	63079940-63144221	"Predicted membrane proteins"	"Ion transport, Lipid metabolism, Steroid metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;kidney: 4.4"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 5.9;Proximal tubular cells: 11.8"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045015	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045015: AB_2679183"							"unprognostic (5.72e-3)"						"unprognostic (1.80e-7)"					0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984967	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"kidney: 196.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 310.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.0	0.0	1.3	0.0	2.5	0.0	0.0	3.6	2.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	196.5	0.0	0.0	0.0	7.0	5.5	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.5	3.6	2.3	1.3	3.8	7.0	5.5	3.1	3.3	7.6	1.2	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	310.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015841	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"choroid plexus: 111.4;kidney: 335.0"	"Cell type enriched"	"Detected in some"	38	"Proximal tubular cells: 347.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.0	111.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	335.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.7	3.6	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	1.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	347.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291116-100306547	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 419.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	28.0	44.6	57.6	5.3	66.1	13.5	34.4	71.1	74.2	46.8	72.2	20.2	8.1	32.1	37.5	36.3	84.4	12.2	30.5	56.9	57.8	124.5	35.9	44.1	8.1	91.8	69.3	49.9	22.2	6.6	62.8	6.6	83.8	69.1	5.3	47.4	45.5	12.6	11.9	42.4	18.5	8.2	68.7	20.5	26.6	44.8	66.8	8.8	419.6	6.0	5.7	26.9	27.0	94.9	11.0	23.2	29.7	39.0	6.8	2.5	17.4	8.2	8.9	16.8	9.9	5.4	6.7	0.0	20.4	2.8	8.6	11.5	12.7	4.2	5.6	4.2	5.4	10.4	35.8	9.9	16.1	6.1	13.0	7.4	12.9	7.7	7.1	25.5	23.3	35.7	3.4	1.2	4.9	34.8	37.9	33.6	14.8	9.7	22.5	49.1	12.4	0.8	55.5	7.7	42.9	52.8	19.3	13.2	15.4	12.5	33.0	10.2	24.5	6.1	11.7	8.6	12.9	2.9	1.3	1.4	6.9	14.9	7.6	1.5	1.1	2.1	0.9	0.2	0.0	0.1	0.4	0.9	1.2	0.5	0.1	0.6	1.2	0.1	0.0	0.5	0.6	0.2	57.6	66.1	71.1	74.2	56.9	57.8	91.8	69.3	83.8	68.7	66.8	94.9	23.5	9.6	26.5	108.7	5.8	6.5	16.3	14.8	22.8	17.9	57.1	38.5	1.4	11.5	23.3	123.2	75.0	6.2	17.8	9.4	17.6	31.4	19.7	136.7	24.8	20.9	20.9	3.8	26.4	11.8	0.7	10.9	12.2	136.0	14.5	22.6	31.8	9.5	7.4	21.9	22.4	8.8	12.2	2.8	30.0	62.4	2.5	11.7	10.6	30.9	8.8	21.0	12.3	42.7	78.5	14.2	17.0	6.0	4.1	39.6	4.6	13.1	45.1	82.7	13.1	7.0	12.6	4.2	5.0	24.5	6.5	18.6	6.4	6.3	14.3	13.8
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360194-140375141	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"kidney: 35.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051307	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.5	35.5	0.0	0.1	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.7	0.3	0.5	0.9	0.6	1.0	0.5	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.7	1.9	0.0	0.1	0.0	0.1	0.1	0.1	0.2
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 41.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 33.7;Proximal tubular cells: 76.9"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.8;non-classical monocyte: 4.8"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.8"	"Cell line enriched"	"Detected in some"	5	"U-937: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052014	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.2	0.2	0.1	0.6	0.1	2.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.0	0.0	41.6	0.5	0.4	0.9	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.9	1.4	0.0	0.1	3.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.8	0.3	8.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	33.7	0.0	0.5	1.8	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	0.0	0.7	0.1	0.0	76.9	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.6	0.0	0.0	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 54.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 59.7;Late spermatids: 145.7;Proximal tubular cells: 142.9;Spermatocytes: 31.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041603	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	54.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	3.7	0.3	0.2	0.3	0.1	0.2	0.0	0.5	0.2	0.4	0.5	1.5	0.1	9.2	0.0	0.2	0.1	0.1	7.9	0.6	59.7	0.6	0.5	0.2	0.0	0.0	0.1	0.5	0.1	0.4	1.5	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.5	2.0	0.0	0.5	145.7	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	1.5	0.0	0.1	4.7	142.9	1.7	0.2	0.0	0.1	0.2	31.7	1.1	0.0	0.3	0.1	1.4	0.1	0.6	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225381-1246189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	76	"kidney: 8.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 55.6"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	55.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
SLC7A13	"AGT-1, XAT2"	ENSG00000164893	"Solute carrier family 7 member 13"	Q8TCU3	8	86214063-86321146	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	234	"kidney: 42.0"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.34e-1)"						"unprognostic (2.62e-1)"					"unprognostic (1.12e-1)"	"unprognostic (2.96e-5)"					0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SMIM32		ENSG00000271824	"Small integral membrane protein 32"	A0A1B0GUA5	5	136191468-136193162	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	13	"brain: 17.7;intestine: 12.9;kidney: 49.2"	"Cell type enriched"	"Detected in some"	11	"Proximal tubular cells: 394.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"	"Group enriched"	"Detected in many"	6	"basal ganglia: 17.7;cerebral cortex: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	1.0	0.2	17.7	0.0	0.0	1.8	4.5	0.0	0.0	4.9	12.9	0.0	0.0	0.0	0.0	2.0	0.0	1.1	1.4	49.2	0.3	0.0	0.0	1.0	1.4	0.0	0.4	0.0	0.0	0.0	0.8	0.4	1.5	0.0	0.1	0.0	0.6	0.0	6.2	0.0	0.8	0.0	1.4	0.3	0.9	0.0	1.2	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	17.7	1.8	4.5	1.1	1.4	1.0	1.4	0.8	0.8	0.9	1.7	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	33.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	394.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0
SMIM34A		ENSG00000243627	"Small integral membrane protein 34A"	A8MWV9	21	34418715-34423951	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 1.2;kidney: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029085	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"					"HPA029085: AB_10669867"																		0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.2	0.1	0.2	2.5	0.2	0.3	0.0	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.2	0.3	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM34B		ENSG00000278961	"Small integral membrane protein 34B"	P0DPE8	21	7784482-7793954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"breast: 4.8;kidney: 17.2"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 5.9;Endometrial ciliated cells: 5.0;Respiratory ciliated cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HDLM-2: 3.0"									HPA029085	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA029085: AB_10669867"																		0.1	0.2	0.6	0.0	0.9	0.0	4.8	1.1	1.0	0.2	2.1	0.1	0.0	0.1	0.5	0.1	3.2	0.2	0.6	0.9	0.0	17.2	0.3	0.7	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.2	0.1	0.0	1.6	0.1	0.3	0.5	1.1	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.9	1.1	1.0	0.9	0.0	0.1	0.4	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940709-21994837	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	29.7	94.3	52.0	34.7	53.5	50.8	49.6	56.0	61.9	42.7	43.7	52.0	54.9	44.7	63.6	30.6	28.6	40.5	53.0	53.9	50.2	119.9	44.3	36.2	47.8	48.6	46.7	91.2	24.1	28.0	31.5	114.2	49.1	136.0	50.4	49.5	39.7	42.2	34.6	21.4	50.9	39.6	47.0	41.3	39.3	30.2	53.9	50.7	55.3	32.5	47.3	55.1	32.0	49.6	664.3	161.2	265.3	107.1	71.9	121.4	86.3	174.6	102.6	261.7	249.1	204.0	213.0	239.5	59.8	180.0	722.9	142.2	265.5	318.2	508.2	111.0	128.6	124.4	201.0	145.5	129.4	242.2	103.8	76.8	93.7	266.4	497.2	189.2	254.5	93.6	270.6	32.7	366.7	139.2	181.3	244.1	474.9	149.0	244.3	176.0	188.5	182.9	354.3	90.1	131.4	105.7	143.1	181.8	489.1	687.6	163.9	101.3	232.3	194.4	193.6	405.0	294.5	23.8	52.6	142.2	378.4	107.5	275.6	9.1	57.5	102.5	18.9	59.9	23.7	34.6	29.6	33.3	51.1	22.0	19.1	22.8	55.7	31.4	73.9	10.7	55.4	37.3	52.0	53.5	56.0	61.9	53.9	50.2	48.6	46.7	49.1	47.0	53.9	49.6	43.4	25.6	21.9	33.6	61.5	65.9	203.0	206.1	42.1	35.7	116.2	66.3	36.1	81.5	115.0	110.3	12.5	644.3	46.7	61.2	608.4	246.3	1.9	126.4	70.4	61.9	58.8	95.2	45.6	152.3	313.1	86.6	57.6	215.9	40.5	249.5	59.6	49.8	364.7	21.9	40.2	103.6	146.5	157.3	200.3	7.1	95.4	153.1	92.5	21.5	250.7	46.8	48.4	22.1	8.1	165.6	63.9	103.4	45.6	276.2	137.0	466.7	78.9	43.2	65.7	76.6	114.2	6.0	181.3	54.1	50.6	869.6	63.7	271.2	119.1	153.1
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753738-43758791	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 13.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.4;Collecting duct cells: 1.8"	"Cancer enhanced"	"Detected in some"		"lung cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 5.2;SuSa: 3.0"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.0"	"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	13.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	113.1	24.4	276.0	59.5	490.3	1.0	70.2	652.0	736.4	27.5	265.0	44.9	9.5	131.2	9.8	4.8	52.8	2424.4	37.0	301.6	417.1	3587.6	35.6	18.8	9.1	813.2	645.3	9.9	292.0	19.2	20.6	2791.9	781.8	15.7	7.6	745.5	88.7	22.1	16.0	2.7	14.4	38.3	472.6	9.2	11.0	11.7	633.1	8.4	8.3	0.4	5.7	25.0	6.0	855.0	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	276.0	490.3	652.0	736.4	301.6	417.1	813.2	645.3	781.8	472.6	633.1	855.0	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
SPRING1	"C12orf49, FLJ21415, LUR1, POST1, SPRING"	ENSG00000111412	"SREBF pathway regulator in golgi 1"	Q9H741	12	116710171-116738070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 37.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.5;Cytotrophoblasts: 11.5;dendritic cells: 9.8;Extravillous trophoblasts: 37.5;Hofbauer cells: 40.9;Syncytiotrophoblasts: 17.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026905	Uncertain				"Intracellular and membrane"	NA	NA		330000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA026905: AB_10603446"	"unprognostic (2.74e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (2.56e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.91e-11)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.73e-1)"	5.4	8.2	13.0	7.9	14.8	6.2	5.9	14.3	13.0	3.5	8.5	11.1	6.6	4.3	8.5	7.8	3.4	5.7	7.0	11.5	15.5	15.2	8.7	18.5	8.5	18.2	16.3	3.5	6.8	7.1	6.8	4.4	16.4	4.6	8.4	5.7	13.7	4.2	3.1	6.3	6.4	3.9	13.7	7.2	11.4	9.2	18.4	9.8	37.4	2.4	8.8	5.4	4.1	12.1	12.6	16.7	15.2	15.2	17.4	13.8	19.0	8.6	11.5	9.5	8.2	32.9	9.3	32.3	16.6	11.9	14.1	16.0	21.3	13.2	10.6	26.0	17.1	9.2	8.5	31.6	12.2	17.8	27.3	16.8	16.3	12.4	14.0	16.1	14.5	21.3	10.0	7.3	15.3	18.9	16.2	16.5	24.4	19.2	19.4	24.0	10.3	14.0	24.1	33.7	14.0	17.4	14.0	14.0	25.9	17.1	16.9	18.3	18.9	14.1	19.4	20.0	17.1	15.0	48.7	45.6	22.9	18.2	16.9	3.1	2.4	4.1	4.5	3.3	4.6	5.6	3.5	3.7	2.2	4.9	3.0	4.1	1.7	2.9	2.3	4.3	3.9	1.7	13.0	14.8	14.3	13.0	11.5	15.5	18.2	16.3	16.4	13.7	18.4	12.1	10.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	11.5	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	37.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	17.9	1.6	0.0	0.0	0.0
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 39.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 19.6;Hofbauer cells: 22.0;Kupffer cells: 32.0;Macrophages: 11.8;Proximal tubular cells: 46.3;Smooth muscle cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 53.3;NB-4: 31.0;U-937: 52.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB022745	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	3.5	0.8	0.0	1.3	0.1	8.1	1.0	0.0	0.2	0.2	0.0	0.5	1.2	0.1	0.1	0.2	0.1	0.5	0.7	0.0	0.2	39.9	5.2	2.6	1.9	0.2	0.2	0.1	0.0	3.4	0.0	0.2	0.3	0.1	0.8	0.0	0.6	0.1	0.0	1.0	1.0	0.7	0.1	7.0	7.8	0.1	0.4	0.9	9.3	0.1	0.6	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	8.7	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.2	0.3	0.1	0.4	0.2	8.4	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.5	0.1	3.7	0.0	0.1	1.4	0.0	19.6	0.0	0.5	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	4.3	22.0	0.0	0.0	0.2	8.2	32.0	8.1	0.4	0.0	11.8	0.0	8.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	46.3	1.5	0.0	0.0	0.1	11.2	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.1
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7101970	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 2.9;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Inhibitory neurons: 2.2;Oligodendrocyte precursor cells: 1.0;Squamous epithelial cells: 5.7;Urothelial cells: 1.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-698: 12.3"									"HPA050857, HPA060073"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA050857: , HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	0.3	0.0	0.1	0.0	1.3	0.0	0.3	0.1	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.8	0.3	0.4	0.2	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.4	0.1	0.4	0.2	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.2	3.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.3	0.0	0.0	0.0	1.1
TDGF1	"CR, CR-1, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582457	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.4;lymphoid tissue: 20.9"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 121.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 11.2;pons and medulla: 8.7"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.4	3.4	2.4	0.5	1.9	0.3	0.3	2.1	4.8	0.7	1.4	2.6	0.7	1.0	2.0	0.1	0.1	0.6	0.6	1.8	1.7	23.4	1.3	0.4	0.4	2.1	1.8	7.7	0.4	0.1	0.1	0.2	2.2	0.4	4.6	0.4	1.0	0.3	1.5	0.3	0.5	1.2	1.7	20.9	2.7	0.5	3.1	15.1	0.8	1.5	0.1	0.2	0.1	1.9	0.1	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	25.7	0.2	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	110.6	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	66.3	0.1	0.1	1.8	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.9	0.3	0.1	0.1	0.0	0.0	2.4	1.9	2.1	4.8	1.8	1.7	2.1	1.8	2.2	1.7	3.1	1.9	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.9	121.3	0.2	5.0	0.3	0.1	8.2	2.4	0.0	0.0	0.0	0.0	0.3	8.2	0.2	0.0	14.3	0.4	1.4	0.1	0.0	0.0	5.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.1	17.7	6.1	0.0
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 97.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.9	0.3	0.9	1.7	1.6	0.2	28.7	1.7	1.1	18.1	19.0	19.0	0.6	0.5	8.3	13.3	3.5	2.9	0.2	1.7	0.9	49.1	0.2	5.6	0.2	1.6	2.1	0.1	6.4	2.6	0.8	7.4	1.1	13.6	22.6	0.0	97.5	2.0	2.6	31.9	3.2	0.6	0.7	1.8	16.3	1.1	1.9	0.2	37.6	0.1	1.2	1.8	10.9	0.7	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.7	1.1	1.7	0.9	1.6	2.1	1.1	0.7	1.9	0.7	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370365-11832198	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 7.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Bipolar cells: 183.8;Horizontal cells: 208.6;Inhibitory neurons: 494.3;Oligodendrocyte precursor cells: 262.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	54	"basophil: 5.3"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"A549: 10.3;HUVEC TERT2: 6.7;REH: 7.1;SH-SY5Y: 10.2;THP-1: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"	NA	NA		6100000	"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favorable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	2.4	0.7	2.9	0.7	2.3	0.0	2.1	3.2	4.4	3.3	0.0	1.0	0.3	2.8	0.8	0.5	2.1	2.6	0.7	4.2	3.5	7.5	0.6	1.1	0.3	2.8	4.9	2.5	0.4	1.2	1.6	4.1	2.5	3.4	0.7	5.0	0.5	2.1	0.2	0.5	0.5	2.4	3.4	0.9	0.5	0.8	4.8	0.2	1.9	1.2	0.2	1.8	1.7	2.4	0.0	10.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.6	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	7.1	0.0	0.0	0.3	0.1	0.7	10.2	0.0	0.3	0.0	1.6	0.1	19.2	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.3	3.2	4.4	4.2	3.5	2.8	4.9	2.5	3.4	4.8	2.4	46.9	22.4	8.2	150.5	0.0	2.7	1.4	0.0	1.2	183.8	0.8	0.5	1.5	21.5	2.8	55.2	112.6	23.5	0.1	0.4	7.9	7.0	1.2	4.9	22.4	42.6	41.7	0.0	56.6	2.2	4.3	8.1	0.5	18.8	0.0	6.1	28.2	1.3	2.2	208.6	494.3	0.8	0.0	1.5	2.9	0.5	24.2	0.5	12.4	105.9	0.0	20.7	0.0	262.4	5.4	5.5	6.8	1.5	0.1	7.7	0.1	8.8	0.1	9.3	0.0	10.6	5.0	1.6	1.1	0.6	2.4	51.9	0.8	21.5	1.2	1.1
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390142	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 110.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.8"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 1.7;pons: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"RPTEC TERT1: 91.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.0	11.7	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.0	110.4	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.8	0.0	0.0	0.0	0.2	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	1.7	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.0	0.0	48.6	23.5	0.0	1.0	0.1	0.0	0.0	9.7	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	72.5	207.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	18.4	0.0
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26971579-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 258.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 553.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	38.0	48.8	23.1	28.2	25.1	66.0	33.2	19.2	27.3	37.8	34.6	60.5	40.4	29.9	48.6	61.2	40.7	58.3	18.3	23.1	25.2	258.0	138.4	53.7	29.1	25.8	22.8	32.9	117.9	42.4	20.1	36.0	24.6	36.1	69.1	38.9	41.6	43.9	13.7	40.5	35.3	45.8	26.1	32.7	48.7	30.6	26.3	101.4	44.0	35.4	39.9	47.5	28.6	30.7	70.0	147.8	82.6	104.7	122.1	74.3	438.7	74.3	132.8	65.1	109.9	73.3	289.2	80.9	92.3	78.1	61.1	71.5	85.9	553.0	77.0	84.1	46.7	126.9	168.2	134.1	76.7	439.5	84.9	48.7	382.6	144.3	111.7	191.8	177.2	242.2	53.8	60.1	97.1	114.9	232.4	189.3	170.5	266.8	75.4	216.9	131.8	164.2	93.7	278.2	14.4	72.9	84.8	56.6	121.0	391.6	151.8	77.2	62.4	53.9	92.1	140.3	93.4	38.5	97.3	152.9	115.5	133.7	78.5	11.2	7.4	19.0	6.0	8.1	5.4	8.7	8.0	7.8	12.4	13.5	11.1	7.1	6.2	13.7	3.8	10.1	13.9	4.7	23.1	25.1	19.2	27.3	23.1	25.2	25.8	22.8	24.6	26.1	26.3	30.7	23.2	12.8	27.6	28.4	20.2	28.8	52.4	78.7	96.8	50.0	17.2	19.8	10.3	127.2	46.0	42.3	43.8	40.0	35.2	22.2	17.6	62.1	82.4	23.0	5.7	19.4	13.2	49.0	83.1	39.6	15.2	23.5	32.1	21.1	14.0	48.5	22.5	42.5	39.5	23.5	50.4	24.0	28.5	25.7	11.1	148.8	15.5	27.1	65.8	26.2	27.4	30.8	27.8	63.8	40.0	25.3	28.1	23.0	38.2	18.1	25.5	143.7	24.9	38.4	6.6	27.4	18.4	10.1	22.3	65.0	27.8	16.3	21.8	21.6	31.3	37.6
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 26.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	4.9	2.4	1.7	10.2	2.1	3.3	4.1	1.2	2.9	3.8	2.4	3.6	4.0	3.6	1.7	1.5	3.3	3.6	2.1	1.6	2.5	21.9	3.5	5.2	6.9	6.2	3.0	7.8	3.1	2.4	1.6	10.1	3.8	2.5	5.3	0.8	2.8	3.1	1.1	1.3	3.4	8.8	2.8	9.7	4.8	3.3	6.1	4.0	5.3	1.5	6.1	4.8	2.4	4.1	3.1	0.9	0.4	0.2	3.8	4.1	2.3	7.8	5.0	6.7	10.5	2.3	6.4	4.5	1.5	12.1	2.6	1.3	0.8	1.0	7.8	7.1	0.0	3.2	2.7	10.7	2.2	0.1	16.8	2.6	0.2	12.5	0.3	2.4	6.0	5.3	0.1	3.2	8.5	1.3	5.5	2.1	0.3	0.0	0.0	4.0	1.3	2.7	2.9	0.2	0.6	0.0	1.5	3.7	1.8	1.6	5.5	4.5	6.8	3.3	0.4	3.3	1.6	5.0	0.5	1.4	2.8	5.4	6.7	26.7	5.1	5.7	1.5	5.6	0.7	1.9	1.0	1.5	4.2	3.2	0.7	1.3	1.4	2.1	2.0	6.0	2.9	2.2	1.7	2.1	1.2	2.9	1.6	2.5	6.2	3.0	3.8	2.8	6.1	4.1	4.5	3.2	4.5	1.3	13.6	2.4	11.0	2.4	0.6	4.3	6.5	4.2	1.2	0.0	3.9	7.3	2.1	5.0	22.7	3.9	3.9	2.0	5.9	2.6	7.1	6.5	3.0	2.5	1.0	4.0	8.3	6.6	10.7	3.9	8.2	45.6	5.0	1.7	45.3	0.0	1.0	4.5	0.0	44.8	35.6	2.7	14.0	25.2	0.0	17.8	16.5	1.2	14.4	3.5	4.0	5.5	3.4	7.2	5.4	10.9	2.1	17.8	6.0	3.7	13.1	4.0	4.6	7.4	3.6	0.5	1.7	5.2	7.3	3.2	2.9	13.1
TMEM174	"FLJ31268, MGC13034"	ENSG00000164325	"Transmembrane protein 174"	Q8WUU8	5	73173193-73175143	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	309	"kidney: 153.2"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 160.6"	"Cancer enriched"	"Detected in single"	126	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA037975	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA037975: AB_10672732"					"unprognostic (8.11e-2)"								"prognostic favorable (3.30e-6)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
TMEM207		ENSG00000198398	"Transmembrane protein 207"	Q6UWW9	3	190428655-190449901	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	115	"kidney: 17.8"	"Cell type enriched"	"Detected in some"	18	"Distal tubular cells: 68.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014332	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"			"HPA014332: AB_2204907"															"unprognostic (4.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 76.0;salivary gland: 52.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 144.8;Melanocytes: 26.6"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 2.1;neutrophil: 1.1;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054059	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.1	0.5	0.2	0.5	1.1	4.7	0.6	0.7	2.8	0.4	0.1	1.3	0.2	0.6	0.3	0.1	0.2	0.0	0.6	0.1	76.0	0.1	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.4	0.4	0.1	0.3	52.3	1.2	0.1	5.3	0.3	0.1	0.0	0.2	0.4	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	2.1	0.2	0.2	0.3	0.2	0.4	0.2	0.1	0.2	0.1	0.3	0.2	0.1	1.1	2.0	0.2	0.2	0.1	0.1	0.5	0.5	0.6	0.7	0.6	0.1	0.2	0.1	0.4	0.0	0.5	1.0	0.1	3.2	9.9	0.0	0.1	0.0	0.9	3.0	0.0	0.4	14.1	7.9	0.4	0.0	4.4	53.3	0.0	0.0	0.2	0.0	144.8	0.0	0.0	0.9	0.4	0.5	0.0	0.0	0.6	0.2	0.1	0.2	0.0	1.3	1.3	0.1	0.0	0.0	0.1	1.7	0.4	0.0	2.0	0.0	0.8	0.0	0.0	0.1	26.6	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.9	3.5	1.3	0.0	0.5	0.2	0.0	0.2	0.0	0.4	0.0	0.6	0.0	0.2	0.6
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"kidney: 175.8"	"Cell type enriched"	"Detected in some"	15	"Distal tubular cells: 712.1"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 95.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058096	Enhanced		Approved	"Focal adhesion sites"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.1	0.6	0.8	0.9	3.4	0.3	0.8	0.9	0.1	0.9	0.1	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.7	0.7	175.8	0.2	0.7	0.2	1.3	0.8	0.0	0.3	0.1	0.0	6.0	1.2	0.1	0.1	0.1	1.9	0.0	0.0	0.4	0.2	0.4	1.0	0.1	0.4	0.3	1.2	0.1	0.2	0.0	0.2	0.2	0.0	1.6	2.3	0.1	0.0	0.1	0.0	0.0	1.1	2.2	0.0	0.1	0.0	95.9	0.1	0.0	0.1	0.7	4.9	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	7.0	8.9	0.0	3.0	5.0	1.4	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	4.7	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.9	0.8	0.9	0.7	0.7	1.3	0.8	1.2	1.0	1.2	1.6	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	12.9	0.0	44.7	0.0	0.1	712.1	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.8	0.0	2.5	3.2	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.2	0.0	0.0	0.8	1.1	0.1	0.3	4.2	1.8	2.8	1.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	19.4	0.1	0.0	0.0	0.1
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911316-44937010	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 51.2;kidney: 74.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 27.6;Distal enterocytes: 21.1;Distal tubular cells: 33.2;Late spermatids: 15.9;Paneth cells: 8.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	123	"RPMI-8226: 44.0;U-937: 26.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039894, HPA062907"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favorable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.7	0.5	0.0	51.2	6.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	1.5	74.4	0.1	0.0	0.0	1.7	1.5	0.0	9.1	0.5	0.2	0.0	1.4	0.0	7.7	0.2	2.4	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.2	2.8	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	3.5	1.5	1.7	1.5	1.4	0.2	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	0.0	21.1	33.2	0.1	5.5	0.7	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118951885	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 29.9;thyroid gland: 101.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 134.3;Collecting duct cells: 73.5;Ductal cells: 32.7;Proximal tubular cells: 117.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	40	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	40	"dendritic cells: 3.9"	"Group enriched"	"Detected in many"	4	"BJ: 546.7;BJ hTERT+: 2013.0"	"Low region specificity"	"Detected in all"							CAB034939	Approved				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (3.88e-4)"	3.3	3.3	2.6	5.3	3.1	0.0	2.6	2.6	4.1	1.1	3.5	2.5	1.4	10.2	0.5	0.4	1.4	5.8	9.4	2.5	2.7	29.9	14.2	9.4	7.0	5.0	3.0	0.3	1.8	0.5	1.8	4.9	3.3	1.6	3.5	0.3	1.4	1.0	0.4	0.5	2.2	2.6	3.1	2.6	1.2	0.1	3.0	1.3	101.8	0.8	2.9	10.7	0.3	3.8	0.0	0.9	8.6	0.0	27.5	5.3	0.0	546.7	2013.0	25.9	7.2	6.3	1.1	0.0	143.7	302.4	0.0	5.6	0.0	0.0	13.2	0.1	0.0	0.0	23.1	0.0	3.6	0.0	0.0	2.9	0.0	26.7	0.0	10.9	0.3	0.0	0.0	0.0	73.8	13.6	0.0	0.1	0.9	2.6	3.3	0.0	1.0	0.0	23.6	0.0	1.3	0.0	4.8	0.2	0.0	0.3	0.0	0.1	1.2	16.9	8.6	10.1	1.2	0.6	0.0	0.1	2.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	2.6	3.1	2.6	4.1	2.5	2.7	5.0	3.0	3.3	3.1	3.0	3.8	2.1	3.2	0.0	7.2	0.7	2.2	0.6	1.4	0.0	0.2	134.3	4.1	3.8	22.8	1.0	73.5	0.0	0.0	0.2	2.5	9.8	32.7	0.1	0.6	1.4	7.4	9.5	0.0	0.8	1.3	0.2	9.4	0.0	1.7	0.0	0.0	4.6	2.0	0.5	0.0	0.3	9.2	2.0	0.3	3.9	0.3	0.3	1.1	0.0	0.0	8.3	1.2	0.0	3.0	0.3	9.2	0.8	0.0	0.0	6.8	1.1	117.3	0.1	0.1	0.0	0.4	4.3	0.1	0.3	0.0	1.1	0.0	0.4	0.0	2.8	0.3
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155077	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 76.4;liver: 68.8;thyroid gland: 76.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 144.6;Proximal tubular cells: 307.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA		39000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.8	16.4	9.2	12.9	12.2	10.0	10.0	10.5	12.2	7.7	9.6	34.5	34.5	6.9	17.5	10.3	7.0	10.4	12.2	10.4	9.7	76.4	68.8	9.3	10.0	9.8	9.7	4.5	11.6	18.0	7.5	5.6	9.9	10.8	35.1	13.1	12.1	6.6	13.2	10.3	28.9	10.5	9.3	11.0	12.2	6.7	9.9	9.2	76.9	11.7	10.1	15.9	7.4	9.8	24.5	7.3	7.9	19.9	12.9	24.9	19.5	27.7	30.8	23.3	36.2	17.1	5.9	3.1	20.3	37.0	18.0	12.0	11.3	20.0	38.6	16.2	16.2	20.0	12.0	25.2	14.1	9.3	17.4	14.5	21.2	26.0	16.5	15.1	32.9	13.5	40.6	5.6	17.2	11.1	9.6	12.7	13.2	33.9	20.7	11.9	19.6	13.8	27.2	24.8	13.0	10.0	18.3	31.9	36.9	19.9	22.9	9.0	14.0	53.1	10.3	28.0	40.0	8.1	38.9	8.0	19.0	12.3	54.5	8.7	22.1	7.2	11.6	46.7	14.9	2.7	9.2	11.1	32.3	2.6	8.1	11.2	2.2	10.4	40.7	6.5	16.2	17.2	9.2	12.2	10.5	12.2	10.4	9.7	9.8	9.7	9.9	9.3	9.9	9.8	13.9	16.0	15.5	4.6	12.6	42.7	41.3	23.0	13.6	15.3	20.9	15.0	22.9	25.8	15.8	35.0	22.9	20.7	20.5	144.6	115.4	52.7	1.2	38.4	15.3	14.3	24.0	18.1	18.7	37.4	25.3	11.3	14.8	39.4	22.9	4.3	17.5	86.5	44.9	6.7	13.2	34.8	22.4	48.5	60.9	2.8	4.1	41.1	24.9	9.4	32.6	33.5	29.9	11.1	10.2	76.8	106.6	10.1	9.7	38.8	80.8	307.6	12.2	19.5	0.0	9.3	13.9	0.7	7.7	19.5	34.5	17.5	21.1	9.5	50.7	78.9
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.9"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 74.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060514	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	2.8	3.8	0.4	1.7	0.4	2.0	3.2	0.2	0.4	2.2	0.8	2.1	0.5	3.2	4.8	4.3	3.2	2.3	0.9	0.4	0.6	20.9	0.8	2.1	0.6	0.9	0.6	4.3	1.3	1.3	0.9	5.4	0.6	2.5	1.7	0.2	10.5	3.6	0.8	1.0	1.1	5.2	0.6	3.7	1.0	9.3	0.8	1.3	3.8	0.6	1.3	2.6	2.8	0.7	0.7	16.2	1.1	0.0	2.0	2.9	18.7	4.4	3.3	4.3	4.2	0.4	3.6	0.0	2.5	4.5	12.1	2.9	7.5	6.7	6.1	0.6	5.0	2.0	1.6	0.1	0.7	6.6	8.7	5.1	6.4	6.2	4.3	6.4	3.8	0.1	8.0	0.2	1.8	0.2	0.0	0.9	22.2	2.6	5.7	7.7	0.0	0.1	0.9	6.6	0.1	0.2	0.0	8.4	0.8	36.7	3.2	1.1	19.2	4.0	21.3	0.1	4.7	0.2	0.1	0.0	3.7	0.0	3.5	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.1	0.4	0.4	0.2	0.4	0.4	0.6	0.9	0.6	0.6	0.6	0.8	0.7	1.2	0.0	4.8	0.0	0.1	0.5	0.6	0.5	1.8	0.0	3.1	1.8	0.4	0.0	0.8	1.8	0.0	12.5	0.0	0.2	3.9	1.2	1.2	0.7	1.7	1.5	0.0	2.1	0.0	0.2	15.5	2.1	0.0	1.0	0.0	4.1	0.0	0.5	3.1	0.0	0.0	0.3	2.0	3.5	0.3	0.8	0.9	1.1	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.4	0.3	74.4	1.1	0.0	0.0	0.5	0.7	10.8	3.3	1.8	0.4	5.7	0.4	4.1	0.2	0.3
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933746	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.1;kidney: 4.4"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA063175	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	4.4	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.1	0.5	0.5	0.6	0.6	0.6	0.5	0.7	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144707-129169699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	3.2	4.4	8.2	9.1	8.0	3.9	3.0	6.9	7.2	2.0	5.4	6.4	3.6	1.5	10.9	3.9	2.1	3.1	8.6	6.8	11.9	64.8	28.2	5.0	16.3	10.8	13.4	2.4	21.2	11.1	19.9	3.8	12.2	7.4	3.4	1.3	18.8	7.0	13.0	7.6	12.3	2.2	11.0	16.9	6.2	11.4	14.1	6.7	8.4	4.4	14.4	7.9	3.8	10.0	1.5	4.3	1.0	23.2	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.7	2.1	18.4	1.8	0.4	12.9	1.7	12.3	4.0	0.5	18.7	14.0	38.2	0.8	8.2	0.9	5.5	0.8	0.9	3.8	0.2	1.2	0.0	0.5	9.4	0.4	2.6	0.0	4.6	11.5	0.1	8.5	0.8	4.5	3.9	0.5	0.4	1.4	5.0	5.8	6.9	2.3	0.7	13.6	5.3	4.7	2.4	0.1	0.1	1.8	1.9	0.6	48.8	5.8	8.1	0.4	18.4	2.7	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.6	1.3	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.4	8.2	8.0	6.9	7.2	6.8	11.9	10.8	13.4	12.2	11.0	14.1	10.0	0.9	0.0	0.6	3.3	27.8	2.5	0.7	0.8	0.6	3.5	10.5	9.8	6.2	0.0	0.2	5.5	4.2	0.1	7.6	0.7	13.7	2.2	2.5	2.7	0.5	1.4	3.5	5.2	3.6	8.7	0.2	6.7	0.0	1.6	0.0	1.4	0.4	15.8	8.4	0.0	1.7	0.6	0.0	23.6	84.0	4.2	2.8	32.0	1.8	3.7	44.8	8.4	0.0	3.5	0.1	2.4	1.1	32.7	1.3	1.9	1.0	59.2	2.2	1.7	0.0	11.3	1.0	0.8	4.1	0.4	3.0	0.1	2.2	8.4	0.4	1.3
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333051-20356301	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	693	"kidney: 2277.8"	"Group enriched"	"Detected in some"	146	"Collecting duct cells: 248.3;Distal tubular cells: 950.9"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	NA	NA	55000000	66000000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2277.8	0.8	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	248.3	0.0	0.0	0.0	0.0	950.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093308-106194301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 323.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		24000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	16.3	17.6	20.4	25.0	18.7	40.4	15.3	30.4	29.3	19.6	20.6	21.7	15.5	24.3	33.1	24.1	29.2	19.6	29.3	25.9	20.3	60.0	15.7	46.0	27.9	15.0	23.0	24.4	15.8	37.3	16.3	54.6	19.3	23.2	24.0	10.5	14.6	25.9	31.9	14.0	14.3	21.4	18.5	25.0	26.2	31.9	31.0	22.2	30.0	28.6	30.4	29.5	18.3	23.7	66.5	48.8	50.9	39.0	88.4	65.2	110.2	71.4	66.9	49.9	61.5	96.9	110.4	12.0	87.0	74.1	111.2	32.8	22.6	58.2	54.5	64.2	40.5	37.0	21.4	110.6	34.9	30.5	39.0	42.8	63.8	50.3	33.5	57.5	52.5	22.8	22.1	28.5	103.6	46.8	34.3	66.8	60.1	64.2	65.4	70.3	38.6	34.3	323.0	60.9	16.7	19.0	51.5	45.7	44.3	67.7	17.0	93.7	48.0	55.1	58.5	45.4	45.4	34.4	51.4	17.9	55.0	70.1	103.8	11.3	24.7	28.5	23.1	20.8	25.7	15.3	64.3	41.4	19.1	30.5	68.8	49.1	6.1	37.5	16.0	13.5	130.4	44.3	20.4	18.7	30.4	29.3	25.9	20.3	15.0	23.0	19.3	18.5	31.0	23.7	15.4	89.8	88.8	18.9	22.1	16.8	26.8	117.3	14.8	9.9	11.6	10.5	18.7	17.2	61.6	86.5	4.2	71.2	17.7	20.5	50.9	46.9	80.2	41.5	19.3	25.5	6.6	12.0	49.8	25.0	74.1	34.2	16.8	40.6	29.8	13.1	10.8	15.0	33.2	8.4	37.5	15.6	34.6	20.1	12.5	18.5	15.2	33.9	14.2	33.7	56.2	10.8	18.6	24.1	11.7	30.4	16.2	12.8	10.2	35.7	9.6	17.5	38.8	7.9	19.7	19.0	35.1	17.0	81.6	22.6	13.2	24.6	33.7	51.6	18.0	19.8
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571161-107965180	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 83.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.5;Basal squamous epithelial cells: 163.9;Syncytiotrophoblasts: 246.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 28.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 52.8;RH-30: 61.7;RPTEC TERT1: 86.2;T-47d: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002012	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	3.1	1.7	4.1	10.8	4.4	19.3	34.1	5.9	7.1	6.9	15.4	41.2	9.3	4.5	4.0	34.9	3.7	2.6	1.5	2.2	3.5	83.9	2.4	4.1	10.4	4.2	7.1	0.5	17.4	1.5	1.4	34.3	4.3	4.3	50.9	7.4	7.3	11.5	0.9	49.0	15.2	3.6	1.5	11.2	7.2	5.1	9.2	8.8	9.9	1.2	16.6	12.7	16.1	3.0	0.0	12.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.5	16.9	0.6	0.2	0.0	0.0	4.5	17.4	5.8	10.2	0.0	16.3	6.5	0.0	36.6	0.0	1.1	0.0	0.0	8.5	0.0	13.3	0.2	5.7	34.2	4.2	5.0	0.2	1.2	52.8	61.7	0.4	86.2	29.5	2.8	2.6	16.4	7.2	0.3	1.5	107.2	29.7	1.2	0.6	0.0	0.1	0.6	8.0	3.3	0.5	13.0	26.1	1.2	4.7	0.6	0.7	2.1	0.5	1.1	1.7	0.6	1.0	2.6	2.0	0.1	1.4	1.7	2.1	0.2	1.6	2.6	0.7	4.1	4.4	5.9	7.1	2.2	3.5	4.2	7.1	4.3	1.5	9.2	3.0	7.3	0.0	1.7	263.5	37.0	11.7	10.3	13.3	163.9	15.0	48.5	21.5	2.4	5.7	17.8	51.5	2.1	108.8	91.0	87.3	117.4	7.9	55.7	11.2	1.1	9.6	21.1	11.3	38.2	0.0	25.6	3.1	2.6	5.8	7.6	0.0	10.0	0.2	23.6	0.0	77.7	29.1	4.1	15.7	10.6	40.1	0.3	22.1	3.6	23.4	13.3	3.8	69.0	36.2	2.4	0.1	47.2	0.4	32.7	2.1	25.2	79.6	12.3	28.4	6.6	51.1	1.6	1.3	3.0	108.7	21.0	246.0	30.3	8.8	45.9	4.7
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.2;kidney: 27.0;lung: 29.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 266.0;Alveolar cells type 2: 175.9;Distal tubular cells: 46.9;Early spermatids: 64.5;Late spermatids: 84.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.3;renal cancer: 4.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 92.0;hTERT-RPE1: 96.7;HUVEC TERT2: 245.1;TIME: 147.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.4	20.2	0.2	0.1	0.3	2.2	1.9	0.8	0.1	3.1	11.1	0.8	0.7	0.3	17.6	0.0	5.4	0.9	0.2	0.7	0.4	27.0	0.5	29.4	0.0	2.7	1.1	0.2	13.1	2.1	17.1	1.3	2.9	1.4	0.8	0.4	2.5	2.8	0.1	1.5	0.1	0.2	0.4	4.0	0.9	2.9	0.4	0.1	2.0	0.1	0.0	0.4	0.3	0.2	7.3	0.8	16.0	0.0	9.2	33.8	0.0	41.9	92.0	12.2	17.7	1.1	6.4	0.0	16.0	45.3	1.9	0.3	0.5	1.0	67.2	0.2	0.0	7.3	0.8	0.0	2.9	0.0	0.1	9.9	0.7	51.9	10.3	96.7	245.1	0.0	2.5	0.0	33.4	0.9	0.0	0.0	6.6	1.9	6.2	0.0	1.2	0.0	6.1	3.6	0.6	0.0	1.3	1.9	17.0	0.2	70.7	0.1	147.2	48.0	1.6	16.8	58.0	0.0	0.0	0.0	38.6	0.0	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.2	0.3	0.8	0.1	0.7	0.4	2.7	1.1	2.9	0.4	0.4	0.2	0.1	266.0	175.9	1.6	0.5	1.8	0.2	0.0	0.0	0.2	4.5	3.7	0.5	22.8	14.3	31.3	2.1	1.8	0.2	1.2	46.9	6.9	64.5	11.1	0.5	0.9	0.0	0.0	2.8	10.1	0.1	0.9	0.0	4.4	0.0	0.8	0.0	0.0	0.2	0.0	3.3	0.4	0.0	0.0	0.3	84.7	1.5	2.3	28.4	0.0	0.7	1.5	0.0	0.0	0.9	1.8	3.2	0.4	0.0	0.3	0.0	28.7	8.1	0.5	0.0	0.1	1.3	0.3	0.9	0.0	0.4	0.0	0.6	0.9	0.8	0.2
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 105.7;liver: 33.1;thyroid gland: 57.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 12.8;Collecting duct cells: 22.0;Glandular and luminal cells: 13.2;Hepatocytes: 44.3;Proximal tubular cells: 93.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.9;OE19: 18.3;RPMI-8226: 17.5;RPTEC TERT1: 10.1;SuSa: 15.2;U-266/70: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.1	7.2	0.0	0.6	2.6	1.4	0.5	0.4	2.6	3.9	0.1	0.0	0.1	105.7	33.1	0.8	0.1	0.1	0.4	0.2	3.5	1.8	0.3	0.1	0.1	0.1	0.8	0.7	18.4	0.6	0.0	2.0	0.9	0.0	0.0	0.1	1.1	0.5	0.1	0.0	57.9	0.0	0.0	1.7	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	3.2	0.1	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	18.3	0.1	0.0	0.1	17.5	10.1	3.5	1.9	0.0	0.0	0.1	0.0	15.2	2.4	0.0	0.1	0.3	0.5	0.0	0.1	7.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	6.4	3.6	0.0	0.5	0.1	1.1	0.0	0.6	0.5	0.0	0.1	0.6	12.8	0.0	22.0	0.0	0.6	0.0	0.2	9.8	3.2	1.2	4.9	1.0	0.1	0.0	0.0	0.4	0.5	2.1	0.2	0.0	13.2	0.0	0.0	0.0	44.3	0.1	3.3	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	93.2	0.1	0.1	0.0	0.0	0.1	1.0	1.6	0.9	0.4	0.1	0.7	0.0	0.3	6.4
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235798-159286703	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	6.7	10.9	9.1	4.6	10.2	10.6	12.0	10.7	12.0	7.8	11.7	6.7	4.9	8.2	17.5	7.5	9.8	5.9	10.1	8.9	9.3	23.5	6.9	9.0	7.9	9.7	9.3	13.5	10.6	13.9	9.1	9.7	9.8	9.1	7.6	11.1	10.4	6.8	6.7	6.9	5.8	6.6	8.9	8.6	7.4	6.7	9.4	7.0	17.3	6.5	5.8	6.2	6.3	11.7	8.4	6.3	5.4	9.0	10.1	11.4	19.1	6.7	13.0	11.4	20.4	13.7	13.6	11.7	6.9	9.9	20.3	5.2	15.9	5.9	16.1	4.5	13.4	12.1	6.8	14.0	12.2	10.2	15.6	6.7	21.5	14.4	12.0	22.2	9.8	14.9	16.0	8.5	11.1	8.8	7.3	18.5	7.5	14.3	13.6	11.3	8.3	6.2	13.6	12.2	10.3	6.8	7.0	8.6	15.9	26.0	6.7	17.3	4.1	8.2	6.2	11.8	6.5	4.2	7.7	10.7	14.4	12.6	5.3	3.9	11.1	3.5	14.3	8.6	10.9	11.8	5.6	9.1	12.2	9.9	6.7	8.0	0.8	20.8	7.9	11.6	3.3	7.8	9.1	10.2	10.7	12.0	8.9	9.3	9.7	9.3	9.8	8.9	9.4	11.7	8.2	12.8	6.8	28.4	10.7	5.4	8.7	13.0	11.4	6.9	9.3	8.0	11.3	10.0	11.3	20.2	2.1	25.4	11.2	5.1	35.2	9.5	4.5	13.7	6.9	7.0	5.4	6.7	42.4	3.6	9.2	9.9	10.2	16.1	12.0	13.2	6.4	2.0	17.3	5.0	52.0	4.5	12.2	14.8	4.8	2.9	12.8	10.2	5.4	29.0	9.2	6.6	14.4	31.7	34.6	4.0	7.0	11.3	3.8	6.8	6.9	23.7	15.0	9.7	0.0	12.0	7.8	10.1	22.5	11.1	6.3	23.0	9.1	12.7	7.1	7.3
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
ZNF804B	FLJ32110	ENSG00000182348	"Zinc finger protein 804B"	A4D1E1	7	88759700-89338528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;thyroid gland: 3.9"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 608.6;Inhibitory neurons: 266.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026702	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026702: AB_1859459"					"unprognostic (1.10e-1)"							"unprognostic (5.00e-2)"			"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"		0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.0	0.0	0.0	0.2	0.9	0.1	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.5	0.2	0.7	0.2	0.9	0.4	0.0	0.8	0.5	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	608.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	266.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	1.8	29.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	1.2	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0